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Abbreviations 
AC  Audiological Centre 
ANOVA Analysis of Variance 
BEPTA  Better Ear Pure Tone Average 
CBA  Cost-Benefit Analysis 
CEAC  Cost-Effectiveness Acceptability Curve 
CI  Confidence Interval 
CEA  Cost-Effectiveness Analysis 
CEN  Comité Européen de Normalisation 
CMA  Cost-Minimization Analysis 
CUA  Cost-Utility Analysis 
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DCE  Discrete Choice Experiment 
ENT  Ear, Nose and Throat 
EO  Expert Opinion 
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EVPI   Expected Value of Perfect Information 
GP   General Practitioner 
HA  Hearing Aid 
HC  Hospital Costs 
HRQOL Health Related Quality of Life 
HTA  Health Technology Assessment 
HUI2  Health Utilities Index Mark II 
HUI3  Health Utilities Index Mark III 
ICC  Intra-Class Correlation Coefficient  
ICER  Incremental cost-effectiveness ratio 
IR  Interquartile Range 
kHz  Kilohertz 
MTA  Medical Technology Assessment 
NA  Not Applicable 
NC  Not Calculated 
OS  Observational Study 
PC  Personal Communication 
QALY  Quality Adjusted Life Year 
SD  Standard Deviation 
SE  Standard Error 
SG  Standard Gamble 
StAr  Stichting Audicienregister 
TAIL  Technology Assessment Iterative Loop 
TTO  Time Trade-Off 
UK  United Kingdom 
US  United States 
VAS  Visual Analogue Scale 
WTA  Willingness to Accept 
WTP  Willingness to Pay 
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This thesis focuses on the evaluation of organizational innovation in health care. As a case, 
shared care in hearing aid provision is evaluated. The increasing burden of chronic 
diseases on today’s health care system has resulted in an increasing importance of 
redesigning health care to patient-centered care, and of attuning the tasks of health care 
professionals. With regard to hearing aid provision, the current growth of the ageing 
population causes a proportional growth of the population with hearing impairment. This 
raises the burden of disease and the medical consumption for hearing impairment and, as a 
consequence, increases the costs of hearing rehabilitation. Increasing attention is therefore 
paid to attuning the tasks of all professionals involved in the care for hearing-impaired 
persons. This has resulted in shared care initiatives in hearing aid provision. 
Health technology assessment aims to examine medical, social, ethical and economic 
implications of technologies in health care (Banta, 1982; Platform HTA, 2001). In this 
context technologies can be anything, from pharmaceuticals to organizational change. 
However, health technology assessment is mostly applied to medical interventions such as 
pharmaceuticals. Organizational innovation has rarely been the focus of health technology 
assessment. 
The aim of the thesis is to use health technology assessment to evaluate whether an 
organizational innovation, shared care in hearing aid provision, benefits the care for 
hearing-impaired persons. This general introduction first touches upon the concepts of 
health and health care, to illustrate the context of the thesis. Next, the concept of 
organizational innovation is explained. Subsequently, it is described how health 
technology assessment can be used to evaluate organizational innovations. Furthermore, 
the case of shared care in hearing aid provision is sketched. The final part of this chapter 
states the general objective and research questions, and provides an outline of the thesis. 
 
 
Health and health care 
Health is defined by the World Health Organization as ‘a state of complete physical, 
mental and social well-being and not merely the absence of disease or infirmity’ (World 
Health Organization, 1946). Since its publication in 1946 this definition has been criticized 
and, to this very day, ongoing debates about the scope of health proceed. In these debates, 
consensus has emerged that health is a separate concept from well-being, that health is 
comprised of states or conditions of functioning of the human body and mind, and that 
health is an attribute of an individual person (Salomon et al., 2003). 
The historical evolution of health can be described in health transition stages (Martens, 
2002). Historically, health has shifted from an age of pestilence and famine, with high 
levels of mortality and fertility, to an age of receding pandemics. The age of receding 
pandemics involved a reduction of the prevalence of infectious diseases and a fall in 
mortality rates, high fertility rates and the introduction of modern health care and health 
technologies. At present we have reached the age of chronic diseases, which is 
characterized by improved health care, low levels of mortality and fertility, and relatively 
high levels of morbidity, especially for the elderly. The low levels of mortality and fertility 
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lead to the ageing of the population. Hence, there is an increasing demand for health care 
related to the conditions of older people, where the emphasis is often more on care instead 
of cure. 
The transition to an age of chronic illness has implications for the organization of health 
care (Wagner et al., 1996). More than ever patients need to be placed centre stage in the 
organization of health care. This is however at odds with the fact that health care 
professionals have grown more and more specialized, resulting in increasingly more 
professionals involved in the care for one condition. In such a fragmented health care 
system, patients are often transferred to different professionals or institutions, without 
complete information regarding the patient’s condition, medical history and services 
provided in other settings. Especially in the care for older people, who often suffer from 
multi-morbidity, it is therefore important that health care professionals work together, and 
that tasks of different professionals are attuned, to allow for modernization of health care 
while maintaining or improving its quality. 
 
 
Organizational innovation in health care 
Organizational innovation in health care is a very diffuse concept, as it encompasses any 
change in the delivery of care. Due to the increasing attention to patient-centered care 
policy makers, health care providers and health insurance companies are continuously 
forced to seek new ways to provide the best possible care for patients within a given 
budget. Hence, several health delivery models have been developed to facilitate 
interdisciplinary care that involves the full range of health providers for a disease. Related 
to interdisciplinary care numerous terms such as shared care, integrated care, disease 
management or transmural care are used interchangeably (Grone & Garcia-Barbero, 2001; 
Kodner & Spreeuwenberg, 2002). In this thesis we define shared care as care that, geared 
to the needs of the patient, is provided on the basis of agreement regarding cooperation 
and co-ordination between health care providers, with shared responsibility and explicit 
sub-responsibilities (Nationale Raad voor de Volksgezondheid & College voor Ziekenhuis-
voorzieningen, 1995). The goals of shared care are to achieve effectiveness, patient-
orientation, continuity, availability, efficiency and integration of care (Spreeuwen-berg & 
Pop, 2000). Goals like efficiency of care set the boundaries of shared care. That is, if shared 
care does not lead to improvement of care within existing budgets, or a reduction of costs 
while maintaining quality, it is not worthwhile to implement shared care models. 
In shared care models often some form of substitution of tasks is applied. Tasks can be 
substituted either horizontally or vertically (Nancarrow & Borthwick, 2005; Van Wijmen et 
al., 2000). Horizontal substitution represents the transfer of care among equally qualified 
professionals, while vertical substitution is the transition of care from a higher to a lower 
qualified professional, for example from a physician to a specialized nurse. Vertical 
substitution occurs in several health care sectors (Adams, 2004; Nancarrow & Borthwick, 
2005; Norris, 2001; Stevens et al., 2007). 
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In the design of organizational innovations one should keep in mind that innovations 
should fit the needs of the involved parties, including the patients. Innovations also should 
be supported by the professionals and the professional bodies to which these professionals 
belong. It is also important that innovations are manageable, and that they include 
sufficient education, training and support. Finally, organizational innovations should fit the 
current working standards. 
By assessing in an early stage, for different subgroups, which barriers might impede 
implementation of an innovation, and which facilitators might enhance implementation, 
patients and professionals can be involved in the process of designing the innovation. This 
may advance that the above mentioned preconditions, such as the fitting of needs of 
involved parties and having the support of the professionals, are met. It may improve 
expectations towards the innovation and hence facilitate the professionals’ and patients’ 
will to change their behavior (Grol, 1997). 
Generally, implementing organizational innovation in health care is not easy, especially 
when innovations require better collaboration among disciplines, changes in patients’ 
behavior or changes in the organization of care (Grol et al., 2007). Determining potential 
barriers and facilitators is an important step in an implementation process (Grol, 1997; Grol 
& Grimshaw, 2003; Robertson et al., 1996; Van Bokhoven et al., 2004; Wensing et al., 
1999). Ideally, possible barriers and facilitators should be examined before strategies to 
implement the change are developed (Bosch et al., 2007; Grol, 1997). That is, insight into 
barriers and facilitators will help to design the most effective implementation strategy. 
Therefore, potential barriers and facilitators should be repeatedly measured in an 
innovation process, starting at a very early stage and possibly continuing when the 
innovation is implemented. Various theories and frameworks for change exist that mention 
a multitude of factors that may affect successful implementation of change (Grol & 
Wensing, 2004; Robertson et al., 1996). One of these frameworks is that of Cabana et al. 
(1999), which focuses on the individual professional. In this framework barriers are 
classified into three main categories: barriers related to knowledge (familiarity, awareness), 
barriers that affect attitudes (agreement, self-efficacy, motivation, outcome expectancy) and 
external barriers (patient factors, guideline factors, environmental factors). 
Ideally, innovations should not diffuse widely before there is sufficient evidence on their 
safety and efficiency (Battista, 1989). However, in the real world there is often little 
evidence available. In general organizational innovations can be designed in different 
ways, which makes it difficult to perform large trials to collect evidence. Moreover, 
organizational innovation is often a social process, which makes classical randomized 
experiments less appropriate (Winkens & Klazinga, 2000). Evaluation of an organizational 
innovation generally requires implementation of the innovation, and when agreements 
among professionals are made in a trial, it may well be difficult to undo these changes. 
Also, collecting data is expensive, and often not enough budget is available to remove all 
of the existing uncertainty (Hadley, 2000). The latter is connected with the fact that there is 
not enough knowledge on which additional evidence would be most valuable. Such 
knowledge would be helpful to allocate research budgets in the most efficient way. 
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Health technology assessment 
Health Technology Assessment (HTA) seeks to inform health policy makers by examining 
medical, social, ethical and economic implications of technologies in health care (Banta, 
1982; Platform HTA, 2001). HTA can be seen as a bridge between the scientific evidence 
and policy decision-making (Battista & Hodge, 1999). The term HTA is increasingly used 
instead of medical technology assessment to emphasize that technology assessment is not 
confined to new drugs or diagnostic or screening activities in health care, but includes the 
organization of care and its infrastructure (Platform HTA, 2001). 
Characteristics of HTA are that it is interdisciplinary and scientific, that it is society and 
future oriented, that different alternatives are compared and that it is aimed at decision-
making (Habbema, 1989). Aspects of research within different disciplines (i.e. medicine, 
epidemiology, law, ethics, economics and sociology) are synthesized to inform policy 
makers on whether or not to implement innovations in health care. Health technology 
assessment is an iterative process, and the assessment needs to continue throughout the life 
of a technology (Tugwell et al., 1986). This iterative process is illustrated by the 
Technology Assessment Iterative Loop (TAIL), which is represented in Figure 1.1. 
Figure 1.1  The Technology Assessment Iterative Loop (TAIL) (Tugwell et al., 1986) 
 
 
First, information on the burden of illness is collected to identify the technologies with the 
greatest potential for reducing the burden of illness. Next, the efficacy of the technology is 
assessed. Subsequently it is important to identify those persons who will benefit from the 
efficacious technology, and to examine how well the technology will work in the field. 
Hereafter the trade-off between the costs and consequences of the technology is examined. 
The sixth step integrates feasibility, estimated community effectiveness and efficiency to 
  General introduction 
17 
make recommendations for implementation of the technology. The TAIL emphasizes that 
the assessment of a health technology is not finished when the technology is implemented, 
but that the technology should be continuously monitored and reassessed. By assessing 
whether the technology has reduced the burden of illness one will eventually arrive at the 
first step in the cycle, whereupon the cycle will be repeated. 
HTA is most often applied to evaluate curative innovations, for example in a 
pharmaceutical context. In the Netherlands an extensive guideline exists on pharmaco-
economic research, as conclusive evidence needs to be generated before a new drug can 
be introduced to the market (College voor Zorgverzekeringen, 2006). This conclusive 
evidence is not required for organizational innovations. Hence, organizational innovations 
or technologies related to ‘care’ have rarely been the focus of health technology assessment 
(Groot & Maassen van den Brink, 2006). It is questionable whether HTA in its current form 
is appropriate for evaluating organizational innovation. As mentioned earlier, it can be 
difficult to collect conclusive evidence on efficacy or community effectiveness of an 
organizational innovation, and organizational innovation requires implementation before it 
can be evaluated  (Winkens & Klazinga, 2000). This indicates that the TAIL may not be 
directly applicable to organizational innovations such as shared care. 
A frequently used tool for HTA is the economic evaluation, in which two or more 
alternatives are compared in terms of both costs and consequences (Drummond et al., 
2005). Recently, there has been increasing attention to patient-based health technology 
assessment (Bridges & Jones, 2007). The next paragraphs describe these topics and discuss 
potential methodological issues when evaluating organizational innovations. 
 
Economic evaluation 
Economic evaluation is the ‘comparative analysis of alternative courses of action in terms 
of both their costs and consequences’ (Drummond et al., 2005). Hence, the basic tasks of 
an economic evaluation are to identify, measure, value and compare the costs and 
consequences of the alternatives that are being considered. There are four types of 
economic evaluation, which differ in the way the consequences of an intervention are 
expressed (Drummond et al., 2005). These four types are the cost-minimization analysis, 
the cost-effectiveness analysis, the cost-utility analysis and the cost-benefit analysis. In a 
cost-minimization analysis (CMA) only the costs of the alternatives are compared. A CMA 
is performed when the alternatives are equally effective, but its use has been criticized as it 
is rarely an appropriate method of analysis (Briggs & O'Brien, 2001). In a cost-effectiveness 
analysis (CEA) the incremental effectiveness of an intervention is quantified and compared 
with its incremental costs. Effectiveness can be measured using various measures of 
outcome, such as years of life saved, episode-free days or percentage cholesterol reduction. 
A cost-utility analysis (CUA) is quite similar to a CEA, but in a CUA the measure of 
effectiveness is the quality adjusted life year (QALY). QALYs are a combined measure of 
life expectancy and quality of life. Quality of life is expressed in a utility score, ranging 
from 0 to 1, where 0 represents death and 1 represents perfect health. Use of such a 
generic outcome measure allows for comparisons across different interventions and health 
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care sectors. Utility scores can be measured either directly or indirectly. The three most 
widely used direct measures are the visual analogue scale (VAS), the standard gamble and 
the time trade-off (Drummond et al., 2005). However, only the standard gamble is based 
directly in the fundamental axioms of utility theory. As directly measuring utility is rather 
time-consuming and complex, indirect measures are increasingly used to elicit utility 
scores. Indirect measures make use of pre-scored multi-attribute health status classification 
systems. Examples of such systems are the EuroQol 5D (The EuroQol Group, 1990), the 
Health Utilities Index (Feeny et al., 1995) and the Short Form 6D (Brazier et al., 2002). 
A final type of economic evaluation is the cost-benefit analysis (CBA), where  both costs 
and consequences are expressed in monetary terms (Drummond et al., 2005). Expressing 
both costs and consequences in monetary terms facilitates the calculation of an 
intervention’s net benefit (benefits minus costs). This gives the decision-maker a single 
measure, where a positive net benefit (indicating higher benefits than costs) would indicate 
the intervention to be worthwhile. CBA is not frequently used though, as assigning 
monetary values to health outcomes is difficult and controversial (Anell & Norinder, 2000). 
In health care, monetary valuations often are assessed through stated preferences 
(Drummond et al., 2005). Stated preferences can be elicited with contingent valuation. The 
contingent valuation method involves directly asking individuals what they would 
maximally be willing to pay for a good or intervention, or how much compensation they 
would minimally require for loosing it, in a hypothetical market. The resulting willingness 
to pay (WTP) or willingness to accept (WTA) respectively is a measure of how much the 
respondent values the good or intervention.  
An alternative method to measure stated preferences is conjoint analysis. Conjoint analysis 
is developed in mathematical psychology and marketing, and is increasingly used in health 
care (Louviere et al., 2000; Ryan & Farrar, 2000; Ryan & Gerard, 2003). It is grounded in 
random utility theory and based on the principle that complex decisions are not based on a 
single criterion or factor, but on several factors ‘considered jointly’. Any intervention can 
be described by its attributes, and the extent to which an individual values an intervention 
depends on the levels of these attributes (Louviere et al., 2000; Ryan & Farrar, 2000). In 
conjoint analysis, respondents are presented with various alternative descriptions of an 
intervention, each of which represents the attributes at different levels. Respondents are 
asked to rank the various alternatives (ranking), to rate them (rating) or to choose their most 
preferred (Louviere et al., 2000). The latter is referred to as discrete choice experimentation 
(DCE), and is increasingly used in health care (Ryan, 2004; Ryan & Farrar, 2000; Ryan et 
al., 2001). When a cost attribute is included in the experiment, the willingness to pay or 
the willingness to accept compensation for a unit change in an attribute can be calculated. 
Subsequently, each alternative set of change in the levels of the attributes can be given a 
monetary value.  
There is increasing attention to the incorporation of patient perspectives in HTA (Bridges & 
Jones, 2007; Platform HTA, 2001; Ryan & Farrar, 2000). That is, we should not just give 
them a seat at the decision-making table, but rather scientifically incorporate patient 
preferences in HTA (Bridges & Jones, 2007). Conjoint analysis is a useful tool to 
scientifically measure patient preferences. Much of the appeal of using conjoint analysis to 
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elicit patient preferences lays in that it enables us to understand the trade-offs between the 
attributes. This can for example provide valuable information for health care workers 
deciding between alternative ways of organizational innovation. 
 
Methodological issues in outcome measurement 
There are a number of methodological issues regarding the measurement of the 
consequences of an intervention for use in an economic evaluation. First, an important 
advantage of using a generic outcome measure such as the QALY is that it allows for 
comparisons across different interventions and health care sectors. Different utility 
measures however tend to lead to different utility scores (Barton et al., 2005; Bosch & 
Hunink, 2000; Brazier et al., 2004; Conner-Spady & Suarez-Almazor, 2003; Espallargues et 
al., 2005; Feeny et al., 2004; Kaplan et al., 2005; Kopec & Willison, 2003; Longworth & 
Bryan, 2003; Marra et al., 2004; Marra et al., 2005; O'Brien et al., 2003; Oostenbrink et 
al., 2002; Petrou & Hockley, 2005). 
In both the Netherlands and the United Kingdom pharmaco-economic guidelines advocate 
the use of cost-utility or cost-effectiveness analyses (College voor Zorgverzekeringen, 2006; 
National Institute for Clinical Excellence, 2004). QALYs focus on health gain and thus on 
the effects of cure, and much less on the effects of care. As QALYs are limited to health 
outcomes, it is doubtful whether a QALY is an appropriate outcome measure when 
evaluating different forms of the organization of care. When evaluating organizational 
innovation one should probably look broader than to health outcomes alone. 
The cost-benefit analysis potentially allows a broader evaluative space than CUA, as it 
expresses consequences in monetary terms. Despite the widespread use of contingent 
valuation to measure monetary values, there are some methodological controversies. One 
of these controversies is which type of question should be asked (Diener et al., 1998; 
O'Brien & Gafni, 1996). Four types of questions exist to directly measure WTP or WTA: the 
open-ended, payment scale, bidding game and discrete-choice format (Frew et al., 2003; 
O'Brien & Gafni, 1996; Smith, 2000). Different question formats have been found to elicit 
different results, but there is no consensus on which method elicits the most valid results 
(Diener et al., 1998; O'Brien & Gafni, 1996; Smith, 2000). Another methodological 
controversy is that numerous contingent valuation studies have found that WTA exceeds 
WTP (Horowitz & McConnell, 2002; O'Brien et al., 2002). This disparity between WTA 
and WTP has large implications, as the choice of format may influence the results of a cost-
benefit analysis, and hence may alter policy recommendations. Whether one should 
always use WTP (Arrow et al., 1993; Bayoumi, 2004), or use WTP when respondents 
potentially gain utility from implementing the intervention and WTA when respondents 
potentially lose utility from implementing the intervention (Drummond et al., 2005; 
O'Brien & Gafni, 1996) remains unclear. 
An advantage of using conjoint analysis to measure monetary values is that conjoint 
analysis does not directly ask respondents to express an amount of money. Hence, strategic 
behavior or protest answers are less likely to occur. However, because of some 
methodological issues the inclusion of a cost attribute to elicit monetary valuations with 
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conjoint analysis should be done with caution (Hanley et al., 2003; McIntosh, 2006; 
Ratcliffe, 2000; Slothuus Skjoldborg & Gyrd-Hansen, 2003). Additionally, it is unknown 
whether the disparity between WTA and WTP also occurs in conjoint analysis. 
 
Integrating evidence and handling uncertainty 
Economic evaluations can be based on a randomized trial, in which data on resource use 
and effectiveness are collected simultaneously (Drummond et al., 2005). However, as 
mentioned before, in organizational innovations randomized trials are often not 
appropriate. Therefore, in organizational innovations data on resource use and 
effectiveness are generally not only scarce, but also fragmented. As a result, economic 
evaluations need to draw on evidence from a range of sources, and the evidence is often 
surrounded by considerable uncertainty (Claxton et al., 2002). 
Decision-analytic modeling is a tool in economic evaluation to synthesize evidence 
(Weinstein et al., 2003). It can be used to combine data from different sources to inform 
decision making under conditions of uncertainty (Briggs et al., 2006; Fenwick et al., 2006). 
In a decision-analytic model, costs and outcomes are simulated, and the effect of an 
intervention on these outcomes can be investigated. This can be done by using a decision 
tree, a Markov model or Discrete Event Simulation (Briggs et al., 2006). When input 
parameters are uncertain, this uncertainty can be incorporated in the model by assigning a 
range of values to this parameter. One can also model different alternative designs of an 
innovation, to compare them to each other and the current organization. Additionally, 
when using a decision-analytic model one can assess the value of additional research, and 
specifically what type of additional evidence would be most valuable. It can therefore 
assist in making a twofold decision: 1) whether or not an intervention should be 
implemented, and 2) whether it is worthwhile to perform additional research to reduce the 
uncertainty surrounding the first decision (Claxton et al., 2002). 
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The case of hearing aid provision 
Hearing impairment is a frequently occurring health problem, with an estimated 
prevalence of 15% in the western adult population (Davis, 1995; Johansson & Arlinger, 
2003). Hearing impairment is positively related with age (Davis, 1995; Johansson & 
Arlinger, 2003). The ageing of the population will therefore lead to increasing numbers of 
hearing impaired persons.  
There are two types of hearing losses: conductive and sensorineural hearing losses 
(Cummings, 2005). A conductive hearing loss occurs when sound is not conducted 
efficiently through the outer ear canal to the eardrum and the middle ear. This type of 
hearing loss is associated with several conditions such as otitis externa, earwax or otitis 
media,, and can often be medically or surgically corrected. A sensorineural hearing loss 
occurs when there is damage to the inner ear or to the nerve pathways from the inner ear 
to the brain. It is mostly a permanent loss, which cannot be medically or surgically 
corrected, thus resulting in a chronic disease. Sensorineural hearing loss is caused by 
ageing or noise exposure, and hearing aids are the only option for rehabilitation. 
Sensorineural hearing losses are more common than conductive hearing losses and 
account for approximately 90% of all hearing losses (Parmet et al., 2007). 
Hearing loss can adversely affect a person’s social participation, emotional and behavioral 
wellbeing, and hence one’s quality of life (Barton et al., 2005; Dalton et al., 2003; Mulrow 
et al., 1990). Hearing impaired persons can benefit from using a hearing aid. The use of 
hearing aids improves social, emotional and communication functions and reduces 
depression (Appollonio et al., 1996; Joore et al., 2003a; Mulrow et al., 1990). Hearing aid 
fitting is found to be both an effective (Larson et al., 2000; Mulrow et al., 1990) and a cost-
effective (Joore et al., 2003b) intervention. Despite the potential benefit, only 
approximately 20 to 25% of all persons with hearing problems are fitted with hearing aids 
(Duijvestijn et al., 1999; Popelka et al., 1998; Stephens et al., 2001). Hearing aid uptake 
can be influenced by several factors, including awareness of the hearing loss, organization 
of hearing aid provision, stigma and costs (Stephens, 1987; Stephens et al., 2001). 
When hearing-impaired persons in the Netherlands seek help for their hearing complaints, 
they need to visit their general practitioner (GP) first. A GP can refer a person to either an 
Ear Nose and Throat (ENT) specialist or an Audiological Centre (AC). In an AC a 
multidisciplinary team of audiologists, psychologists and social workers, managed by a 
clinical audiologist, offers specialized care for persons with more serious or complicated 
hearing impairment. Only ENT-specialists and ACs are entitled to prescribe hearing aids. 
Based on this prescription, the hearing aid is generally fitted by a private hearing aid 
dispenser. When both the dispenser and the patient are satisfied with the fitted hearing 
aid(s), the patient returns to the prescriber for an evaluation and an approval of the hearing 
aid fitting, which entitles him to (partial) reimbursement of the hearing aid(s). In the 
Netherlands, patients with a hearing loss exceeding 35 dB, averaged over 1, 2 and 4 kHz 
in the better ear, were entitled to a maximum reimbursement by their health insurance of   
€ 657,50 per hearing aid in 2007. This organization of hearing aid provision will be 
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referred to as the ‘referral pathway’ or ‘current pathway’ throughout this thesis, and is 
illustrated by the solid lines in Figure 1.2. 
The fact that a small proportion of hearing-impaired adults have a conductive hearing loss 
where management other than hearing aid fitting is required does not mean that all 
hearing-impaired persons need to see an ENT-specialist or AC (Swan & Browning, 1994). 
Therefore, increasing attention is paid to shared care in hearing aid provision. Since 2002, 
a number of health insurance companies in the Netherlands decided that some of the tasks 
of ENT-specialists and ACs can be substituted to hearing aid dispensers. This shared care 
model permits direct hearing aid provision by dispensers, without prescription or approval 
of an ENT-specialist or AC. This model will be referred to as the ‘direct pathway’ or shared 
care in hearing aid provision and is illustrated by both the solid and dashed lines in    
Figure 1.2. Alternative shared care models are also possible, such as introducing a triage at 
the private dispenser, but maintaining the evaluation at the ENT-specialist or AC, or 
maintaining the initial assessment at the GP and ENT-specialist or AC, but omitting the 
evaluation of the hearing aid fitting by an ENT-specialist or AC. 
Figure 1.2  Graphical representation of the referral pathway (solid lines) and the direct pathway 
(solid and dashed lines) 
 
 
The main reason for this development was the ageing of the population, which causes a 
proportional growth of the population with hearing impairment and hence increases health 
care costs associated with hearing rehabilitation. Additionally, an estimated future shortage 
of ENT-specialists and the fact that this organization of hearing aid provision may be 
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perceived as a barrier for help-seeking, lead to increasing attention to direct hearing aid 
provision by private dispensers. This induced the Dutch Health Care Insurance Board (CvZ) 
to grant a multi-centre project regarding the safety, quality and efficiency of direct hearing 
aid provision for persons aged 50 and older, by private dispensers in the Netherlands 
(AZOS working group, 2006). 
Also in other countries, such as Germany and the UK, increasing attention is paid to the 
involvement of the private sector in hearing aid provision. In the United Kingdom (UK) 
direct hearing aid provision without medical care has already proven to be safe 
(Abdelkader et al., 2004; Koay & Sutton, 1996; Swan & Browning, 1994). GPs can refer 
patients to an ENT-specialist or directly to an audiology department. Patients can also 
directly visit an audiology department (The British Society of Hearing Aid Audiologists, 
2005). Unfortunately this has led to a significant range in patient waits from zero to up to 
three years (British Academy of Audiology, 2006). As a result, the Health Committee 
recently carried out an inquiry into audiology services in England, with particular interest 
in the role of the private sector (Health Committee, 2007b), which yielded a wide range of 
views on the private sector’s role in hearing aid provision (Health Committee, 2007a). 
Despite the increasing attention little is known about how patients and professionals 
involved in the care for hearing-impaired persons feel about shared care, and what the 
relevant issues in the field are. It is therefore unknown whether patients see shared care in 
hearing aid provision as an improvement. Moreover, little evidence is available on whether 
private dispensers are capable of distinguishing between persons in need of medical or 
specialized audiological care (referred to as patients) and persons not in need of medical or 
specialized audiological care (referred to as clients). It is also uncertain whether hearing aid 
dispensers will provide good quality hearing aid fittings when these are not evaluated by a 
third party, and whether shared care will actually save costs. Policy makers therefore 
require more information before they can make an informed decision on whether or not to 
allow direct hearing aid provision by private dispensers. Thus, more evidence is needed to 
allow for evidence-based decision-making regarding shared care in hearing aid provision. 
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Objective and research questions 
The objective of the thesis is to use health technology assessment to evaluate whether an 
organizational innovation, shared care in hearing aid provision, benefits the care for 
hearing-impaired persons. 
The thesis focuses on three aspects of this objective. The first aspect deals with the 
measurement of barriers and facilitators in an early stage of an organizational innovation 
process, to become aware of which issues are of importance in the field, and to guide the 
design process of the innovation. Secondly, outcome measures are considered, both in 
terms of utilities and monetary valuations. Thirdly, all available evidence is integrated in a 
decision-analytic model to make a trade-off between the benefits and risks of shared care 
in hearing aid provision. 
We formulated research questions according to these three aspects: 
1) What are the expectations of patients and professionals, and potential barriers and 
facilitators towards shared care in hearing aid provision? 
2) How should we measure outcome in shared care in hearing aid provision? 
a. How practical, valid, corresponding and responsive are the EuroQol 5D and 
the Health Utilities Index when measuring health state utility in a population 
with hearing complaints? 
b. How corresponding and valid are the open-ended and payment scale 
question when directly measuring willingness to pay for a hearing aid? 
c. Does the disparity between willingness to accept and willingness to pay 
occur in a discrete choice experiment? 
d. Which preferences do patients have regarding the organization of hearing aid 
provision? 
3) Is shared care in hearing aid provision efficient? 
 
 
Research methods and design 
To answer this rather wide range of research questions, various research methods are 
needed. Barriers and facilitators were elicited in a survey using two study populations. The 
first study population consisted of professionals involved in the care for hearing-impaired 
persons, being GPs, hearing aid dispensers, ENT-specialists and clinical audiologists. The 
second study population consisted of persons with hearing complaints aged 50 years and 
older. The respondents in the second study population were participants in a multi-centre 
non-controlled prospective evaluation study examining shared care in hearing aid 
provision versus the referral pathway. 
The second research question, regarding outcome measurement in shared care in hearing 
aid provision, was addressed by three research designs. First, utility scores were measured 
before and after hearing aid fitting as part of the above-mentioned prospective evaluation 
study. Secondly, willingness to pay for a hearing aid was directly measured using a 
questionnaire designed for self-completion. The study population consisted of a 
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convenience sample of adult hearing aid users, both first time and experienced hearing aid 
users, who consulted at the participating hearing aid dispenser practices or ACs. Thirdly, 
the disparity between WTA and WTP was examined using a discrete choice experiment. 
Two trained interviewers conducted face-to-face interviews at four private hearing aid 
dispenser practices, chosen to be representative for the region. Participants were adults 
with hearing complaints visiting the dispenser. A WTA version and a WTP version of the 
questionnaire were randomly conducted by both interviewers and were randomly assigned 
to the respondents in all four practices. The patients’ preferences were elicited with the 
same discrete choice experiment, but only the data from the respondents who received the 
WTA format were used. 
To answer the third research question, whether shared care in hearing aid provision is 
efficient, all available evidence on this topic was synthesized using a decision-analytic 
Markov model. The available evidence consisted of data from the prospective evaluation 
study, as well as a patient cohort study, published literature and expert opinion. From the 
prospective evaluation study we used the subset of participants of whom we were able to 
collect sufficient information regarding their hearing aid use, medical status and quality of 
the hearing aid at the end of the study. 
 
 
Outline of the thesis 
The thesis starts with an inquiry into the expectations and potential barriers and facilitators 
towards direct hearing aid provision (Chapter 2). Views on this subject were elicited in a 
survey among patients with hearing complaints and professionals involved in hearing aid 
provision. 
The second part of the thesis focuses on how one should measure outcome in shared care 
in hearing aid provision, and consists of Chapters 3 to 6. In Chapter 3 utility scores are 
elicited in a population with hearing complaints, before and after hearing aid provision. 
The differences between preference-based utility measures EuroQol 5D, Health Utilities 
Index mark II and Health Utilities Index mark III, and their impact on the incremental cost-
effectiveness ratio for hearing aid fitting are examined. Chapter 4 examines contingent 
valuation. In contrast to most contingent valuation studies in health care, the amount a 
person is willing to pay for a hearing aid can be compared to what the person actually has 
paid for a hearing aid. This makes hearing aid provision a useful subject to examine the 
validity of contingent valuation elicitation formats. Therefore, Chapter 4 examines the 
validity of two elicitation formats: the open-ended question and the payment scale.  
Chapter 5 focuses on the disparity between WTA and WTP, by examining whether this 
disparity also occurs in discrete choice experiments. It also addresses the question which 
format should be used, specifically in a DCE regarding shared care in hearing aid 
provision. Chapter 6 describes the results of a DCE that elicited patient preferences for 
transferring elements of hearing aid provision from the medical sector to private hearing aid 
dispensers. 
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In the third part of this thesis the available evidence is integrated to make a trade-off 
between the benefits and risks of shared care in hearing aid provision. In Chapter 7 the 
evidence on shared care in hearing aid provision is synthesized using a decision-analytic 
model. The long-term efficiency of different alternative shared care models in hearing aid 
provision is assessed, and the value of additional research is calculated. 
Chapter 8 gives an overview of the thesis. The main findings for each research question are 
summarized and discussed, followed by the methodological considerations. Finally, 
recommendations for policy as well as practice are presented, and areas of future research 
are identified. 
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Abstract 
Background 
Because of the increasing costs and anticipated shortage of Ear Nose and Throat (ENT) 
specialists in the care for hearing-impaired persons, an integrated care pathway that 
includes direct hearing aid provision was developed. While this direct pathway is still 
under investigation, in a survey we examined expectations and potential barriers and 
facilitators towards this direct pathway, of patients and professionals involved in the 
pathway. 
Methods 
Two study populations were assessed: members of the health professions involved in the 
care pathway for hearing-impaired persons (general practitioners (GPs), hearing aid 
dispensers, ENT-specialists and clinical audiologists) and persons with hearing complaints. 
We developed a comprehensive semi-structured questionnaire for the professionals, 
regarding expectations, barriers, facilitators and conditions for implementation. We 
developed two questionnaires for persons with hearing complaints, both regarding 
evaluations and preferences, and administered them after they had experienced two key 
elements of the direct pathway: the triage and the hearing aid fitting. 
Results 
On average GPs and hearing aid dispensers had positive expectations towards the direct 
pathway, while ENT-specialists and clinical audiologists had negative expectations. 
Professionals stated both barriers and facilitators towards the direct pathway. Most 
professionals either supported implementation of the direct pathway, provided that a 
number of conditions were satisfied, or did not support implementation, unless roughly the 
same conditions were satisfied. Professionals generally agreed on which conditions need to 
be satisfied. Persons with hearing complaints evaluated the present referral pathway and 
the new direct pathway equally. Many, especially older, participants stated however that 
they would still visit the GP and ENT-specialist, even when this would not be necessary for 
reimbursement of the hearing aid, and found it important that the ENT-specialist or 
Audiological Centre evaluated their hearing aid. 
Conclusions 
This study identified professional concerns about the direct pathway for hearing-impaired 
persons. Gaps exist in expectations amongst professions. Also gaps exist between users of 
the pathway, especially between age groups and regions. Professionals are united in the 
conditions that need to be fulfilled for a successful implementation of the direct pathway. 
Implementation on a regional level is recommended to best satisfy these conditions. 
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Background  
An important step in an implementation process is to determine the barriers that will 
impede implementation, and the facilitators that will enhance implementation, within 
different subgroups (Grol, 1997; Grol & Grimshaw, 2003; Robertson et al., 1996; Van 
Bokhoven et al., 2004; Wensing et al., 1999). Insight into barriers and facilitators will help 
to design the most effective implementation strategy. In the Netherlands a new care 
pathway for hearing-impaired adults is currently under investigation. The present study 
focuses on potential barriers and facilitators for implementation of this new care pathway. 
Most hearing-impaired adults have an age-related sensorineural hearing loss, where 
hearing aids are the only option for rehabilitation. Until recently, in the Netherlands all 
hearing-impaired persons who seek help first had to consult their general practitioner (GP) 
for referral to an Ear Nose and Throat (ENT) specialist or Audiological Centre (AC). In an 
AC a multidisciplinary team under the direction of a clinical audiologist offers specialized 
care for the more serious or complicated hearing problems. Only ENT-specialists and ACs 
were entitled to prescribe hearing aids. Generally, a hearing aid dispenser performed the 
actual hearing aid fitting. Once a satisfying hearing aid was fitted, the hearing-impaired 
persons returned to the ENT-specialist or AC for approval of the hearing aid, which entitled 
them to (partial) reimbursement by their medical insurance. We will refer to this pathway 
as the care pathway for hearing-impaired persons by referral (Figure 2.1), in short the 
referral pathway. 
Since 2002 however a number of health insurance companies in the Netherlands permit 
hearing aid reimbursement without a referral, prescription or approval. This allows for 
direct hearing aid provision by the hearing aid dispenser. One reason for this new care 
pathway was to reduce health care costs. Approximately 10% of the general population of 
western countries is hearing impaired, and this prevalence heavily increases with age 
(Chorus et al., 1995; Davis, 1995). As a result the current growth of the ageing population 
causes a proportional growth of the population with hearing impairment. This will raise 
medical consumption for hearing impairment and, as a consequence, increases the costs of 
medical care. Another reason for the new care pathway was to reduce the workload of 
ENT-specialists, since a report was published in 2000 that alerted to a future shortage of 
ENT-specialists in the Netherlands (Van der Velden & Hingstman, 2000). 
It has been suggested that a proportion of hearing-impaired individuals can safely be fitted 
with a hearing aid without medical care (Abdelkader et al., 2004; Hawthorne et al., 1991; 
Koay & Sutton, 1996; Swan & Browning, 1994). These individuals are defined as clients 
throughout the present study. In order to distinguish these ‘clients’ from the ‘patients’ who 
require medical attention or treatment of an AC, a set of criteria was developed by a 
national body of professionals involved in the care pathway for hearing-impaired persons 
(Veldhuizen et al., 2002). The criteria for referral relate to otoscopy (i.e. skin aberration, 
fluid in the auditory canal), audiometry (i.e. asymmetrical hearing loss or sudden deafness) 
and psychosocial aspects (i.e. communication problems at work). This set of criteria is part 
of a recently developed integrated care pathway for hearing-impaired persons. Integrated 
care pathways are structured multidisciplinary care plans which detail essential steps in the 
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care of patients with a specific problem (Campbell et al., 1998). The new integrated care 
pathway is referred to as the direct care pathway for hearing-impaired persons including 
direct hearing aid provision, in short the direct pathway (Figure 2.1). In parts of the United 
Kingdom, direct hearing aid provision is by now daily routine (The British Society of 
Hearing Aid Audiologists, 2005). While in the Netherlands the safety and efficiency of the 
direct pathway are still under evaluation, we found it important to examine whether 
persons with hearing complaints and professionals support the direct pathway, and what 
they consider to be barriers and facilitators, in order to anticipate on the implementation 
process of the direct care pathway. 
The objective of this study was therefore to gain insight into the expectations and potential 
barriers and facilitators towards the direct pathway. 
 
 
 
 
 
 
 
 
Figure 2.1 Graphical representation of referral pathway (black lines) and the direct pathway (black 
and grey lines), including the study pathway (b), the study population (italic) and the 
questionnaire timing (rounds) 
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Methods 
Study population 
Two study populations were assessed in the present study. The first study population 
consisted of members of the health care professions involved in the care pathway for 
hearing-impaired persons: GPs, hearing aid dispensers, ENT-specialists and clinical 
audiologists. We approached professionals from three regions in the Netherlands 
(Amsterdam, Maastricht and Rotterdam), divided over the four professions. 
The second study population consisted of persons who consulted for hearing complaints. 
We included persons of 50 years and older with hearing complaints, who consulted ENT 
departments and ACs or hearing aid dispensers in the three regions. Persons who had 
consulted for hearing complaints in the preceding year were considered to be under 
treatment and were therefore excluded. 
 
Design 
Data for this exploratory survey were collected as part of a multi-centre non-controlled 
prospective evaluation study examining the direct pathway versus the referral pathway 
(AZOS working group, 2006). The study was carried out from April 2004 until August 2005 
in three regions (Amsterdam, Maastricht and Rotterdam) in the Netherlands. The study was 
approved by the Medical Ethical Committees of the participating hospitals, and written 
consent was obtained from all participants. Three teaching hospitals and 11 hearing aid 
dispensers participated in the study. Since the hospital in Maastricht is the only hospital in 
its region, it also has a community function. The hospitals in Amsterdam and Rotterdam 
mainly operate as centers for secondary referral for patients in need of specialized care. 
The study focused on two key elements of the direct care pathway: distinguishing persons 
who need medical or specialized audiological care (the patients) from persons who do not 
need medical or specialized audiological care (the clients), and the quality of the hearing 
aid provision. For the purpose of the study, participants first visited the hearing aid 
dispenser for a triage visit (dispenser-triage, Figure 2.1). At the triage visit, the hearing aid 
dispenser examined whether the participant was in need of medical or specialized 
audiological care or not and hence should be defined as a patient or client respectively. To 
perform this examination, the hearing aid dispenser had followed a training program 
especially designed for this purpose. The main topics of the training program were 
audiometry and otoscopy. Regardless of the outcome of the triage, all participants 
subsequently visited the ENT-specialist and AC for a second examination (ENT/AC-
examination), to evaluate whether the dispenser had correctly defined the participant as 
patient or client. If the participant received a prescription for hearing aids, the hearing aid 
dispenser fitted a hearing aid. Once a satisfying hearing aid fitting was obtained, the 
participant returned to the AC for a control visit, to evaluate the quality of the hearing aid 
fitting. 
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Framework 
Barriers and facilitators are defined as factors that prevent or enhance, respectively, 
behavioral change (Wensing et al., 1999). Various theories and models for change point to 
a multitude of factors that may affect change (Grol & Wensing, 2004; Robertson et al., 
1996). Cabana et al. (1999) developed a framework that focuses on the individual 
professional. In this framework barriers are classified into three main categories: barriers 
related to knowledge (familiarity, awareness), barriers that affect attitudes (agreement, self-
efficacy, motivation, outcome expectancy) and external barriers (patient factors, guideline 
factors, environmental factors). We used this framework to structure the barriers and 
facilitators that health care professionals perceived regarding the implementation of the 
direct pathway. 
In the care pathway for hearing-impaired persons, patient factors play an important role as 
well. Therefore, patient factors were examined separately in a survey among persons with 
hearing complaints. Wensing and Elwyn (2004) distinguish three types of patient views: 
evaluations (reactions to their service experience), preferences (ideas about what should 
occur) and reports (objective observations). In this study we focused on subjective patient 
views, and therefore examined evaluations and preferences. 
 
Questionnaire for professionals 
Health care professionals involved in the care pathway (GPs, hearing aid dispensers, ENT-
specialists and clinical audiologists) were asked to complete a comprehensive semi-
structured questionnaire regarding the direct pathway (see Appendix 2.1). First, we paid 
explicit attention to the outcome expectancies. Professionals were asked on five point 
Likert scales whether they expected the direct pathway to have positive or negative 
consequences for different aspects of the hearing aid provision. These six aspects were: 
diagnosing hearing impairment; indicating a hearing aid; paying attention to medical, 
audiological and psychological complications; giving objective information about the 
impairment, treatment options and hearing aids; choice and fine-tuning of the hearing aid; 
and the quality of the ear moulds. Next, using open questions the professionals were asked 
to report if they thought the direct pathway was an improvement for some hearing-
impaired persons, and for whom, and whether it was a deterioration for some hearing-
impaired persons, and for whom. They were also asked to report possible risks and benefits 
of the direct pathway. Finally, professionals were asked if the direct pathway should be 
implemented and, if applicable, under which conditions. 
 
Questionnaire for persons with hearing complaints 
Two questionnaires for persons with hearing complaints, designed for self-completion, 
were developed. The questionnaires were administered after the participants had 
experienced the two key elements of the direct pathway: the triage and the hearing aid 
fitting. The first questionnaire was administered directly after the ENT/AC-examination (see 
Appendix 2.2). Two questions concerned evaluations of the hearing aid dispenser: whether 
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participants had confidence that the hearing aid dispenser, who had received additional 
training, was able to distinguish between clients and patients, and whether they were 
satisfied with the way the hearing aid dispenser behaved towards them. Regarding their 
preferences, we asked the participants if they would be inclined to obtain a hearing aid 
sooner when they didn't have to visit their GP and an ENT-specialist or AC first. Also, they 
were asked whether they would still visit the GP and ENT-specialist or AC if this was not a 
prerequisite for (partial) reimbursement of the hearing aid. The questions were answered on 
five point Likert scales and participants were also given the option that they did not know. 
As our study population consisted of persons with hearing complaints, and not only 
hearing aid applicants, not all participants had a hearing aid fitted. The subset of persons 
with hearing complaints who were fitted with a hearing aid within the study period 
completed the final questionnaire after the control visit at the AC (see Appendix 2.3). Both 
the referral pathway and the direct pathway were described and participants were asked to 
value both pathways with a grade between 1 and 10, with 10 being the most favorable. 
After these two evaluative questions, three preference questions were asked on five point 
Likert scales, including a ‘don’t know’ option. Participants were asked whether they 
expected that the hearing aid dispenser would fit a good hearing aid without involvement 
of the ENT-specialist or AC and to report if they found it important that the hearing aid 
fitting would be advised and evaluated by the ENT-specialist or AC. 
We checked the results for differences in sex (male versus female) and age group (below 
versus above median age) using Mann-Whitney U tests. Differences between the regions 
(Amsterdam, Maastricht, Rotterdam) were examined with Kruskal Wallis tests, and Mann-
Whitney U tests for post-hoc pairwise comparisons. 
 
 
Results  
Professional views 
Outcome expectancy 
A total of 60 health care professionals completed the questionnaire regarding their 
expectations towards the direct pathway. This group consisted of 14 GPs, 16 hearing aid 
dispensers, 16 ENT-specialists and 14 clinical audiologists. 
The professional groups gave significantly different answers on all aspects: diagnosing 
hearing impairment; indicating a hearing aid; paying attention to medical, audiological and 
psychological complications; giving objective information about the impairment, treatment 
options and hearing aids; choice and fine-tuning of the hearing aid; and the quality of the 
ear moulds (Kruskal Wallis, p-value <0.01). On average GPs and hearing aid dispensers 
expected the direct pathway to have positive consequences for all aspects (Figure 2.2). The 
ENT-specialists expected on average negative consequences for all aspects except the 
quality of the ear moulds, for which they expected no change. The clinical audiologists 
expected on average negative consequences for all six aspects. 
Chapter 2  
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Expectations of profession groups towards the direct pathway, elicited with five point 
Likert scales, ranging from 2 (positive) to -2 (negative) 
 
Barriers and facilitators 
All professionals considered the direct pathway an improvement for a subpopulation of 
hearing-impaired persons (Table 2.1). Professionals defined this subpopulation as ‘older’ 
persons, persons with hearing loss due to ageing only, persons with initial resistance for 
seeking medical care, and experienced hearing aid users. Almost all professionals (98%) 
saw benefits in the direct pathway. These benefits were breaking down barriers, efficiency 
gain, quicker access to medical care for those in need of it, minimization of costs, 
reduction in the duration of the pathway, and reduction of the burden on the ENT-
specialist, resulting in more time for medical specialist care. Hearing aid dispensers also 
reported closer collaboration between the involved professions as a benefit. 
The majority of professionals (78%) on the other side considered the direct pathway a 
deterioration for persons in need of medical care, ‘younger’ persons, and persons who are 
dissatisfied with their hearing aid. The majority of professionals (83%) mentioned the risk of 
undetected pathology, wrongful indication for a hearing aid or commercialization of care 
as potential risks of the direct pathway. In addition, GPs emphasized that their role as 
gatekeeper should be maintained. They reported that a medical cause of the hearing 
problems should be ruled out first and that diagnostics and treatment should not go hand in 
hand. By this they meant that the hearing aid dispenser should not both diagnose hearing 
impairment and provide the hearing aid. Clinical audiologists additionally reported that 
both the GP and the hearing aid dispenser are not capable of distinguishing adequately 
between patients and clients. 
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Table 2.1 Opinions of professionals on improvement, deterioration, risks and benefits of the direct 
pathway 
Profession group Valid N Improvement?
% Yes
Benefits?
% Yes
Deterioration?
% Yes
Risks? 
% Yes 
General practitioner 14 100% 100% 64% 79% 
Hearing aid dispenser 16 100% 100% 56% 63% 
ENT- specialist 16 100% 94% 94% 100% 
Clinical audiologist 14 100% 100% 100% 93% 
Total  60 100% 98% 78% 83% 
 
Conditions for implementation 
Ten out of 14 GPs stated that they supported the direct pathway, provided that specific 
conditions were met (Figure 2.3). These conditions mostly concerned their own role in the 
pathway: GPs wanted to stay involved in the direct care pathway and emphasized the 
importance of a good communication between hearing aid dispensers and themselves. 
Other conditions were adequate training for hearing aid dispensers, that direct hearing aid 
provision should only be possible for persons of 65 years and older, and that, especially in 
the beginning, the care should be evaluated frequently. 
Two GPs completely supported implementation. One GP reported not to support 
implementation, unless GP and hearing aid dispenser would work together, and one GP 
reported absolutely not to support implementation. 
Twelve out of 16 hearing aid dispensers reported that they supported implementation, but 
only when adequate training, strict requirements for hearing aid dispensers, clear criteria 
for referral, excellent communication between professionals, and good arrangements 
regarding task division were provided. Four hearing aid dispensers reported to support the 
implementation completely. 
Eight out of 16 ENT-specialists stated to support implementation of the direct pathway, 
provided that the quality of audiometry and otoscopy would be sufficient, that hearing aid 
dispensers would not prescribe hearing aids for commercial reasons only, that the 
professional education for hearing aid dispenser would improve, and that clear criteria for 
referral, a good evaluation system and a complaints service would be present. Five ENT-
specialists reported not to support implementation, unless some of the above mentioned 
conditions were satisfied. Two ENT-specialists did not support implementation and one 
ENT-specialist reported to completely support implementation of the direct pathway. 
Six out of 14 clinical audiologists stated that they did support implementation, provided 
that quality would be guaranteed, that there would be a second-opinion possibility, that 
task division, responsibilities and criteria for referral would be clear, and that hearing aid 
dispensers would be adequately trained for their new tasks. Four clinical audiologists did 
not support implementation, except when hearing aid dispenser and GP would recognize 
all pathology, hearing aid dispensers were sufficiently trained, and a random evaluation of 
the care pathway would exist. Three clinical audiologists did absolutely not support 
implementation, in contrast to one who completely supported implementation. 
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Figure 2.3 Responses to the question whether professionals support implementation of the direct 
pathway 
 
Views of persons with hearing complaints 
Study population 
Between April 2004 and August 2005, a total of 337 persons with hearing complaints were 
included in the study and were asked to complete the first questionnaire after the ENT/AC-
examination. A total of 332 participants (99%) completed the questionnaire after the 
ENT/AC-examination (Figure 2.1). Their mean age was 69.6 years (sd 9.0; median 70) and 
60% were male. The participants were included in Amsterdam (n=75), Maastricht (n=186) 
and Rotterdam (n=71). 
Of the 337 participants in the study, 181 (54%) had a hearing aid fitted. Of them, 88 (49%) 
attended the AC for the control visit after the hearing aid trial. Ninety-three participants 
(51%) who had a hearing aid fitted did not show up at the control visit. These participants 
had not finished their hearing aid trial before the end of the study (n=35), or had a hearing 
aid fitted at a different dispenser that not participated in the study (n=58) and therefore 
dropped out of the study. Of the 88 participants who did attend to the control visit, 85 
(97%) completed the final questionnaire. These 85 participants had a mean age of 70.6 
years (sd 7.8; median 71) and 72% were male. The participants were included in 
Amsterdam (n=14), Maastricht (n=53) and Rotterdam (n=18). 
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Evaluations 
After the ENT/AC-examination, 89% of the persons with hearing complaints reported to 
have confidence in the trained hearing aid dispenser (Table 2.2). Even more respondents 
(96%) were satisfied with the way the hearing aid dispenser behaved towards them. 
The subset of persons with hearing complaints who had finished their hearing aid trial and 
therefore completed the whole pathway (n=85), completed the final questionnaire after the 
AC control visit. They graded the referral pathway and the direct pathway equally (7.6 and 
7.7 respectively). Both scores ranged from 2 to 10, with a median of 8 for both pathways. 
The grades were not significantly different (Wilcoxon Signed Ranks Test, p-value 0.896). 
 
 
Table 2.2 Evaluations and preferences of persons with hearing complaints 
Question Valid N Yes Neutral No Don’t 
know 
Evaluations after ENT/AC examination (N=332)   
Confidence in hearing aid dispenser? 330 89% 5% 2% 4% 
Satisfied with hearing aid dispenser? 331 96% 2% 2% 0% 
   
Preferences after ENT/AC examination (N=332)   
Earlier fitted with a hearing aid without GP/ENT/AC visit? 328 24% 21% 52% 3% 
Visit GP with hearing complaints if not necessary? 329 54% 12% 32% 2% 
Visit ENT/AC with hearing complaints if not necessary? 329 64% 13% 21% 3% 
   
Preferences after hearing aid fitting (N=85)   
Expect dispenser to fit good hearing aid without mediation 
ENT/AC? 85 80% 12%
 
6% 
 
2% 
Important to be advised by ENT/AC? 84 60% 21% 17% 2% 
Important that hearing aid is evaluated by ENT/AC? 83 64% 17% 19% 0% 
 
Preferences 
In the first questionnaire, a quarter of the persons with hearing complaints (24%) reported 
that they would be inclined to obtain a hearing aid sooner when they didn't have to visit 
their GP, an ENT-specialist or AC first (Table 2.2). This indicates that a quarter of the 
participants consider the visits to GP, ENT-specialist and AC as a barrier for hearing aid 
fitting. Of the participants, 32% would not visit the GP and 21% would not visit the ENT-
specialist and AC with their hearing complaints when this was not necessary for 
reimbursement of the hearing aid. 
In the final questionnaire, 80% of the subset of participants who had a hearing aid fitted 
expected the hearing aid dispenser to perform a good hearing aid fitting, even when the 
ENT-specialist and AC would not be involved in the process of hearing aid fitting. Even 
though, a majority of the participants reported that they found it important that an ENT-
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specialist or AC would advise them (60%), and found it important that the ENT-specialist or 
AC evaluated the hearing aid fitting (64%). 
 
Differences between groups 
Additionally, we checked the results for differences in sex (male versus female), age group 
and region (Amsterdam, Maastricht, Rotterdam). The age groups were defined below and 
above the median age, being 70 for the group with hearing complaints that completed the 
first questionnaire, and 71 for the group with a hearing aid fitting that completed the 
second questionnaire. This resulted in a comparison of persons younger than 70 versus 70 
years and older for the first questionnaire, and a comparison of persons younger than 71 
versus 71 years and older for the second questionnaire. 
No statistically significant differences were found between men and women. There were 
differences in preferences between the age groups. Of the group of persons aged 70 years 
and older, 69% would still visit the ENT-specialist or AC, even if this was not necessary for 
reimbursement of the hearing aid, versus 58% of those younger than 70 years. This 
difference is statistically significant (Mann-Whitney U, p-value 0.041). Also, statistically 
significantly more persons of 71 years and older (79%) than persons younger than 71 (49%) 
found it important that an ENT-specialist or AC evaluated their hearing aid fitting (Mann-
Whitney U, p-value 0.005). 
We also found differences in preferences for the regions, specifically in whether 
respondents would still visit their GP when this was not necessary (Kruskal Wallis Test, p-
value 0.005). Pairwise comparison showed that in Maastricht (60%) and Amsterdam (57%) 
statistically significantly more persons stated that they would still visit the GP for their 
hearing complaints than in Rotterdam (37%) (Mann Whitney U, p-values 0.001 and 0.019). 
 
 
Discussion 
This exploratory study provides insight in the barriers and facilitators of implementing the 
direct care pathway for hearing-impaired persons. Hearing aid dispensers and GPs had on 
average positive expectations towards the direct pathway, while ENT-specialists and 
clinical audiologists had on average negative expectations. Also more ENT-specialists and 
clinical audiologists found the direct pathway a deterioration and stated possible risks, and 
they were somewhat more reluctant to implement the direct pathway. Besides concerns 
about safety and quality, a possible explanation for this is that in the direct pathway, ENT-
specialists and clinical audiologists will lose domain in the health care for hearing-
impaired persons. They have to hand over part of their work to the GP and hearing aid 
dispenser. They may feel that their professional authority will decline if they are relegated 
more to the role of specialist, seeing patients only on referral from hearing aid dispensers 
and GPs. Hearing aid dispensers on the other hand experience an expansion of their tasks 
in the care for hearing-impaired persons, as they will have greater autonomy in the direct 
pathway. This makes hearing aid dispensers a so-called ‘encroaching profession’. Also in 
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other health care settings established professions develop strategies to protect their 
boundaries, while encroaching professions try to expand their work areas (Adams, 2004; 
Nancarrow & Borthwick, 2005; Norris, 2001; Stevens et al., 2007). 
In 2005 an updated report regarding the labor market of ENT-specialists was published. 
This report concluded that the predicted shortage of ENT-specialists was tackled, and that a 
sufficient number of ENT-specialists will be available in the near future (Hansen et al., 
2005). These findings possibly play a role in the expectations of especially the ENT-
specialists, since they may be more reluctant to hand over a number of tasks when their 
workload will not be as heavy as they expected it to be. The latter also happened in the 
field of orthopaedic surgeons, who decided to discard a number of unwanted tasks when 
there was an undersupply of orthopaedic surgeons, and wished to reclaim these tasks when 
an oversupply arose (Nancarrow & Borthwick, 2005). 
Although negative expectations exist, the results of this study show that most health care 
professionals either supported implementation of the direct pathway, provided that a 
number of conditions are satisfied, or did not support implementation, unless roughly the 
same conditions are satisfied. The professionals generally agreed on which conditions need 
to be satisfied. In general, these conditions are: good communication between the 
professionals involved in the direct care pathway, adequate training for the hearing aid 
dispensers, frequent evaluation, clear criteria for referral, clear division of tasks, a second 
opinion possibility, and a complaints service. 
Before implementing the direct care pathway, all parties involved (GPs, hearing aid 
dispensers, ENT-specialists, clinical audiologists and hearing-impaired persons) should 
reach a consensus on the criteria for referral and the division of tasks. Regardless of these 
criteria and the division of tasks, it should always be possible for hearing-impaired persons 
to visit the ENT-specialist or AC for a second opinion. Furthermore, the parties must agree 
on clear requirements regarding the training of the hearing aid dispensers, and these 
requirements must concur with the referral criteria and task description of the hearing aid 
dispensers. Next, a complaints service should be facilitated, possibly by the patients’ 
association. Especially in the beginning the direct care pathway should be evaluated 
carefully. Good communication between professionals is of great importance, but this is 
probably not easy to realize. Regional implementation may be part of the solution, as in 
small regions it is less difficult to create a basis of trust among the professionals involved. 
When the professionals and hearing-impaired persons make agreements on a regional 
level, they will get to know each other better. As a result this might improve their 
communication and their confidence in the other professionals’ capabilities. 
All four groups of professionals stated that the direct pathway had risks as well as benefits. 
When we apply the framework of Cabana et al. (1999) to the barriers mentioned by the 
professionals, all are barriers that affect attitudes. The GPs mentioned barriers related to 
lack of agreement, being the importance of their gatekeeper role and that diagnostics and 
treatment should not go hand in hand. Most barriers however are related to lack of 
outcome expectancy. This is clear from the negative expectations of ENT-specialists and 
clinical audiologists (Figure 2.2) towards the direct pathway, but also shows in the risks that 
were stated by all professionals. Professionals stated the risk of undetected pathology, the 
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risk of wrongful indications for a hearing aid, and the risk of fitting hearing aids for 
commercial reasons only. Some professionals considered the GP and hearing aid dispenser 
not capable of distinguishing between persons who need medical or specialized 
audiological care (patients) and persons who do not need medical or specialized 
audiological care (clients). If the direct pathway will be implemented, it is important to first 
consider and appropriately influence the attitudes of the professionals. This may be more 
successful on a regional level, since closer collaboration between the professionals will 
probably result in more confidence in each other’s capabilities. Information with regard to 
the safety of the direct pathway is likely to be crucial. Although barriers related to 
knowledge were not mentioned in this study, when implementing the direct pathway it is 
important to make sure that everyone involved has sufficient knowledge of the pathway. 
The professionals did not perceive any external barriers, but we examined these separately 
by asking persons with hearing complaints for their evaluations and preferences. Due to the 
study design, approximately half of the participants fitted with a hearing aid could not be 
asked to complete the final questionnaire. We checked whether age and region in this 
group were different from the group that did complete the final questionnaire, as these 
characteristics were found to influence preferences. Since there was no statistically 
significant difference, we had no reason to believe that the low response rate of the final 
questionnaire influenced the results. 
Although participants evaluated both pathways equally and had confidence in the hearing 
aid dispenser, many participants stated that they would still visit the GP and ENT-specialist, 
even when this would not be necessary for reimbursement. This means that after 
implementation of the direct pathway, clients may still choose to visit the ENT-specialist, 
bypassing the direct pathway. It is therefore important that persons with hearing complaints 
are well informed about the direct pathway and are involved in the implementation 
process. 
A larger proportion of older participants stated that they would visit the ENT-specialist or 
AC, even when this was not necessary for reimbursement of the hearing aid, and found it 
important that the ENT-specialist or AC evaluated their hearing aid fitting. This indicates 
that older persons are more attached to the opinion of the medical specialist. This 
difference was not caused by differences in hearing aid experience. The implication of this 
difference is that especially older clients may bypass the direct care pathway by still visiting 
the ENT-specialist or AC for their examination and control visit. Older persons therefore 
may need special attention in the implementation process. Differences in preferences were 
found between the regions, which is probably due to the variety in care pathways for 
hearing-impaired persons that currently exist among regions. Since 2002 a number of 
health insurance companies already permit some form of direct hearing aid provision 
without consultation of the involved professionals. This makes the current care for hearing-
impaired persons diffuse. The differences between the regions and the current diffuse forms 
of care for hearing-impaired persons argue for implementation on a regional level. The 
different types of hospitals may have caused the difference in participant numbers included 
in the study. Maastricht included more participants than Rotterdam and Amsterdam, 
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possibly because the hospital in Maastricht also has a community function and sees more 
persons that are not referred by another hospital. 
Since multidisciplinary collaboration and task substitution play an important role in many 
other integrated or shared care pathways (Campbell et al., 1998; Grone & Garcia-Barbero, 
2001; Mur-Veeman et al., 2001; Stevens et al., 2007), the barriers and conditions for 
implementation found in this study are likely to apply to other integrated care pathways as 
well. 
While the direct care pathway is still under investigation, we have already obtained 
valuable information regarding support of the direct care pathway and potential barriers 
and facilitators. Barriers and facilitators to change are often examined after or during 
implementation (Cabana et al., 1999; Espeland & Baerheim, 2003; Foy et al., 2005; 
Haagen et al., 2005). By determining barriers in an earlier stage, we can use the 
information to develop the implementation process and to increase the chance of 
successful implementation. 
 
 
Conclusion 
This exploratory study identified professional concerns about the direct care pathway for 
hearing-impaired persons. It is clear that gaps in expectations amongst GPs, hearing aid 
dispensers, ENT-specialists and clinical audiologists exist. It is also clear that gaps in 
expectations exist among the users of the care pathway, especially with older persons 
demonstrating a preference for the traditional pathway. Also, persons from different regions 
where currently different pathways exist demonstrated different preferences. Despite these 
differences and despite the fact that implementation of the direct pathway is not yet 
broadly based, professionals are united in the conditions that need to be fulfilled for a 
successful implementation of the direct pathway. It is important that these conditions are 
met before implementing the direct pathway in the Netherlands. Implementation on a 
regional level is recommended to best satisfy the stated conditions. 
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Appendix 2.1   Questionnaire for professionals 
7. Do you think the new care pathway will be an improvement for a subset of persons? 
What consequences do you think that the new care pathway for hearing-impaired persons will have 
with regard to the following aspects: 
1. Diagnosing hearing impairment? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
2. Indicating a hearing aid? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
3. Paying attention to medical, audiological and psychological complications? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
4. Giving objective information on hearing impairment, treatment options and hearing aids? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
5. Choice and fine-tuning of the hearing aid? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
6. The quality of the ear moulds? 
 -2 -1 0 1 2  
Negative consequences Positive consequences 
  Yes, that is…  
  No, because…  
8. Do you think the new care pathway will be a deterioration for a subset of persons? 
  Yes, that is…  
  No, because…  
9. Do you think the new care pathway will have possible risks? 
  Yes, that is…  
  No, because…  
10. Do you think the new care pathway will have possible benefits? 
  Yes, that is…  
  No, because…  
11. Do you think that the new care pathway should be implemented? 
  Yes, completely  
  Yes, provided that…  
  I don’t know, because…  
  No, unless…  
  Absolutely not  
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Appendix 2.2   First questionnaire for persons with hearing complaints 
With the following statements we would like to find out how you think about the care for persons with 
hearing complaints. Could you please indicate whether you agree with the following statements? 
 
Totally 
agree 
Quite 
agree 
Neither 
agree 
nor 
disagree
Quite 
disagree
Totally 
disagree 
Don’t 
know 
1. I have confidence that the trained 
hearing aid dispenser is able to 
determine whether referral to an 
ENT-specialist or AC is necessary 
     O 
       
2. I am satisfied with the way the 
hearing aid dispenser behaved 
towards me 
     O 
       
3. I am inclined to obtain a hearing aid 
sooner, when I don’t have to visit my 
GP and an ENT-specialist or AC first 
     O 
       
4. I would still visit my GP for my 
hearing complaints if this was not 
necessary for reimbursement of the 
hearing aid  
     O 
       
5. I would still visit the ENT-specialist 
or AC for my hearing complaints if 
this was not necessary for 
reimbursement of the hearing aid 
     O 
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Appendix 2.3   Final questionnaire for persons with hearing complaints 
 
The care for hearing-impaired persons can be organized in different ways. With the next questions we 
would like to know what you think about two possible ways of organizing this care. 
In the current pathway the hearing-impaired patient first visits the ENT-specialist or the AC. Here he is 
examined and receives a prescription for a hearing aid. Next, the hearing aid dispenser and the 
patients start a hearing aid trial, where the patient can try several hearing aids. When the patient and 
dispenser are satisfied with the hearing aid, the patient visits the ENT-specialist or AC to evaluate the 
hearing aid. 
 
1. If you were asked to value this pathway with a grade from 1 to 10, with 10 being the most 
favorable, what grade would you give? 
   
       
In the new pathway the hearing-impaired patient first visits the hearing aid dispenser. The dispenser 
examines whether the patient needs medical care. When necessary the dispenser refers the patient to 
an ENT-specialist or AC. When the patient is not in need of medical care, the dispenser and patient 
directly start the hearing aid trial, without prescription. When the patient and dispenser are satisfied 
with the hearing aid, the patient can go home without having his hearing aid evaluated by an ENT-
specialist or AC. 
 
2. If you were asked to value this pathway with a grade from 1 to 10, with 10 being the most 
favorable, what grade would you give? 
       
       
Could you please indicate whether you agree with the following statements? 
 
Totally 
agree 
Quite 
agree 
Neither 
agree 
nor 
disagree
Quite 
disagree
Totally 
disagree 
Don’t 
know 
3. I expect that the hearing aid 
dispenser will fit a good hearing aid 
without involvement of the ENT-
specialist or AC 
     O 
       
4. I find it important that the hearing 
aid is advised by an ENT-specialist 
or AC 
     O 
       
5. I find it important that the hearing 
aid is evaluated by an ENT-specialist 
or AC 
     O 
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Abstract 
Objectives 
To generate insight into the differences between utility measures EuroQol 5D (EQ-5D), 
Health Utilities Index Mark II (HUI2) and Mark III (HUI3) and their impact on the 
incremental cost-effectiveness ratio (ICER) for hearing aid fitting. 
Methods 
Persons with hearing complaints completed EQ-5D, HUI2 and HUI3 at baseline and, when 
applicable, after hearing aid fitting. Practicality, construct validity, agreement, 
responsiveness and impact on the ICER were examined. 
Results 
All measures had high completion rates. HUI3 was capable of discriminating between 
clinically distinctive groups. Utility scores (n=315) for EQ-5D UK and Dutch tariff (0.83; 
0.86), HUI2 (0.77) and HUI3 (0.61) were significantly different, agreement was low to 
moderate. Change after hearing aid fitting (n=70) for HUI2 (0.07) and HUI3 (0.12) was 
statistically significant, unlike the EQ-5D UK (0.01) and Dutch (0.00) tariff. ICERs varied 
from € 647 209 per QALY for the EQ-5D Dutch tariff to € 15 811 per QALY for HUI3. 
Conclusion 
Utility scores, utility gain and ICERs heavily depend on the measure that is used to elicit 
them. This study indicates HUI3 as the instrument of first choice when measuring utility in 
a population with hearing complaints, but emphasizes the importance of a clear notion of 
what constitutes utility with regard to economic analyses. 
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Introduction 
Hearing loss affects the ability to exchange information and therefore affects a person’s 
quality of life (Dalton et al., 2003). Of the western adult population, approximately 15% 
are hearing impaired (Davis, 1995), and for these persons hearing aid use has proven to be 
effective (Appollonio et al., 1996; Mulrow et al., 1990). The growth of the elderly 
population has far-reaching implications for auditory health service delivery and 
expenditure since the prevalence increases heavily with age. As a result, increasingly more 
economic evaluations are undertaken on interventions such as hearing aid fitting. In 
economic evaluations health related quality of life (HRQoL) should be measured with a 
preference-based utility measure (Drummond et al., 2005). Until recently, the benefits of 
hearing aid fitting had not translated into a statistically significant improvement in health 
state utility (Bess, 2000; Joore et al., 2003a; Joore et al., 2003b). In 2004 Barton et al. 
(2004) confirmed this for the EuroQol 5D (EQ-5D), but did find statistically significant 
utility gain after hearing aid fitting with the Health Utilities Index Mark III (HUI3). This 
difference may result from differences in the descriptive system, and the way the scoring 
function is derived. 
Also with regard to other conditions, a number of studies have found that different utility 
measures tend to lead to different utility scores (Bosch & Hunink, 2000; Brazier et al., 
2004; Conner-Spady & Suarez-Almazor, 2003; Espallargues et al., 2005; Feeny et al., 
2004; Kaplan et al., 2005; Kopec & Willison, 2003; Longworth & Bryan, 2003; Marra et 
al., 2004; Marra et al., 2005; O'Brien et al., 2003; Oostenbrink et al., 2002; Petrou & 
Hockley, 2005). In general there is need for head-to-head comparisons of utility measures, 
in order to assess the implications for the interpretation and comparability of economic 
analyses, especially in conditions where only subtle changes after treatment are expected 
(Brazier & Deverill, 1999; Pickard et al., 2005). In these comparisons the comparison of 
different tariffs should also be incorporated. But most importantly, the impact of the 
differences between measures on incremental cost-effectiveness ratios (ICERs) should be 
made apparent. Surprisingly, the latter has not yet received much attention. 
The objective of this article is to compare the two most frequently used utility measures in 
economic analyses (Rasanen et al., 2006) in a Dutch population with hearing complaints. 
Utility scores derived with the EQ-5D UK tariff (Dolan, 1997), the EQ-5D Dutch tariff 
(Lamers et al., 2005), the Health Utilities Index Mark 2 (HUI2) and HUI3 (Feeny et al., 
1995) are compared to generate further insight into the differences between the measures, 
and the impact on the ICER for hearing aid fitting. In particular, this article considers: 
1) practicality of using the EuroQol and HUI in a population with hearing complaints; 
2) construct validity of the EQ-5D UK tariff, EQ-5D Dutch tariff, HUI2 and HUI3; 
3) agreement between the EQ-5D UK tariff, EQ-5D Dutch tariff, HUI2 and HUI3; 
4) responsiveness of the EQ-5D UK tariff, EQ-5D Dutch tariff, HUI2 and HUI3 after 
hearing aid fitting; 
5) and the impact of on the ICER for hearing aid fitting. 
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Methods 
The EQ-5D, HUI2 and HUI3 
The five questions of the EQ-5D descriptive system each represent one dimension of 
health-related quality of life (mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression) (The EuroQol Group, 1990). Each question has three levels and the 
questions together classify persons into one of 243 health states. The commonly used 
scoring function is based on a British study (EQ-5D UK tariff) (Dolan, 1997), with 
preferences derived with the time trade-off (TTO) method, in a representative sample of the 
UK population of 2,997 respondents. The scoring function is additive and the possible 
range of utility scores is −0.59 to 1.00. Recently, Lamers et al. (2005) developed a Dutch 
scoring function for the EQ-5D (EQ-5D Dutch tariff), based on TTO in a sample of 298 
respondents, with utility scores ranging from −0.33 to 1.00. 
The 15 questions of the HUI descriptive system classify respondents into either HUI2 or 
HUI3 health states. The HUI system focuses on health ‘within the skin’, meaning that they 
purely focus on impairment and not on the social context of the impairment (Feeny et al., 
1995). HUI2 consists of seven attributes (sensation, mobility, emotion, cognition, self-care, 
pain and fertility), with three to five levels, leading to 24 000 possible health states. The 
optional fertility attribute was not used in the present study. The multiplicative scoring 
function was derived using standard gamble (SG) and Visual Analogue Scale (VAS) in a 
random sample of 293 Canadian respondents and utility scores range from −0.03 to 1.00 
(Torrance et al., 1996). HUI3 consists of eight attributes (vision, hearing, speech, 
ambulation, dexterity, emotion, cognition and pain), with five to six levels and leads to  
972 000 possible health states. The multiplicative scoring function was derived from SG 
and VAS, in a random sample of the Canadian general population (n=504), resulting in 
possible utility scores varying from −0.36 to 1.00 (Feeny et al., 2002). 
 
Study population and data collection 
Data were collected as part of a before-after study examining direct hearing aid provision 
versus provision by referral (AZOS working group, 2006). The study was carried out in 
2004–2005 in three regions (Maastricht, Rotterdam and Amsterdam) in the Netherlands. 
Persons with hearing complaints were recruited from the participating Ear Nose and Throat 
(ENT) departments, audiological centres and hearing aid dispensers. Both EQ-5D and HUI 
were administered at the first visit to the ENT department. Questionnaires were completed 
at the department, and respondents were helped by a trained interviewer if requested. 
Patients who were fitted with a hearing aid were asked to attend the ENT department for a 
follow-up visit to evaluate the hearing aid fitting. During the evaluation at the ENT 
department this subset of patients completed both questionnaires for a second time. Again, 
questionnaires were completed at the department, and respondents were helped by a 
trained interviewer if requested. 
 Choosing between measures 
53 
Practicality of the questionnaires 
Especially in an elderly population, an important aspect of a utility measure is the ease of 
completion. The practicality of using the EQ-5D and the HUI in a population with hearing 
complaints was therefore assessed by the completion rate, using a Wilcoxon Signed Ranks 
Test to test whether the completion rates were significantly different. Additionally we 
examined the item non-response. 
 
Construct validity 
In absence of a gold standard to measure health state utility, there is no clear technique to 
determine the construct validity of utility measures. A way to examine the construct validity 
is to examine whether utility scores are different for distinctive groups (Gross Portney & 
Watkins, 1993; Holland et al., 2004). Other studies have demonstrated differences of 
quality of life scores by sex (Burstrom et al., 2001; Holland et al., 2004; Lubetkin et al., 
2005) and age (Burstrom et al., 2001; Devlin et al., 2000; Kind et al., 1998; Lubetkin et al., 
2005). Comparisons were made between EQ-5D UK and Dutch tariff, HUI2 and HUI3 
scores by age (above versus below median) and sex. It was expected that persons of a 
higher age and females have lower utility scores. In addition, the respondents were divided 
into five clinically distinctive groups, based on their hearing loss and hearing aid use. 
Hearing loss was defined as the better ear pure tone average (BEPTA) hearing loss for the 
frequencies 1000, 2000 and 4000 Hz. The groups were: persons who were not entitled to 
reimbursement of a hearing aid (BEPTA < 35 dB); persons who were entitled to 
reimbursement (BEPTA ≥ 35 dB) but did not apply for a hearing aid (non-applicants); first 
time hearing aid applicants; experienced hearing aid users who were about to have a new 
hearing aid fitted (re-applicants); and experienced hearing aid users who did not have a 
new hearing aid fitted. 
It was expected that persons with a BEPTA smaller than 35 dB would have a higher quality 
of life score than persons in the other four groups, because they are likely to experience 
less problems with hearing. It was also expected that non-applicants had a higher utility 
score than first time applicants, since the latter group is expected to experience more 
hearing complaints, resulting in fitting a hearing aid as a solution for their hearing 
problems. 
Descriptive summary statistics were provided and normality was tested for all data using 
the Kolmogorov–Smirnov test. Kruskal–Wallis one way ANOVA and pairwise comparison 
tests (Mann–Whitney U) were used to explore the differences between the groups. 
 
Agreement 
To assess agreement between the measures, a Wilcoxon Signed-Rank test and a Paired t-
test were used to test whether the scores of the EQ-5D (UK and Dutch tariff), HUI2 and 
HUI3 had the same distribution and mean. Correlations (Kendall’s Tau) and the Intra-class 
Correlation Coefficient (ICC) were computed. The ICC was based on a two-way mixed 
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effect model, such that the subject effect was random and the instrument effect was fixed, 
and computed at the individual patient level. An ICC below 0.75 implies poor to moderate 
agreement; above 0.75 implies good agreement (Gross Portney & Watkins, 1993). 
 
Responsiveness 
Responsiveness was tested in the subpopulation with a valid score both before and after 
hearing aid fitting. Effect size and standardized response mean were calculated. Effect size 
is the change in score divided by the standard deviation of scores at baseline. Standardized 
response mean is the change in score divided by the standard deviation of the change in 
score. Both were interpreted using benchmarks for effect size: 0.20 through 0.49 is 
interpreted as small, 0.50 through 0.79 as moderate and ≥ 0.80 as large (Cohen, 1988). 
Also, a Wilcoxon Signed Ranks Test and a Paired t-test were conducted on the before and 
after scores. The change in score after hearing aid fitting was tested for differences between 
first time hearing aid applicants and re-applicants. It was expected that re-applicants had a 
smaller change in utility, since they already had a hearing aid and therefore expectedly less 
hearing problems at baseline. 
 
Impact on the ICER 
To illustrate the impact on the ICER, straightforward one year ICERs of hearing aid fitting 
versus no hearing aid fitting (doing nothing) were calculated. Quality Adjusted Life Years 
(QALYs) were calculated using the area under the curve method, for the EQ-5D (UK and 
Dutch tariff), HUI2 and HUI3 (Drummond et al., 2005). Baseline utility scores were used to 
estimate the effects of ‘no hearing aid fitting’. Costs of no hearing aid fitting were assumed 
to be zero. This was compared to the costs and effects after hearing aid fitting. The costs of 
hearing aid fitting were calculated prospectively for each respondent, including General 
Practitioner (GP) visit(s), ENT visit(s) and hearing aid(s). We used standard costs for medical 
consumption (Oostenbrink et al., 2004), and the actual price of the hearing aid. As costs 
and utility scores are generally not normally distributed, a non-parametric bootstrap 
sampling method was used to calculate the 95% confidence interval around the ICERs 
(Briggs et al., 1997). Cost-effectiveness acceptability curves for all measures were created 
to characterize the likelihood that hearing aid fitting will be deemed cost-effective based 
on the incremental costs and outcomes, for a range of ceiling ratios. Ceiling ratios reflect 
societies’ maximum willingness to pay for a unit of outcome. 
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Results 
Practicality 
Of the 337 persons with hearing complaints included in the study, in total 315 (93%) fully 
completed both the EQ-5D and the HUI descriptive system at baseline. Each item on the 
EQ-5D had six missing values, except for mobility (n=5). Regarding the HUI, all questions 
had six or seven missing values, except for the questions on hearing in a group 
conversation (n=12), pain and discomfort (n=10), and hearing in a conversation with one 
other person (n=8). Although completion rates were high for both questionnaires, EQ-5D 
was fully completed by 328 persons (97%), which is significantly more than the 318 
persons (94%) who completed the HUI (P-value 0.012). 
Of the 315 persons who completed both EQ-5D and HUI at baseline, 173 persons (55%) 
had a hearing aid fitted. Of them, 82 (47%) attended the ENT department for the follow-up 
visit after hearing aid fitting. Ninety-one respondents (53%) who had a hearing aid fitted 
did not show at the follow-up visit because they had not finished their hearing aid fitting 
before the end of the study (n=37), or because they had a hearing aid fitted at a dispenser 
not participating in the study (n=54), and were therefore lost to follow up. Of the 82 
respondents who did attend the follow-up visit, 70 (85%) fully completed both the EQ-5D 
and HUI descriptive system. Each item on the EQ-5D had five missing values, except for 
pain/discomfort (n=6). Regarding the HUI, the hearing questions both had four missing 
values, and the other questions had four to seven missing values. Seventy-six persons (93%) 
fully completed the EQ-5D, while 71 persons (87%) fully completed the HUI. This 
difference is not statistically significant (P-value 0.059). 
 
Construct validity 
Mean age of the respondents was 69.6 years (sd 8.9; median 70), and BEPTA was on 
average 42 dB. The respondents were divided into groups below 70 years old (n=156) 
versus 70 years and older (n=159) and male (n=189) versus female (n=126), see Table 3.1. 
The scores on the EQ-5D, HUI2 and HUI3 were not normally distributed (Kolmogorov–
Smirnov test, P-value 0.000). Only the EQ-5D detected differences in reported health by 
both age and sex. HUI3 detected a difference in utility between the age groups, HUI2 did 
not detect any differences. 
Furthermore, the respondents were divided into five clinically distinctive groups: BEPTA < 
35 dB (n=69), non-applicants (n=46), first time hearing aid applicants (n=108), re-
applicants (n=65), and experienced hearing aid users not applying for a new hearing aid 
(n=12). The latter group was excluded from the analysis because of the small sample size. 
Fifteen persons could not be classified into a clinical group because they were lost to 
follow-up after the first visit. 
Based on the EQ-5D and HUI2, no distinction could be made between any of the clinically 
distinctive groups. A logarithmic transformation was performed on the EQ-5D and HUI2 
data to compensate for skewness. Even after transformation, and also when correcting for 
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age, sex and BEPTA, no differences were found between the groups. Only HUI3 scores 
demonstrated a significant difference between the clinically distinctive groups (Kruskall–
Wallis; P-value 0.004). More specifically, HUI3 found significant differences between 
persons with a BEPTA < 35 dB and first time applicants (Mann–Whitney U; P-value 0.002), 
and between persons with a BEPTA < 35 dB and re-applicants (P-value 0.001). HUI3 did 
not confirm our expectation that non-applicants had significantly higher utility scores than 
first time applicants. As expected, non-applicants stated less problems on the hearing 
attribute than first time applicants, but they also stated more problems on the ambulation 
and pain attributes. 
 
Agreement 
A summary of the utility scores is presented in Table 3.2. Mean utility scores for the 
population with hearing complaints were higher for the EQ-5D Dutch tariff (mean 0.86; 
standard deviation 0.18) and EQ-5D UK tariff (0.83; sd 0.21) than for the HUI2 (0.77; sd 
0.14) and HUI3 (0.61; sd 0.24). The differences in mean scores and distributions are 
statistically significant. The UK and Dutch tariff of the EQ-5D and HUI2 and HUI3 were 
found to have good agreement, since they were strongly correlated (0.90; 0.71) and had an 
ICC of 0.98 and 0.74, respectively. The scores on all other measures showed statistically 
significant, but low correlations and their agreement was moderate to poor (Table 3.3). 
Ceiling effects were observed in the EQ-5D UK tariff (Figures 3.1 and 3.2), results were 
similar for EQ-5D Dutch tariff. As measured with the EQ-5D (both UK and Dutch tariff), 
44% of the respondents reported perfect health, despite their hearing complaints. Measured 
with the HUI2 or HUI3, less than 1% of the respondents reported perfect health. For 
respondents reporting perfect health on the EQ-5D, mean utility scores were 0.83 on the 
HUI2 (range 0.35–1.00) and 0.71 on the HUI3 (range 0.06–1.00). 
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Table 3.2 Utility scores in baseline population with hearing complaints (n=315) 
Measure Minimum Maximum Median* Interquartile 
range
Mean** Standard 
Deviation 
EQ-5D UK tariff -0.25 1.00 0.85 0.27 0.83 0.21 
EQ-5D Dutch tariff -0.03 1.00 0.86 0.19 0.86 0.18 
HUI2 0.23 1.00 0.79 0.15 0.77 0.14 
HUI3 -0.07 1.00 0.62 0.38 0.61 0.24 
* All statistically significantly different: Wilcoxon Signed-Rank test; p < 0.01 
** All statistically significantly different: Paired t-test; p < 0.01 
 
 
Table 3.3 Agreement in the baseline population with hearing complaints (n=315) 
Pairs of utility functions Kendall’s Tau* ICC (95% Confidence Interval) 
EQ-5D UK tariff versus HUI2 r = 0.41 0.51 (0.42 to 0.59) 
EQ-5D UK tariff versus HUI3 r = 0.37 0.47 (0.38 to 0.55) 
EQ-5D UK versus Dutch tariff r = 0.90 0.98 (0.97 to 0.98) 
HUI2 versus HUI3 r = 0.71 0.74 (0.68 to 0.78) 
HUI2 versus EQ-5D Dutch tariff r = 0.40 0.51 (0.42 to 0.59) 
HUI3 versus EQ-5D Dutch tariff r = 0.36 0.44 (0.35 to 0.53) 
ICC = Intraclass Correlation Coefficient 
* All statistically significant, p < 0.01 
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Figure 3.1  Scatterplot of utility scores derived with EQ-5D UK tariff and HUI2  
 
 
 
Figure 3.2 Scatterplot of utility scores derived with EQ-5D UK tariff and HUI3 
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Responsiveness 
Responsiveness was tested in the subpopulation with a valid score both before and after 
hearing aid fitting (n=70). The effect size and standardized response mean of the EQ-5D 
UK (0.05; 0.05) and Dutch tariff (0.03; 0.02) were less than small. HUI2 and HUI3 were 
more responsive to change after hearing aid fitting, since both had a moderate effect size 
(0.64; 0.55) and standardized response mean (0.57; 0.66). 
Mean change in utility after hearing aid fitting (Table 3.4) was highest when measured with 
the HUI3 (mean 0.12; sd 0.18) and HUI2 (0.07; sd 0.13), while almost no change was 
measured with the EQ-5D (UK tariff 0.01, sd 0.13; Dutch tariff 0.00, sd 0.12). The change 
in utility measured with HUI2 and HUI3 is statistically significant (Paired t-test, P-values 
0.005 and 0.000). No change was observed in any attribute of the EQ-5D (Figure 3.3a). 
The change in HUI2 utility score after hearing aid fitting occurred in the sensation attribute 
(Figure 3.3b) and in the HUI3 score in the hearing attribute (Figure 3.3c). Almost no change 
was observed in any of the other attributes of the HUI2 and HUI3. 
The mean change in utility score after hearing aid fitting, when measured with HUI2 and 
HUI3, was higher for first-time hearing aid applicants (0.08; 0.13) than for re-applicants 
(0.06; 0.10). This outcome was in line with our expectations, but is not significantly 
different. 
 
 
 
 
 
 
 
 
 
Table 3.4 Change in health state utility after hearing aid fitting and ICER with 95% Confidence 
Interval (CI) (n=70) 
Measure Mean Standard 
deviation
Median  
 
IR Min Max ICER1
€ / QALY 
(95% CI) 
€ / QALY 
EQ-5D 
UK tariff 
0.01 0.13 0.00  0.04 -0.60 0.27 286 866 (inferior2 – 47 082) 
EQ-5D  
Dutch tariff 
0.00 0.12 0.00  0.04 -0.60 0.28 647 209 (inferior2 – 61 934) 
HUI2 0.07* 0.13 0.08 ** 0.12 -0.50 0.40 25 337 (19 356 – 38 012) 
HUI3 0.12* 0.18 0.13 ** 0.22 -0.22 0.60 15 811 (11 664 – 24 654) 
Abbreviations: IR = interquartile range ; Min = minimum ; Max = maximum ; ICER = Incremental Cost-
Effectiveness Ratio ; QALY = Quality Adjusted Life Year 
* Statistically significant; Paired t-test; p < 0.01 
** Statistically significantly different: Wilcoxon Signed-Rank test; p < 0.01 
1ICER based on mean scores; 2Inferior means higher costs and lower utility 
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Figure 3.3 Percentage of responses for each level of each attribute before (B) and after (A) hearing 
aid fitting for a) EQ-5D, b) HUI2 and c) HUI3 
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Impact on the ICER 
Mean costs of doing nothing were zero. The mean costs of hearing aid fitting were € 1877. 
The latter consisted of GP visits (€ 37), ENT visits (€ 295) and hearing aid(s) (€ 1545). All 
hearing aids were digital, and hearing aids were bilaterally fitted in 83% of the 
respondents. 
This resulted in mean one-year incremental costs of hearing aid fitting versus doing nothing 
of € 1877. The mean utility gain of 0.01 (sd 0.13), measured with the EQ-5D UK tariff, 
resulted in a ratio of € 286 866 per QALY, with a 95% confidence interval of inferior 
(higher costs, lower utility) to € 47 082/QALY. There was a 36% probability that hearing 
aid fitting was both more costly and less effective (inferior). The mean utility gain of 0.003, 
measured with the EQ-5D Dutch tariff, resulted in an ICER of € 647 209 per QALY (95% 
confidence interval: inferior to € 61 934/QALY). There was a 42% probability that hearing 
aid fitting was inferior. Applying the HUI2 and HUI3, the ICER was € 25 337 per QALY 
(95% confidence interval: € 38 012/QALY to € 19 356/QALY) and € 15 811 per QALY 
(95% confidence interval: € 24 654/QALY to € 11 664/QALY) respectively. For both 
measures there was no probability that hearing aid fitting was inferior. 
The informal Dutch ceiling ratio of € 20 000 per QALY (CBO, 1998) implied that hearing 
aid fitting was only cost-effective when utility was measured with the HUI3. A cost-
effectiveness plane with incremental cost and effect pairs for 1000 bootstrap replications, 
for all measures, is shown in Figure 3.4. Figure 3.5 shows the cost-effectiveness 
acceptability curves for all measures. 
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Figure 3.4  Incremental cost-effectiveness ratio for hearing aid fitting (Incremental costs (euro) are 
displayed at the vertical line, incremental effects (QALYs) on the horizontal line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5  Cost-effectiveness acceptability curves of EQ-5D UK and Dutch tariff, HUI2 and HUI3 
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Conclusion and discussion 
Hearing loss affects the exchange of information and therefore affects a person’s quality of 
life (Dalton et al., 2003). Hearing impaired persons can benefit from using a hearing aid, 
since hearing aid use has proven to be effective, it improves social, emotional and 
communication functions and reduces depression (Appollonio et al., 1996; Mulrow et al., 
1990). 
The results of this study in a relatively healthy population with hearing complaints provide 
insight in the differences between two widely used utility measures, the EQ-5D and the 
HUI system. 
Regarding practicality, both questionnaires had high completion rates, with the EQ-5D 
having a higher completion rate than the HUI. 
With the EQ-5D, differences were detected in utility by age and sex, indicating construct 
validity. The HUI3 detected differences by age, but not by sex. Differences between 
clinically distinctive groups were only detected by HUI3. However, the HUI3 did not 
confirm our expectation that non-applicants would have higher utility values than first-time 
applicants. An explanation for this may be that non-applicants had more health problems 
other than their hearing, as reflected in the ambulation and pain dimensions of the HUI3. 
Overall, HUI2 and HUI3 scores were lower than EQ-5D scores and agreement was 
moderate to poor. Although these measures intend to assess the same construct, namely 
health state utility, this result was expected as the instruments differ in their underlying 
assumptions about what constitutes health state utility. 
As to responsiveness, only HUI2 and HUI3 measured statistically significant improvement 
after hearing aid fitting, the EQ-5D UK and Dutch tariff both were not able to capture this 
effect. Half of the patients (53%) who were fitted with a hearing aid were lost to follow up, 
either because they had not finished their hearing aid fitting before the end of the study, or 
because they had their hearing aid fitted at a dispenser not participating in our study. As 
these patients did not differ from the follow-up group in baseline utility, hearing loss and 
age, we did not expect this low response rate to influence the results. 
The HUI2 and HUI3 change scores resulted in smaller ICERs for hearing aid fitting. 
Although they were only illustrative, the different ICERs found in the present study clearly 
show that the choice of a utility instrument in the economic evaluation of hearing aid 
fitting may heavily influence the cost-effectiveness outcome. 
To calculate the ICER of hearing aid fitting we included the total population of respondents 
considered for hearing aid fitting, regardless of the type of hearing aid fitting. This makes 
the ICERs found in the present study representative for hearing aid fitting in general in the 
Netherlands. However, the one year ICERs calculated in the present study were merely 
illustrative of the impact of different utility scores on the ICER of hearing aid fitting, as the 
cost-effectiveness of hearing aid fitting has thoroughly been examined by Joore et al. 
(2003b). 
Our results confirm Barton et al. (2005; 2004), who compared the EQ-5D UK tariff and 
HUI3 before and after hearing aid fitting in a UK sample. However, the change in utility 
after hearing aid fitting derived with the HUI3 in the present study was twice the change in 
utility derived with the HUI3 in the study of Barton et al. (2004). Respondents in the latter 
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study had a lower baseline utility score and a higher range in utility change after hearing 
aid fitting, which suggests a somewhat different study population. Our results confirm 
previous studies that concluded that the EQ-5D lacks sufficient sensitivity to measure the 
benefit of hearing aid fitting (Bess, 2000; Joore et al., 2003a; Vuorialho et al., 2006b). The 
lower utility scores and higher responsiveness of the HUI3 in relation to the EQ-5D were 
also found in a population with visual impairment (Espallargues et al., 2005). Joore et al. 
(2003b) calculated that hearing aid fitting costs € 15 807 per QALY, using the EQ-5D as 
utility measure. The results of the present study that using the HUI3 as utility measure 
probably had resulted in a more favourable ICER for hearing aid fitting. Vuorialho et al. 
(2006a) recently concluded that counseling of hearing aid users to reduce the number of 
non-users is highly cost-effective, although they were unable to measure any change in 
utility. As they used the EQ-5D, it is possible that they would have been able to 
demonstrate favourable costs per QALY when they would have used the HUI3 to measure 
change in utility. 
Three questions arise from the results of the present study: can differences be explained by 
differences in the measures, are the differences observed between the measures important, 
and what are the implications of the findings for utility measurement and cost-utility 
analysis in populations with hearing complaints? 
First, differences in utility scores can be explained by differences in the descriptive system 
and the way the utility scoring function is derived. Regarding the descriptive system, the 
focus of the EQ-5D on physical, mental and social functioning (Brooks, 1996) differs from 
the ‘within-the-skin’ perspective of HUI, which focuses on the underlying level of 
impairment. However, this does not explain why the EQ-5D does not measure change after 
hearing aid fitting, as previous studies have found that hearing aid fitting improves social 
and emotional functioning (Appollonio et al., 1996; Mulrow et al., 1990). Also, the 
measures differ in the content and number of attributes, items and levels used, and 
therefore differ both in the number and in the content of possible health states. It has 
already been suggested not to use the EQ-5D in relatively healthy populations, given the 
presence of a ceiling effect (Kopec & Willison, 2003). The ceiling effect of the EQ-5D 
found in the present study is likely to contribute to the differences in responsiveness. 
When, as found in our study, 44% of the respondents report perfect health at baseline, it is 
unlikely to find a considerable utility gain from any intervention. Furthermore, since the 
HUI descriptive system pays explicit attention to hearing abilities, it is to be expected that 
in a relatively healthy population with hearing complaints HUI and EQ-5D utility scores 
differ, and HUI is more responsive. As the HUI3 also pays explicit attention to visual 
abilities, this may explain why comparisons of EQ-5D and HUI3 in hearing and vision 
show similar results (Espallargues et al., 2005). 
There are also differences in the utility scoring functions. Although in general SG (used for 
HUI) leads to higher scores than TTO (used for EQ-5D) (Drummond et al., 2005), in the 
present study the EQ-5D scores were considerably higher than the HUI scores. Although 
different populations do not necessarily yield different results (Drummond et al., 2005), the 
population sample in which the preferences are measured may also have impact on the 
differences. In the present study, differences between utilities derived with the UK and 
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Dutch tariff were observed. This difference may be the result of differences in health 
valuation between people from the Netherlands and the UK, but may also result from the 
somewhat questionable representativeness of the population sample used to develop the 
Dutch tariff (Lamers et al., 2005). 
Differences also exist in the type of scoring function. EQ-5D uses an additive system, 
assuming no interaction for preferences among attributes at all. The HUI uses a 
multiplicative scoring function, with the effect that the loss of utility associated with a 
particular dimension is dependent on the level of impairment on other dimensions 
(Drummond et al., 2005). For example, Barton et al. (2005) illustrated that hearing 
impairment (‘unable to hear at all’) has a greater impact on HRQoL as measured with the 
HUI3 when one has no other health problems (−0.53), than when one also has moderate to 
severe pain and is unable to see at all (−0.05). It seems rational that persons find their 
hearing loss a less important aspect of their health state utility when they experience more 
comorbidity. The multiplicative scoring function of HUI takes this influence of comorbidity 
into account and seems to be more suitable for modeling utility scores. 
Are the differences observed between the measures important? The answer to this question 
is a clear ‘yes’. The impact of different utility measures on the ICER for hearing aid fitting is 
of a magnitude that can alter policy decisions and emphasizes that comparisons of QALYs 
across studies and interventions should be interpreted with caution (Conner-Spady & 
Suarez-Almazor, 2003). The general purpose of a utility measure is to capture the health 
effects in terms of HRQoL of a policy or program for use in economic analyses. Health 
economic analyses are a tool to allocate resources in a way that maximizes health (or 
welfare). In order to use the outcomes of economic analyses for policy decisions, there 
should however be a clear notion of what should be maximized. The results of the present 
study show that the potential benefit of an intervention heavily depends on the assumptions 
of what constitutes health underlying the utility measure that is used. Beyond the apparent 
necessity of psychometric quality of a utility measure, an important area for future research 
is whether societies wish, or should, maximize life expectancy corrected for HRQoL from a 
more functional perspective as in the EQ-5D, or from a ‘within-the-skin’ perspective as in 
the HUI. Other studies that have thoroughly examined the psychometric differences 
between utility measures seem to pass over this important question (Brazier et al., 2004; 
Feeny et al., 2004; O'Brien et al., 2003; Petrou & Hockley, 2005; Pickard et al., 2005). 
What are the implications of the findings for utility measurement and cost-utility analysis in 
populations with hearing complaints? Generally, it has been recommended that the 
instrument that is most sensitive to the health states in which one is interested should be 
selected (Conner-Spady & Suarez-Almazor, 2003; Drummond et al., 2005; Guyatt et al., 
1996). From clinical experience it is plain that hearing aid use is effective in alleviating 
hearing loss and does improve health-related quality of life, but the EQ-5D lacks the 
sensitivity to capture this improvement. In an otherwise healthy population, HUI3 has 
proven to be more responsive and therefore more appropriate for evaluating HRQoL in a 
population with hearing complaints, and is therefore the instrument of first choice in this 
population. 
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Abstract 
Rationale & objectives 
Different question formats elicit different willingness to pay (WTP) results, but there is no 
consensus on which method elicits the most valid WTP. In spite of the methodological 
controversies, WTP is a potentially valuable tool in health economics to value health 
services. Our general objective was to provide additional evidence on the validity of two 
WTP elicitation formats: the open-ended question and the payment scale. 
Method 
We elicited WTP for a hearing aid among hearing aid users (n=108), using both a payment 
scale and an open-ended question. We compared the results from both formats. We tested 
criterion validity by comparing both formats with the actual out-of-pocket payment. 
Construct validity was tested by examining whether WTP was consistent with positive 
income elasticity. 
Results 
The WTP results elicited with the payment scale and open-ended question were not 
statistically significantly different. Both formats showed good criterion validity, although the 
open-ended question showed a stronger association with the actual out-of-pocket payment. 
The open-ended format showed better construct validity, as it was influenced by family 
income. 
Conclusion 
The results of the present study showed that the open-ended question was more valid than 
the payment scale question. We therefore recommend that in future WTP studies on 
hearing aids the open-ended question is used to directly elicit WTP values. The same 
recommendation may apply to other studies where respondents are familiar with costs or 
payments for the intervention under evaluation. 
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Background 
In the last decade there has been renewed interest in cost-benefit analysis (CBA) as a 
method for the economic evaluation of health care interventions (Diener et al., 1998). CBA 
distinguishes itself from cost-effectiveness analysis in that not only the costs, but also the 
benefits of health care interventions are valued in monetary units (Drummond et al., 2005). 
A common method to estimate monetary values for health care interventions is direct 
willingness to pay (WTP), also known as contingent valuation. In the WTP approach, the 
maximum amount that an individual is willing to pay to obtain a good is elicited using a 
hypothetical scenario by means of a survey. The WTP technique was originally developed 
by environmental economists, but is increasingly used in health economics. Despite its 
widespread use, there are some methodological controversies, for example with respect to 
the type of question asked (Diener et al., 1998; O'Brien & Gafni, 1996). There are four 
types of questions to directly measure maximum WTP: the open-ended, payment scale, 
bidding game and discrete-choice format (Frew et al., 2003; O'Brien & Gafni, 1996; Ryan 
et al., 1997; Smith, 2000). In an open-ended question the respondent is asked to state the 
maximum amount of money he or she is willing to pay to receive a certain intervention, 
without any clues or options given. In the payment scale approach, each respondent 
chooses an amount from the same pre-specified and ordered list of WTP amounts. When 
using the bidding game, an interviewer suggests WTP amounts that the respondent accepts 
or rejects and continues to make higher or lower offers depending on whether the 
respondent accepts or rejects the previous offers. In the discrete-choice format, different 
respondents receive different offers, and each respondent is required to make an 
accept/reject choice at this single, predetermined offer. As the bidding game format 
requires face-to-face interviews and the discrete choice format requires a very large 
number of respondents, both are not feasible in all situations (Klose, 1999). Different 
question formats have been found to elicit different WTP results, but there is no consensus 
on which method elicits the most valid WTP (Diener et al., 1998; O'Brien & Gafni, 1996; 
Onwujekwe, 2004; Smith, 2000). In spite of the methodological controversies, WTP is a 
potentially valuable tool in health economics to value health services (Olsen & Donaldson, 
1998). The present study therefore provides additional evidence on the validity of two 
elicitation formats: the open-ended question and the payment scale. We collected this 
evidence in a study on willingness to pay for hearing aids. Our first objective was to 
examine whether an open-ended question and payment scale question elicit different 
monetary values. Our second objective was to explore which of the two elicitation formats 
is more valid. 
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Methods 
Setting 
Hearing loss is one of the most common forms of sensory impairment, with an estimated 
prevalence of 15% in the western adult population (Davis, 1995; Johansson & Arlinger, 
2003). Hearing aid fitting has been proven to be effective (Larson et al., 2000). 
Nevertheless, in the past decade, health care policy makers have begun to demand 
economic evidence regarding the efficiency of hearing aids. Joore et al (2003b) 
demonstrated that hearing aid fitting is a cost-effective health care intervention. In light of 
the renewed interest in CBA as a method for the economic evaluation of health care 
interventions a study was carried out to examine how much hearing aid users are willing to 
pay for a hearing aid. 
In most countries hearing aid users have to pay for their hearing aids. In the Netherlands, 
patients with a hearing loss exceeding 35 dB, averaged over 1, 2 and 4 kHz in the better 
ear, are entitled to a maximum reimbursement by their medical insurance of € 657,50 per 
hearing aid. This reimbursement is doubled when patients are fitted with a hearing aid on 
both ears (binaural fitting). Generally, the hearing aid dispenser collects the reimbursement 
and the patient is billed only for that part of the hearing aid price (including the costs of 
fitting) that exceeds the reimbursement. The latter will be referred to as the out-of-pocket 
payment. In contrast to most WTP studies in health care, the amount a person is willing to 
pay can be compared to what the person actually has paid for a hearing aid. This makes 
hearing aid provision a useful subject to examine the validity of WTP. 
 
Study design and population 
The study design was a survey. A questionnaire, designed for self-completion without 
supervision, was distributed at three hearing aid dispenser practices and two Audiological 
Centres in and near Maastricht, the Netherlands. The study population consisted of adult 
hearing aid users, both first time and experienced hearing aid users. For the duration of one 
week in 2003 all consulting hearing aid users were asked to fill out this questionnaire while 
attending the practice or centre. 
 
Questionnaire 
The total questionnaire consisted of 40 questions regarding quality of life, hearing 
handicap, demographic items as well as items addressing the maximum WTP for a hearing 
aid and the amount the respondent had actually paid for his or her hearing aid. The present 
analysis focused on the WTP questions and the actual out-of-pocket payment question. 
Both WTP and actual out-of-pocket payment were defined as the amount exceeding the 
reimbursement, since in the Netherlands hearing aid users are only billed for this part of 
the hearing aid price. We elicited WTP with the two formats most applicable for use in a 
questionnaire for self-completion: the payment scale and open-ended format. In question 
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26 the respondents were asked to state the maximum amount they were willing to pay out-
of-pocket for one hearing aid (Appendix 4.1) on a payment scale. The payment scale had 
the following categories: not willing to pay, € 50, € 100, € 250, € 500, € 1000 and € 2000. 
The range was based on the actual range of out-of-pocket payments for a hearing aid in the 
Netherlands. At the end of the questionnaire (question 40) the exact same WTP question 
was asked, now using the open-ended format (Appendix 4.1). The actual out-of-pocket 
payment for the respondent’s current hearing aid(s) was elicited using an open-ended 
format (question 11; Appendix 4.1). The questionnaire also included several demographic 
questions regarding age, sex, marital status, education, and family income. Respondents 
were requested to answer all questions. The complete questionnaire in Dutch is available 
upon request. 
 
Data analysis 
Descriptive statistics were obtained for the demographics, the payment scale and the open-
ended WTP question. The results on the payment scale WTP question were coded as the 
amounts corresponding to the payment scale categories (not willing to pay, € 50, € 100,    
€ 250, € 500, € 1000 and € 2000). Normality of the data was tested using the Kolmogorov-
Smirnov test. A Wilcoxon Signed Ranks Test was used to test whether the open-ended and 
payment scale format elicited different WTP, and Spearman correlation was calculated to 
examine whether and how strongly they were related. In conformance with Cohen (1988), 
correlation coefficients smaller than 0.3 were considered weak, between 0.3 and 0.5 
moderate and higher than 0.5 a strong relationship. Also, the results on both the payment 
scale and open-ended WTP question were analyzed using multiple regression analysis to 
assess whether the outcome on one WTP question influenced the outcome on the other 
WTP question. The WTP values were used as the dependent variables. In case the 
dependent variables were not normally distributed, we examined the skewness and kurtosis 
and, if necessary, transformed the values by taking the square root to obtain acceptable 
distributions. In both analyses the other WTP question was considered as possible 
explanatory variable. 
To explore which format elicited more valid results, we tested the criterion and construct 
validity of both the payment scale and open-ended WTP question. The criterion validity 
can be examined by comparing the results with a gold standard (Streiner & Norman, 1995). 
For WTP questions, actual payments are the gold standard (Drummond et al., 2005; 
Onwujekwe, 2004). We therefore compared the WTP results with the actual out-of-pocket 
payment to examine the criterion validity. In cases where a respondent was binaurally 
fitted, the answer on the out-of-pocket payment question was divided by two, to obtain the 
actual out-of-pocket payment per hearing aid. A Wilcoxon Signed Ranks Test was used to 
test whether WTP and actual out-of-pocket payment were different, and Spearman 
correlation was calculated to examine whether and how strongly they were related. Also, 
we considered actual out-of-pocket payment as explanatory variable in the multiple 
regression analysis, to examine whether actual out-of-pocket payment was associated with 
WTP. 
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The construct validity can be examined by determining whether the results are consistent 
with theoretical constructs (Streiner & Norman, 1995). We tested whether the data were 
consistent with a theoretical construct from economic theory: positive income elasticity 
(Maxwell, 1981), meaning that higher incomes should be associated with higher WTP. 
First, Spearman correlation was calculated to examine whether and how strongly family 
income and WTP were related. Next, we considered family income as explanatory variable 
in the regression analysis. 
Besides the other WTP question, the actual out-of-pocket payment and family income, age 
and hearing aid experience were included as explanatory variables in the regression 
models. We expected younger respondents to state a higher WTP value, since it is more 
likely that they need hearing aids for work or social activities. We expected persons with 
hearing aid experience to state higher WTP values since they are likely to attach more 
value to, or be more aware of, the benefits of hearing aids. Pairwise inclusion was used, 
meaning that cases which had a valid value for at least one of the independent variables 
were included. All models were fitted by backward elimination and only the final models 
are reported in this paper. 
For all tests a p-value smaller than 0.05 was considered to be statistically significant. All 
analyses were performed using the Statistical Package for the Social Sciences, version 
12.01. 
 
 
Results 
Study population 
A total of 108 respondents completed the questionnaire (Table 4.1). The majority of the 
respondents were male (57%) and the mean age was 67.8 years (standard deviation 12.4). 
Sixteen percent reported a monthly family income of less than € 1150 and 7% a family 
income above € 3400. Approximately half of the respondents (48%) were first time hearing 
aid users and 45% were experienced hearing aid users, for 7% hearing aid experience was 
unknown. Of the respondents 29% were monaurally and 57% were binaurally fitted. 
Almost all respondents (93%) stated to be satisfied with their hearing aid. 
 
Payment scale versus open-ended format 
For the total study population, maximum willingness to pay for a hearing aid was on 
average € 329 (sd 445) when measured with the payment scale and € 316 (sd 337) when 
measured with the open-ended question (Table 4.2). Median scores were € 250 for both 
WTP questions. The data were not normally distributed (Kolmogorov-Smirnov, p-values < 
0.01), but were skewed to the right. Therefore, non-parametric statistics were used. 
However, as mean WTP results are used in economic analyses and therefore are highly 
informative, we also list means, standard deviations and ranges. 
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Table 4.1 Characteristics of the study population. Values are numbers (percentages) unless stated 
otherwise 
Characteristics  
Number of respondents 108  
Age   
 Mean (standard deviation) 
Range 
67.8 (12.4) 
27.9 - 92.5 
 
 
Male 62 57.4 % 
Marital status    
 Married 
Widow/ widower 
Not married 
Living together 
Missing 
73 
21 
9 
2 
3 
67.6 % 
19.4 % 
8.3 % 
1.9 % 
2.8 % 
Education    
 Primary school 
Lower education 
Junior general secondary education (MAVO) 
Senior secondary vocational education (MBO) 
Senior general secondary education (HAVO/VWO) 
Higher professional education (HBO) / university 
Missing 
21 
22 
25 
13 
9 
14 
4 
19.4 % 
20.4 % 
23.1 % 
12.0 % 
8.3 % 
13.0 % 
3.7 % 
Family income    
 € 400 – 1150 
€ 1150 – 1600 
€ 1600 – 2500 
€ 2500 – 5000 
Don’t know 
Not willing to answer 
Missing 
17 
15 
16 
11 
9 
21 
19 
15.7 % 
13.9 % 
14.8 % 
10.1 % 
8.3 % 
19.4 % 
17.6 %  
Hearing aid experience 
   
 First time hearing aid user 
Experienced hearing aid user 
Missing 
52 
49 
7 
48.1 % 
45.4 % 
6.5 % 
Type of hearing aid fitting 
   
 Monaural 
Binaural 
Missing 
31 
61 
16 
28.7 % 
56.5 % 
14.8 % 
Satisfied with hearing aid  97 93.3 % 
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Table 4.2  Descriptives and comparison of the results of the payment scale and the open-ended 
WTP question 
Total group 
Valid N
total
Missing
N (%)
Mean (sd)
€
Range Median 
€
IR 
€
p-value1 Spearman 
correlation 
Payment scale WTP 99 9   (8) 329 (445) 0-2000 250 400  
Open-ended WTP 70 38 (35) 316 (337) 0-1500 250 325   
 
Group for comparison 
 
Payment scale WTP  67 41 (38) 323 (382) 0-2000 250 400
Open-ended WTP 67 41 (38) 320 (341) 0-1500 250 300
0.879 0.775** 
Abbreviations: IR = interquartile range; sd = standard deviation; WTP = willingness to pay 
1 Wilcoxon Signed Ranks Test 
** Correlation is significant at the 0.01 level (2-tailed) 
 
 
The 67 respondents who answered both the payment scale and open-ended WTP question 
had mean WTP values of € 323 (sd 382) and € 320 (sd 341) respectively (Table 4.2). The 
median scores on both the open-ended and payment scale WTP question were € 250 and 
showed no statistically significant difference (Wilcoxon Signed Ranks Test, p-value .879). 
The results on the payment scale WTP question ranged from not willing to pay to € 2000, 
and on the open-ended WTP question the results ranged from not willing to pay to € 1500. 
There were statistically significantly more missing values on the open-ended WTP question 
(35%) than on the payment scale WTP question (8%). The WTP questions had a Spearman 
Correlation of .775 (p-value .000), indicating a statistically significant and strong 
relationship. 
The regression analyses showed that the results on both WTP formats were positively and 
statistically significantly associated with each other (Table 4.3). 
 
 
Table 4.3 Final models of the multiple regression analysis for both the payment scale and open-
ended WTP question 
  Payment scale WTP question Open-ended WTP question 
(square root transformation) 
 Regression model Regression model 
Independent variable b S.E. p-value b S.E. p-value 
Constant -1.63 0.63 0.012 6.79 4.63 0.151 
Open-ended WTP question 0.13 0.012 0.000  
Payment scale WTP question  4.42 0.54 0.000 
Age 0.03 0.008 0.000 -0.13 0.06 0.041 
Family income  1.13 0.43 0.012 
Actual out-of-pocket payment  0.01 0.00 0.026 
 Explained variance = 65.2 % Explained variance = 74.8 % 
Abbreviations: WTP = willingness to pay; S.E. = standard error 
 Willingness to pay for a hearing aid 
75 
Validity 
To test the criterion validity, we compared the WTP results with the actual out-of-pocket 
payments. Of the 108 respondents, 60 answered both the payment scale WTP question and 
the actual out-of-pocket payment question (Table 4.4). Thirty respondents (50%) stated a 
higher WTP than their actual out-of-pocket payment, while for 28 respondents (47%) WTP 
was lower than their actual out-of-pocket payment. The payment scale WTP question and 
actual out-of-pocket payment had median scores of € 250 and € 339 respectively and were 
not statistically significantly different (Wilcoxon Signed Ranks Test, p-value .301). The 
payment scale WTP question and actual out-of-pocket payment had a Spearman 
Correlation of .277 (p-value .032), indicating a statistically significant, weak relationship. 
The regression analysis indicated that the actual out-of-pocket payment did not 
significantly influence the results on the payment scale WTP question (Table 4.3). 
Answers on both the open-ended WTP question and the actual out-of-pocket payment 
question were provided by a total of 47 respondents (Table 4.4). Of them, 21 (45%) had a 
higher WTP than actual out-of-pocket payment, and 25 (53%) had a lower maximum WTP 
than actual out-of-pocket payment. The median scores of the open-ended WTP question 
and the actual out-of-pocket payment were € 250 and € 277 respectively and were not 
significantly different (Wilcoxon Signed Ranks Test, p-value .260). The results on the open-
ended WTP question and the actual out-of-pocket payment had a Spearman Correlation of 
.383 (p-value .008), indicating a statistically significant, moderate relationship. The 
regression analysis showed that the actual out-of-pocket payment significantly and 
positively influenced the results on the open-ended WTP question (Table 4.3). 
To test for construct validity, we examined whether higher family income was associated 
with higher WTP. The results on the payment scale WTP question and family income had a 
Spearman Correlation of .209 (p-value .130), indicating no relationship. In the regression 
analysis with the payment scale WTP question as dependent variable, family income was 
not associated with WTP. 
 
 
Table 4.4 Comparison of the actual out-of-pocket payments with the payment scale and open-
ended WTP question 
 
Valid N
listwise
Missing
N (%)
Mean (sd)
€
Range
€
Median 
€
IR p-value1 Spearman  
correlation 
Actual payment 60 48 (44) 398 (277) 0-1000 339 433
Payment scale WTP 60 48 (44) 398 (531) 0-2000 250 400
0.301 0.277* 
  
Actual payment 47 61 (57) 354 (251) 0-1000 277 351
Open-ended WTP 47 61 (57) 307 (340) 0-1500 250 300
0.260 0.383** 
Abbreviations: sd = standard deviation; IR = interquartile range; WTP = willingness to pay 
1 Wilcoxon Signed Ranks Test 
* Correlation is significant at the 0.05 level (2-tailed) 
** Correlation is significant at the 0.01 level (2-tailed) 
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The results on the open-ended WTP question and family income had a Spearman 
Correlation of .427 (p-value .004), indicating a statistically significant, but moderate 
relationship. With the open-ended question as dependent variable, regression analysis 
showed that a higher WTP was associated with a higher income (Table 4.3). 
Lower age was associated with higher WTP in the regression model with the open-ended 
WTP question as dependent variable (Table 4.3). However, in the regression model with 
the payment scale WTP question as dependent variable, higher age was associated with 
higher WTP. In both question formats, hearing aid experience did not influence WTP. 
 
 
Discussion 
The present study examined willingness to pay for a hearing aid and adds to the limited 
evidence available on the validity of direct willingness to pay formats. 
On average, hearing aid users in the Netherlands were willing to pay at maximum € 329 
for a hearing aid when measured with the payment scale WTP question, and € 316 when 
measured with the open-ended WTP question. We found no statistically significant 
difference, and a strong association between both formats. Thus, in a population of hearing 
aid users, who are familiar with payment for their hearing aid, the payment scale and open-
ended question do not result in statistically significantly different results. Previous studies 
on other health care interventions did report an influence of elicitation methods on WTP 
(Donaldson et al., 1997; Frew et al., 2003; Klose, 1999; Whynes et al., 2003). The realistic 
setting and high level of understanding and experience of the respondents with hearing 
aids in our study may have led to more stable answers (Onwujekwe et al., 2005). The 
percentage missing values in the present study was much higher for the open-ended 
question (35%) than for the payment scale question (8%). The open-ended question seems 
more difficult to answer, possibly because no cues are provided. The payment scale 
question is generally considered to be more valid then the open-ended question, because 
the open-ended question is thought to be too hypothetical and provides insufficient cues 
(Arrow et al., 1993; Donaldson et al., 1997; Ryan et al., 2004). However, the payment 
scale question is also known to cause range bias (Whynes et al., 2004). It may be so that 
responses on the open-ended question are more valid because no cues are provided, as no 
range bias or starting point bias will occur. Also, only persons who have thoroughly 
considered their WTP and are able to construct a WTP value ‘on their own’ answer the 
open-ended question (Cookson, 2003). This may lead to less, but more valid answers. The 
latter is supported by the validity tests we performed. Both the payment scale format and 
the open-ended format showed good criterion validity, but the open-ended WTP question 
showed a stronger association with the actual out-of-pocket payment. Moreover, the open-
ended WTP question showed better construct validity, since it was consistent with the 
theoretical construct of positive income elasticity. Also, the open-ended format confirmed 
our expectation that younger respondents were willing to pay more for a hearing aid. 
There are some limitations of the present study that need to be addressed. First, due to the 
setting no information was available regarding primary non-response. Little is known about 
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response patterns in persons with hearing complaints attending audiological centres and 
hearing aid dispenser practices. In a study in a similar setting, a non-response of 25% out 
of 402 persons asked has been found (unpublished data, 2007). Probably, the present study 
had an even smaller percentage of non-response, since the questionnaire was less time-
consuming and easier to complete. Also, there was a large proportion of missing values on 
the actual out-of-pocket payment question (42%). This can be explained by the fact that 
some respondents were still in the process of their first hearing aid fitting, and had therefore 
not made an out-of-pocket payment yet (29% of the missing values) or that we did not 
know whether they had a monaural or binaural fitting (20% of the missing values). Missing 
values may have also been a result of persons having difficulty remembering what they had 
paid for their hearing aid. Furthermore, the fact that all respondents answered the payment 
scale question before the open-ended question may have caused an ordering effect. This 
would bias the results of the comparison between both question formats. However, by 
dispersing the WTP questions as much as possible over the questionnaire we have 
attempted to minimize an ordering effect. 
 
 
Conclusion 
The present study adds to the limited evidence on the validity of direct willingness to pay 
measures. Although the open-ended format is thought to be less valid than the payment 
scale format, the results of the present study point towards the opposite. We therefore 
recommend that in future WTP studies on hearing aids the open-ended question is used to 
directly elicit WTP values. The same recommendation may apply to other studies where 
respondents are familiar with costs or payments for the intervention under evaluation. 
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Appendix 4.1 
 
Actual out-of-pocket payment question: 
 
11. How much have you paid out-of-pocket for your current hearing aid(s)? 
 
ο €   ,        
 
Payment scale WTP question: 
 
26. How much are you, at a maximum, willing to pay out-of-pocket for one new hearing 
aid? 
 
ο  € 50 ο € 100 ο € 250 ο € 500 ο € 1000 ο € 2000 
ο I am not willing to pay out-of-pocket for a new hearing aid 
 
Open-ended WTP question: 
 
40. How much are you, at a maximum, willing to pay out-of-pocket for one new hearing 
aid? 
 
ο €    ,        
 
 79 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter  
Willingness to Accept versus 
Willingness to Pay in a 
Discrete Choice Experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Janneke PC Grutters 
Alfons GH Kessels 
Carmen D Dirksen 
Debby van Helvoort-Postulart 
Lucien JC Anteunis 
Manuela A Joore 
 
 
Submitted 
Chapter 5  
80 
Abstract 
Objectives 
Our main objective was to compare willingness to accept (WTA) and willingness to pay 
(WTP) in a discrete choice experiment on hearing aid provision. Additionally, income 
effect and endowment effect were explored as possible explanations for the disparity 
between WTA and WTP, and the impact of using a WTA and/or WTP format to elicit 
monetary valuations on the net benefit of the new organization of hearing aid provision 
was examined. 
Methods 
Choice sets were based on five attributes: performer of the initial assessment, accuracy of 
the initial assessment, duration of the pathway, follow-up at the Ear Nose and Throat (ENT) 
specialist, and costs. Persons with hearing complaints randomly received a WTP (cost 
attribute defined as extra payment) or WTA (cost attribute defined as discount) version of 
the experiment. In the versions, except for the cost attribute, all choice sets were equal. 
Results 
The cost coefficient was statistically significantly higher in the WTP format. Marginal WTA 
was statistically significantly higher than marginal WTP for the attributes accuracy and 
follow-up. Disparity was higher in the high educational (as proxy for income) group. We 
did not find proof of an experience endowment effect. Implementing the new intervention 
would only be recommended when using WTP. 
Conclusions 
WTA exceeds WTP, also in a discrete choice experiment. As this affects monetary 
valuations, more research on when to use a payment or a discount in the cost attribute is 
needed before discrete choice results can be used in cost-benefit analyses. 
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Introduction 
Studies that directly measure monetary values have often found a disparity between a 
person’s willingness to pay for a good and his willingness to accept compensation to forgo 
the same good (Horowitz & McConnell, 2002; O'Brien et al., 2002). The aim of our study 
was to examine whether this disparity also occurs when one indirectly measures monetary 
values in a discrete choice experiment. 
Monetary valuations are often elicited using contingent valuation (Bayoumi, 2004; Diener 
et al., 1998). In contingent valuation studies one directly asks respondents how much 
money they would be willing to pay or how much compensation they would request for a 
hypothetical intervention. The resulting willingness to pay (WTP) or willingness to accept 
(WTA) is a measure of how much the respondent values the intervention. Following Hicks 
(1943), one can use either the concept of compensating variation or the concept of 
equivalent variation to measure monetary values. Compensating variation measures the 
amount of money that is required after the change to make a respondent’s level of utility 
the same as before the change, while equivalent variation measures the amount of money 
that is required before the change, to make utility the same as it would be after the change. 
Within both these concepts a distinction can be made between WTA (when a 
compensation is required) and WTP (when a payment is required). 
Numerous contingent valuation studies have found that WTA exceeds WTP (Horowitz & 
McConnell, 2002; O'Brien et al., 2002), but in health care this disparity has only been 
examined four times (Borisova & Goodman, 2003; Carthy et al., 1999; O'Brien et al., 
1998; Van den Berg et al., 2005b). Several explanations for the disparity between WTA and 
WTP have been suggested (Brown & Gregory, 1999). Standard economic theory allows for 
two possible explanations, being an income effect and a lack of substitutes (Hanemann, 
1991). An income effect would occur because payment is constrained by income, while 
demand of compensation is not. A total lack of substitutes would make it impossible to 
compensate an individual for the removal of the good, and would therefore lead to extreme 
WTA values. Another possible explanation, advanced by psychologists instead of 
economists, is the endowment effect (Kahneman & Tversky, 1979). The endowment effect 
is closely related to loss aversion, and suggests that desirable goods are more valuable 
when they are part of one’s endowment. That is, persons value loss of something they own 
or have experienced higher than acquiring the same thing when do not have or have 
experienced it. Other possible explanations are related to the difference between buyers 
and sellers, and are explained elsewhere (Brown & Gregory, 1999). 
In contingent valuation studies, a difference is made between persons who would gain 
utility from implementing the intervention (potential ‘gainers’) and persons who would lose 
utility from implementing the intervention (potential ‘losers’). Potential gainers should be 
asked to state their maximum WTP for the intervention, while potential losers should be 
asked to state their minimum WTA for the intervention (Drummond et al., 2005; O'Brien & 
Gafni, 1996). However, it has also been advocated to always use WTP, as WTP results are 
judged to be more valid and more conservative (Arrow et al., 1993; Bayoumi, 2004). 
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An alternative method to elicit monetary valuations is discrete choice experimentation 
(Ryan, 2004; Ryan & Gerard, 2003). Discrete choice experiments are developed in 
mathematical psychology and marketing, and are increasingly used in health services 
research (Louviere et al., 2000; Ryan & Farrar, 2000; Ryan & Gerard, 2003). When a cost 
attribute is included in the experiment, the willingness to pay or the willingness to accept 
compensation for a unit change in an attribute can be calculated. Subsequently, each 
alternative set of change in the levels of the attributes can be given a monetary value, 
which allows for use in a cost-benefit analysis, where the costs of a program are compared 
to its monetary benefits (Drummond et al., 2005). Much of the appeal of discrete choice 
experimentation lays in that it enables us to understand the trade-offs between attributes. 
This can for instance provide valuable information for health care workers deciding 
between alternative ways of the provision of a health care commodity. Another advantage 
of discrete choice experimentation is that it does not directly ask respondents to express an 
amount of money, so strategic behavior or protest answers are less likely to occur (Van den 
Berg et al., 2005a). 
Until now, to our knowledge no publications have addressed the disparity between WTA 
and WTP in discrete choice experiments. As a result, lack of clarity exists on when to use 
WTA or WTP in discrete choice experimentation. 
The main objective of our study was to examine whether using a WTA and a WTP format 
for the cost attribute in a discrete choice experiment elicits different preferences and 
monetary values. We examined this in a discrete choice experiment on transferring 
elements of hearing aid provision from the medical sector to private hearing aid dispensers. 
If we find a disparity between WTA and WTP, our second objective will be to explore 
whether two possible explanations for the disparity, being the income and endowment 
effect, influence the disparity between WTA and WTP in a discrete choice experiment. Our 
third objective will be to examine the effect of using a WTA format, a WTP format, and a 
WTA format for potential losers and a WTP format for potential gainers to elicit monetary 
values on the net benefit of the new organization of hearing aid provision. 
 
 
Methods 
Setting 
Approximately 10% of the general population of western countries is hearing impaired, 
and this prevalence heavily increases with age (Chorus et al., 1995; Davis, 1995). For most 
hearing-impaired persons hearing aid fitting is an effective intervention (Larson et al., 2000; 
Mulrow et al., 1990). In the Netherlands, persons with a hearing loss exceeding 35 dB, 
averaged over 1, 2 and 4 kHz in the better ear, are entitled to a reimbursement by their 
medical insurance. Generally, the hearing aid dispenser collects the reimbursement and 
the patient is billed only for that part of the hearing aid price that exceeds the 
reimbursement , which is referred to as the out-of-pocket payment. 
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Given the ageing of the population the prevalence and, as a result, the health care costs 
associated with hearing rehabilitation will continue to increase. Because of the increasing 
costs and anticipated shortage of Ear Nose and Throat (ENT) specialists in the care for 
hearing-impaired persons, direct hearing aid provision by private hearing aid dispensers is 
currently under evaluation in the Netherlands, as well as in other countries in Europe. 
Besides issues of safety and efficiency, it is important to consider patient preferences 
regarding the organization of hearing aid provision. Direct hearing aid provision by private 
dispensers can be perceived as both favorable and unfavorable, depending on patients’ 
individual preferences. In a previous study (Grutters et al., 2007b) we asked persons with 
hearing complaints to grade direct hearing aid provision and provision by referral. We 
found that 42% of the respondents preferred hearing aid provision by referral, 39% 
preferred direct hearing aid provision, and 18% graded them equally. As there are patients 
who prefer direct hearing aid provision as well as patients who prefer provision by referral, 
implementation of direct hearing aid provision will generate both gainers and losers. This 
makes the case of direct hearing aid provision especially suitable for examining the 
disparity between WTA and WTP. 
 
Questionnaire design 
Twelve possible attributes of interest were identified by experts. Of these attributes, the five 
most important were identified by hearing-impaired persons (n=21) in a preliminary survey, 
using five point Likert scales. These were 1) the performer of the initial assessment to 
distinguish between persons in need of medical care (referred to as patients) and persons 
not in need of medical care (clients), 2) the accuracy of the initial assessment, 3) the 
duration of the total hearing aid provision, 4) the follow-up at the ENT-specialist to 
evaluate the hearing aid, and 5) costs. Realistic levels, based on the results of a previous 
study (AZOS working group, 2006), were assigned to each attribute (Table 5.1). As we 
assumed the private dispenser to be equally or less accurate than the ENT-specialist, the 
attributes performer and accuracy of the initial assessment had levels that could not 
logically be varied independently from each other. Following Louviere et al. (2000), these 
attributes were combined. The cost attribute was assigned four levels, equal to two other 
attributes, to minimize an attribute effect. The range of the cost attribute was based on the 
answers on an open-ended question in the preliminary survey and the levels were based on 
actual Euro notes. 
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Table 5.1  Attributes and levels used for discrete choice experiment 
Attributes Levels 
Performer and accuracy of initial assessment: * ENT-specialist at hospital 
 * Dispenser at practice, equally accurate 
 * Dispenser at practice, 10% less accurate 
 * Dispenser at practice, 20% less accurate 
Duration of hearing aid provision: * 2 months 
 * 4 months 
 * 6 months 
 * 8 months 
Follow-up at ENT-specialist: * Yes 
 * No 
Discount for WTA / extra payment for WTP: * No 
 * € 20 
 * € 50 
 * € 100 
 
 
We used a fractional factorial design to reduce the number of choices to the smallest 
number necessary for an efficient design. Using the SPSS orthoplan procedure we created 
an orthogonal main effects plan of the four attributes (three attributes with four levels, and 
one attribute with two levels), which ensured both level balance and orthogonality. 
Subsequently, 16 choice pairs were determined using the ‘shifting’ method, recommended 
by Street et al. (2005), ensuring level balance, minimal overlap and orthogonality. In the 
questionnaire respondents were asked to choose their preferred alternative from each 
choice pair, and we included the option that they found the alternatives equally attractive 
(no preference). 
We created two versions of the questionnaire. In one version the cost attribute was defined 
as an extra payment to be paid by the participant (WTP format) on top of his out-of-pocket 
payment for the hearing aid. In the other version the cost attribute was defined as a 
discount off the out-of-pocket payment for the hearing aid (WTA format). By framing the 
cost attribute in relation to the out-of-pocket payment we tried to make it as realistic as 
possible. Respondents were explicitly told that when they had no out-of-pocket payment 
for their hearing aid, the discount would be handed to them in cash in the WTA format, or 
they still had to pay the extra payment in the WTP format. As the difference between the 
attribute levels of two alternatives in a choice set is used as explanatory variable in the 
analysis, for each choice set the increment in the cost attribute was equal in the two 
versions. This means that when in the WTP format the extra payment was € 20 higher for 
alternative B than for alternative A, in the WTA version the discount was € 20 lower for 
alternative B than for alternative A. This resulted in an increment of € 20 in both formats. 
Apart from the cost attribute, all choice sets were equal in the WTA and WTP version of the 
questionnaire. An example of a discrete choice question is given in Appendix 5.1. 
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Additionally we defined a choice set in which one alternative with a lower extra payment 
(or a higher discount), higher accuracy, and all other attribute levels equal unquestionably 
dominated the other, to check whether respondents understood the experiment. The total 
questionnaire therefore consisted of 17 discrete choice questions. 
 
Survey procedure 
In a pilot study, it was examined whether the participants found all attributes important and 
whether they were willing to trade between the attributes, to check whether the chosen 
attributes and levels were appropriate. It was also examined whether the formulation was 
correct, and whether the participants understood the experiment. The pilot questionnaire, 
completed by 35 participants, was administered face-to-face by a trained interviewer at a 
private dispenser practice. Based on the results of the pilot study, we slightly adjusted the 
range of the duration attribute. Following the pilot study, two trained interviewers 
conducted face-to-face interviews at four private hearing aid dispenser practices, chosen to 
be representative for the region. Participants were persons with hearing complaints visiting 
the dispenser. The WTA and WTP versions were randomly conducted by both interviewers 
and were randomly assigned to the respondents in all four practices. 
 
Statistical analysis 
We used a random effects ordered probit model to analyze the data, with choice (A, no 
preference, or B) as the ordinal dependent variable (Train, 2003). Explanatory variables 
were the differences between the levels of the two alternatives. 
For the first objective, to examine whether a WTA and WTP format elicit different 
preferences and monetary values, for each format a regression model was estimated. Before 
the regression models were estimated we examined whether preferences were influenced 
by participants’ characteristics (age, sex, experience with hearing aid provision, and 
income). We included each interaction term in the main attributes model separately, and 
subsequently included all interaction terms with a statistically significant regression 
coefficient in the model simultaneously. For all analyses a p-value smaller than 0.05 was 
considered to be statistically significant. A stepwise backward procedure was used and 
interaction terms with the highest p-value (> 0.05) were excluded from the model one at a 
time. In the presence of interaction the coefficients of the attributes will be dependent on 
patient characteristics. Differences in the distributions of these characteristics between the 
groups will therefore influence the comparison of WTA and WTP. To avoid this influence 
we estimated the models for a group with median characteristics of the total group. The 
monetary valuation of each attribute was calculated by dividing the regression coefficient 
of each attribute by the regression coefficient of the cost attribute. This resulted in the 
marginal willingness to pay or to accept compensation for a change in the level of a certain 
attribute. As the marginal WTA or WTP is the amount of money that would be required 
after the change to make ones utility level the same as before the change, we used the 
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concept of compensating variation. Confidence intervals for WTA and WTP were 
calculated using the delta method (Hanemann & Kanninen, 1998). 
For the second objective, to explore whether an income or endowment effect influences 
the disparity between WTA and WTP, we first examined the disparity for a low income 
group (below median income) versus a high income group (median income or higher). We 
used the ratio between WTA and WTP as an indicator for the disparity. We hypothesized 
that, since WTP is constrained by income whereas WTA is not, the disparity between WTA 
and WTP would be higher in the low income group as opposed to the high income group. 
Next, we explored the influence of initial endowments of experience. We examined 
whether the disparity between WTA and WTP was influenced by the fact that persons had 
previously experienced hearing aid provision. Previous studies have found that once 
someone has experienced something, it becomes part of their endowment, and they value 
it more highly than persons who have not experienced it (Porter & Macintyre, 1984; Ryan 
et al., 1998; Ryan & Ubach, 2003). We therefore hypothesized that in respondents who 
had experienced hearing aid provision the disparity between WTA and WTP would be 
higher than in respondents without experience. 
With respect to the third objective, we examined the effect of using a WTA format, a WTP 
format, and a WTA format for losers and a WTP format for gainers to obtain monetary 
valuation on the net benefit of a new intervention. For this objective losers were 
respondents who potentially lose utility from implementing the intervention, while gainers 
were respondents who potentially gain utility from implementing the new intervention. The 
new, and currently recommended, intervention has all attributes equal to the current 
organization of hearing aid provision, except for omitting the follow-up at the ENT-
specialist (AZOS working group, 2006). With individual regression analyses we checked 
for each respondent whether he or she preferred the follow-up at the ENT-specialist or not. 
Respondents who preferred the follow-up at the ENT-specialist were defined as losers from 
the new intervention, while respondents who preferred no follow-up at ENT were defined 
as gainers. First we calculated the monetary value for the new intervention using the WTA 
format. Next, we calculated the monetary value for the new intervention using the WTP 
format. Third, we calculated the weighted average of the monetary values of the losers in 
the WTA format and the gainers in the WTP format. To examine the impact of the three 
different approaches on the net benefit, we subtracted the incremental costs of the new 
intervention from the incremental benefits. We used the costs of one ENT consultation      
(€ 104) as an estimate of the cost reduction as a result of the implementation of the new 
intervention (Oostenbrink et al., 2004). Data were managed in SPSS 12.0.1 and analyzed 
using STATA 9. 
 
 
 Willingness to accept versus willingness to pay 
87 
Results 
Respondents 
Between August and December 2006, 402 persons were invited to participate in the 
survey. Of them, 300 (75%) agreed to be interviewed. Both versions of the questionnaire 
were completed by 150 participants each. Nine participants (3%) did not answer the 
dominant pair correctly and were therefore excluded from the analysis. Table 5.2 shows 
the characteristics of the participants. Completers of the WTA questionnaire had a median 
age of 72 years (range 18-95), while completers of the WTP questionnaire had a median 
age of 68 years (range 19-92). This difference was statistically significant (Mann-Whitney U 
test, p-value 0.02). Although slightly different, the out-of-pocket payments for the hearing 
aid were not statistically significantly different between the groups (Mann-Whitney U test, 
p-value 0.746). Also for the other characteristics there were no statistically significant 
differences between the groups. 
There were 31% missing values on family income (Table 5.2). Missing value imputation by 
using the regression method resulted in a large standard error. As we expected these 
missing values not to be random, but to occur more often in persons with higher income, 
we decided not to use income in the analyses. Alternatively, we used the participant’s 
educational level as a proxy for income, as educational level was correlated with income 
(Spearman’s rho 0.55, p-value <0.0001), and had no missing values. 
 
WTA versus WTP 
The final sample for analysis consisted of 291 participants, resulting in 4656 choice 
observations, equally divided over the two formats (WTA 2336, WTP 2320). Table 5.3 
shows the final regression models for both formats. The signs and weights of the 
coefficients did not differ between the models, except for the cost attribute (p-value < 
0.0001). The coefficients were all statistically significantly different from zero, except for 
the attribute regarding the initial assessment at the dispenser in the WTP format. 
Next, we compared marginal WTA and WTP (Table 5.3). Participants preferred the initial 
assessment at a private dispenser. In the WTA format the monetary valuation for the initial 
assessment at a private dispenser was 3.2 times higher than in the WTP format (p-value 
0.21). In the WTA format a 10% increase in accuracy was valued 3.0 times higher than in 
the WTP format (p-value 0.01). Regarding duration, the WTA format elicited a 1.7 times 
higher monetary value for two months shorter duration than the WTP format (p-value 0.47). 
The WTA format elicited a monetary value for the follow-up at the ENT-specialist that was 
3.0 times higher than in the WTP format (p-value 0.005). 
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Table 5.2 Characteristics of participants for each format and for the total group of  participants. 
Values are numbers (percentages) unless stated otherwise 
Characteristic WTA format 
(n=146)
WTP format 
(n=145)
Total (n=291) 
Age (years)    
 Mean (standard deviation) 
Median (range) 
71.0
72.4*
(10.7) 
(18 - 95)
67.6
69.4* 
(13.1)
(19 - 92)
69.3 
71.3 
(12.0) 
(18 - 95) 
Male 85 (58%) 83 (57%) 168 (58%) 
Education    
 No education 
Primary school 
Lower education 
Junior general secondary education 
Senior secondary vocational education 
Senior general secondary education 
Higher professional education 
University 
2
35
32
29
15
13
14
6
(1%)
(24%)
(22%)
(20%)
(10%)
(9%)
(10%)
(4%)
2
26
36
23
18
10
25
5
(1%)
(18%)
(25%)
(16%)
(12%)
(7%)
(17%) 
(3%)
4 
61 
68 
52 
33 
23 
39 
11 
(1%) 
(21%) 
(23%) 
(18%) 
(11%) 
(8%) 
(13%) 
(4%) 
Family income   
 € 450 – 1100 
€ 1100 – 1600 
€ 1600 – 2000 
€ 2000 - 3000 
> € 3000 
Don’t know 
Not willing to answer 
18
28
21
23
16
14
26
(12%)
(19%)
(14%)
(16%)
(11%)
(10%)
(18%)
13
30
12
24
16
11
39
(9%)
(21%)
(8%)
(17%)
(11%)
(8%)
(27%)
31 
58 
33 
47 
32 
25 
65 
(11%) 
(20%) 
(11%) 
(16%) 
(11%) 
(9%) 
(22%) 
Previously experienced hearing aid provision 96 (66%) 88 (61%) 184 (63%) 
Out-of-pocket payment for the hearing aid (€)   
 
Mean (standard deviation)  
Median (range) 
839
605
(907)
(0-5000)
911
775
(985)
(0-6000)
875 
735 
(944) 
(0-6000) 
* Statistically significantly different: Mann-Whitney U test; p < 0.05 
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Exploring possible explanations 
We found an education effect, but in the opposite direction of what we hypothesized. The 
disparity between WTA and WTP was higher in the high educational group (Table 5.4a). 
This was due to the fact that an education effect only occurred in the WTA format, where 
participants with a higher educational level found the discount considerably, and 
statistically significantly, less important than participants with a lower educational level. 
We did not find that the disparity between WTA and WTP was higher in persons with 
experience than in those without experience with hearing aid provision (Table 5.4b). It was 
inconclusive which group overall showed a higher disparity, as the disparity varied across 
the attributes. We did find that experienced respondents preferred the initial assessment at 
the dispenser, while respondents who were inexperienced had no statistically significant 
preference. 
 
Effect of different formats on the net benefit 
When using the WTA format, the monetary valuation of the new intervention amounts to - 
€ 227 (Table 5.5). Use of the WTP format resulted in a monetary valuation of - € 77 for the 
new intervention. Third, when the WTA format is used for potential losers (n=118) and the 
WTP format for potential gainers (n=24), monetary values were € 76 for the gainers versus - 
€ 414 for the losers. This resulted in a weighted average of - € 331 for the new 
intervention. All three approaches result in a negative benefit for the new intervention. 
Given the cost reduction of € 104, this would result in a monetary net benefit of € 27 when 
using only the WTP format. As this is a positive net benefit, based on the WTP results one 
would recommend implementation of the new intervention. The other two approaches 
would result in a negative net benefit (- € 123 and - € 227 respectively), based on which 
one would recommend not to implement the new intervention. 
 
 
 
Table 5.5 Monetary valuation of the new intervention, elicited with a WTA format, WTP format, 
and a WTA format for losers and WTP format for gainers, and net benefit 
Format N Monetary 
valuation 
(95% CI) Weighted 
average
Net benefit* 
1) WTA 146 - € 227 (-€ 332 to -€ 123) - € 123 
2) WTP 145 - € 77 (-€ 93 to -€ 61) € 27  
3) WTA for losers 118 - € 414 (-€ 686 to -€ 143)
    WTP for gainers 24 € 76 (€ 32 to € 119)
- € 331 - € 227 
Based on a group with median age (71.3 years), median educational level (junior general secondary 
education), mean proportion of males (58%) and mean proportion of persons who have experienced 
hearing aid provision (63%) 
Abbreviations: CI = Confidence Interval; WTA = willingness to accept; WTP = willingness to pay 
* Net benefit is based on a cost reduction of €104 
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Discussion 
This study compares WTA and WTP in a discrete choice experiment. We found the cost 
attribute to have a statistically significantly higher regression coefficient when it was 
defined as extra payment compared to a discount. Marginal willingness to accept was 
statistically significantly higher than willingness to pay for both accuracy and the follow-up 
at the ENT-specialist. In contrast to our expectations, the disparity between WTA and WTP 
was higher in a high educational group compared to a low educational group. We found 
that persons with a higher educational level found a discount less important than those 
with a lower educational level. Respondents who had experienced hearing aid provision 
did not have a higher disparity between WTA and WTP than those without experience. 
Implementing the new intervention would only be recommended when using a WTP 
format to elicit monetary valuations, and would not be recommended when using a WTA 
format for losers and a WTP format for gainers or only a WTA format. 
 
Interpretation of results 
The fact that we found a disparity between WTA and WTP is not surprising, as it is 
indisputable that a disparity between WTA and WTP exists (Brown & Gregory, 1999; 
Horowitz & McConnell, 2002). In their review, Horowitz and McConnell (Horowitz & 
McConnell, 2002) found WTA/WTP ratios ranging from 1 to 113, with a mean ratio of 7. In 
health care these ratios range from 1 to 6.4 (Borisova & Goodman, 2003; Carthy et al., 
1999; O'Brien et al., 1998; Van den Berg et al., 2005b). The disparity found in this discrete 
choice experiment is within this range of disparities found in health care contingent 
valuation studies. 
Income is thought to influence the disparity between WTA and WTP, as WTP is 
constrained by income, whereas WTA is not (Brown & Gregory, 1999). In our study we did 
not find a higher disparity in a low educational group as opposed to a high educational 
group. Extra payment was found to be equally important in both groups. Possibly the € 100 
range of extra payment we used was not large enough to reach the budget constraint in the 
low educational group. However, an education effect was found only in the WTA format, 
where the group with higher education clearly found the discount less important than the 
group with lower education. The fact that persons with higher education (and hence higher 
income) value a certain amount of money lower than persons with lower income is not 
surprising. We however expected to observe this in the WTP format as well, resulting in no 
influence of educational level on the disparity between WTA and WTP. 
Most of the explanations for the disparity between WTA and WTP relate to the difference 
between buyers who gain a good (in the WTP format) and sellers who lose a good (in the 
WTA format). These explanations may however only apply to discrete choice 
experimentation when each choice set consists of the status quo and an alternative 
scenario. In the present discrete choice experiment we did not use a status quo design. 
Also, we did not label the scenarios, and scenarios were equal in both formats except for 
the cost attribute. By doing this we minimized status quo bias and loss aversion (Salkeld et 
al., 2000). We found no evidence of an experience endowment effect. For one attribute, 
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the initial assessment, we found that respondents without experience showed a stronger 
preference for the real world status quo (initial assessment at ENT-specialist) compared to 
those with experience. Probably, persons who have already experienced a medical 
examination for their hearing problems attached less value to consulting a medical 
specialist for the initial assessment again. Although it was not the focus of our analysis, 
when calculating the WTA for potential losers of the new intervention, we found that the 
WTA for losers was higher than the WTA for the total group (Table 5.5). This result may 
suggest the presence of loss aversion. The loss aversion may not be directly related to what 
persons had or had experienced, and thus to endowment or property rights, but may be 
more related to their attitude towards the new intervention. Possibly loss aversion was 
based more on an intrinsic feeling of loss than on actual losses. 
 
Limitations 
There are some limitations of the present study. First, although our study population was 
sufficiently large for the main analysis on the disparity between WTA and WTP, the study 
population was relatively small for exploring income and endowment effect as 
explanations of the disparity. Because we had to split both samples in two to compare 
different groups, we found regression coefficients with large standard errors that were not 
significantly different from zero. Nevertheless, as our second objective was exploratory we 
decided to show the results and focus on the ratio between WTA and WTP rather than to 
draw conclusions only on statistically significantly different results. Another limitation of 
the present study is that we had no information beforehand on whether the participants 
would gain or lose utility when implementing the new organization of hearing aid 
provision. It would be interesting to assign the WTA or WTP questionnaire depending on 
whether participants are gainers or losers. However, since our main objective was to 
examine whether monetary valuations differ when using a WTA compared to a WTP 
format, we feared that asking preferences beforehand would influence the results of the 
discrete choice experiment, as respondents would possibly be more inclined to choose the 
status quo. Finally, a potential limitation is that we were forced to use educational level as 
a proxy for income, because of the large number of missing values on income. We 
additionally performed the analyses of income effect with income to check whether 
educational level was a valid proxy, and found a similar but stronger effect (results not 
presented). 
 
Implications 
The present study has some important implications. First, defining the cost attribute in a 
discrete choice experiment as a discount or payment changes monetary valuations. When 
using monetary valuation from a discrete choice experiment in a cost-benefit analysis, as 
shown in the present study, this may even alter policy recommendations. Whether 
differences between preferences should be incorporated in decision-making has also been 
discussed by O’Brien et al. (2002), Severens et al. (2005) and Dowie (2004; 2005). As 
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patient preferences gain increasing attention in decision making (Ryan, 2004), and patients 
have preferences over aspects of health care beyond health-related quality of life, discrete 
choice experiments will probably become increasingly important in health services 
research. Most discrete choice experiments in health care use the concept of WTP, but 
WTA has also been used (Telser & Zweifel, 2006; Ubach et al., 2003; Van der Pol & 
Cairns, 1998). Although in other papers it was stated that the inclusion of a cost attribute to 
elicit monetary valuations with discrete choice experiments should be done with caution 
(Hanley et al., 2003; McIntosh, 2006; Ratcliffe, 2000; Slothuus Skjoldborg & Gyrd-Hansen, 
2003), to our knowledge no study has paid explicit attention to when the cost attribute 
should be defined as a payment or a discount. The lack of clarity on how to address the 
disparity between WTA and WTP in discrete choice experiments probably results from the 
fact that before the present study the disparity had not yet been examined and, as a result, 
had not yet been found in discrete choice experiments. 
One can address the disparity between WTA and WTP by asking participants beforehand 
whether they prefer the program that is under evaluation, and assign the WTA or WTP 
version of the discrete choice experiment accordingly. This would however require the use 
of a status quo scenario in each choice set (McIntosh, 2006), which would possibly 
introduce status quo bias (Salkeld et al., 2000). More importantly, a great advantage of a 
discrete choice experiment is its flexibility that monetary values can be calculated for any 
configuration of attributes and levels (McIntosh, 2006). As gainers for one configuration 
can be losers for another, when eliciting WTP from gainers and WTA from losers, one can 
only calculate the monetary valuation of the interventions where this distinction between 
gainers and losers holds, which decreases this flexibility.  
It has been stated that WTP is preferred over WTA in contingent valuation studies (Arrow et 
al., 1993; Bayoumi, 2004), since WTP is said to be more valid and more conservative than 
WTA (Arrow et al., 1993). In the present study however, the WTP for the new intervention 
resulted in a negative WTP. This indicates that for the new intervention, the use of a WTA 
format may have been more appropriate. The net benefit analyses showed that if the new 
intervention would lead to a cost reduction of € 104, implementation of the intervention 
would only be recommended when the monetary valuation was elicited in the WTP 
format. This clearly illustrates that using a WTA format is more conservative when the 
majority of respondents are losers. 
 
 
Conclusions 
The results of this discrete choice experiment confirm that WTA exceeds WTP. This has 
consequences when using the discrete choice results in a cost-benefit analysis. It is 
therefore important that there is consensus on when to define the cost attribute in a discrete 
choice experiment as a payment or a discount. For now, the best option seems to be to 
choose the most conservative format, which is WTP if (the majority of) respondents are 
potential gainers, and WTA if (the majority of) respondents are potential losers. However, 
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as stated, this may affect the flexibility of discrete choice experiments to calculate monetary 
values for different configurations of interest within a cost-benefit analysis. 
Now that we have demonstrated that the disparity between WTA and WTP also occurs in 
discrete choice experiments, more research on when to use a payment or a discount is 
needed before monetary values based on discrete choice experiments can be used in cost-
benefit analyses. 
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Appendix 5.1   Example of a discrete choice question 
 
Attribute Alternative A Alternative B 
Performer and accuracy of the initial 
assessment 
ENT-specialist at hospital Dispenser at practice,  
equally accurate 
Duration of hearing aid provision 2 months 4 months 
Follow-up at ENT-specialist  Follow-up at ENT-
specialist 
No follow-up at ENT-
specialist 
Extra payment / discount1 € 20 / € 50 € 50 / € 20 
   
Which alternative would you choose?  A  B 
   I have no preference 
1 Dependent on format: extra payment was used in the WTP format, a discount was used in the WTA 
format. 
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Abstract  
Objectives 
Our objective was to elicit patient preferences for transferring elements of hearing aid 
provision from the medical sector (Ear Nose and Throat specialists and audiological 
centres) to private hearing aid dispensers, and to understand the trade-offs between 
different elements of hearing aid provision. 
Design 
A discrete choice experiment was administered from 150 hearing-impaired persons in the 
Netherlands. Mean age was 71 (range 18-95) and 57% were male. 
Results 
Participants preferred the initial assessment at the dispenser, higher accuracy in identifying 
persons in need of medical care, shorter duration of the total hearing aid provision, and a 
follow-up at the Ear Nose and Throat (ENT) specialist. They required compensation of at 
least € 17 per two months extra duration, € 54 for an initial assessment at the ENT-
specialist, € 119 per 10% decrease in accuracy, and € 227 to forgo the follow-up at the 
ENT-specialist. Preferences were influenced by sex, age, educational level, and experience 
with hearing aid provision. 
Conclusions 
Hearing-impaired persons are receptive to transferring elements of hearing aid provision 
from the medical sector to private dispensers. Although safety and efficiency issues should 
also be considered, from the present study we can conclude that in the organization of 
hearing aid provision hearing-impaired persons prefer an initial assessment at a private 
dispenser when the dispenser is at least 95% as accurate as the ENT-specialist, and prefer a 
follow-up visit at the ENT-specialist. 
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Introduction 
Hearing impairment is a common health problem, of which the prevalence heavily 
increases with age (Davis, 1995). The ageing of the population predicts that the prevalence 
and, as a result, the health care costs associated with hearing rehabilitation, will continue 
to increase. 
Direct hearing aid provision without medical care has proven to be safe (Abdelkader et al., 
2004; Koay & Sutton, 1996; Swan & Browning, 1994). In the United Kingdom (UK) general 
practitioners can refer patients to an ENT-specialist or directly to an audiology department. 
Some areas have previously encouraged patients to directly visit an audiology department 
(The British Society of Hearing Aid Audiologists, 2005). Unfortunately this has led to a 
significant range in patient waits from zero to up to three years (British Academy of 
Audiology, 2006). Hence, the Health Committee recently carried out an inquiry into 
audiology services in England, with particular interest in the role of the private sector 
(Health Committee, 2007a, 2007b). The UK had previously offered as part of its 
Modernisation of Hearing Aid Services an option for districts to offer an Independent 
Sector, Hearing Aid Dispenser (a regulated profession), service. This was initially greeted 
with some skepticism by professionals and hearing aid patients. However the evaluated 
outcomes showed an equivalence in pilot studies, with considerable patient support in 
qualitative focus group follow-up. For instance a patient said ‘I thought the whole process 
was very efficient and lean. I felt that the process was very thorough and reassuring’. Those 
interviewed at one pilot site had nothing but praise for the interpersonal skills of the 
dispenser. However the experience was not uniform across areas. When asked about 
standards and ensuring quality, the consensus was that they would always trust the 
clinician if they looked and acted competently but they agreed that if initiatives like this 
were more commonplace then the public would need to know that standards were being 
maintained. Subsequently as noted in the Health Committee there was a very mixed review 
and experience when the services were rolled out to those who felt that they could help 
reduce the waiting time for those people who were referred. 
In the United States the Food and Drug Administration requires that consumers see a 
licensed health professional (mostly a doctor or audiologist) before getting a hearing aid 
(Valente, 2006). Possibly such a system, with private hearing aid dispensers becoming 
licensed professionals, would be an adequate system in Europe. 
In the Netherlands, hearing-impaired persons who seek help first need to visit a general 
practitioner for referral to an Ear Nose and Throat (ENT) specialist or an Audiological 
Centre (AC). In an AC a multidisciplinary team offers specialized care to the more seriously 
impaired with additional complications. Only ENT-specialists and ACs are entitled to 
prescribe hearing aids. In general the hearing aid is fitted by a private hearing aid 
dispenser. The patient is entitled to (partial) reimbursement of the hearing aid by their 
medical insurance only when the hearing aid fitting is approved by the prescriber and the 
hearing loss exceeds 35 dB, averaged over 1, 2 and 4 kHz in the better ear. Generally, the 
hearing aid dispenser collects the reimbursement and the patient is billed only for that part 
of the hearing aid price that exceeds the reimbursement, which ranges from no extra 
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payment to over € 1000 per hearing aid. The current organization of hearing aid provision 
in the Netherlands is costly and may lead to a future shortage of ENT-specialists (Van der 
Velden & Hingstman, 2000). Therefore the safety and efficiency of transferring elements of 
hearing aid provision from the medical sector to private hearing aid dispensers are 
currently under investigation (AZOS working group, 2006). In order to distinguish ‘clients’ 
who are not in need of medical care from ‘patients’ who require medical attention or 
treatment of an AC, a set of criteria was developed by a national platform of professionals 
involved in the care for hearing-impaired persons (Veldhuizen et al., 2002). The criteria for 
referral relate to otoscopy (i.e. skin aberration, fluid in the auditory canal), audiometry (i.e. 
asymmetrical hearing loss or sudden deafness) and psychosocial aspects (i.e. 
communication problems at work). Besides issues of safety, quality, and costs, it is 
important to consider patient preferences regarding the organization of health care (Ryan, 
2004; Ryan et al., 2005). This would increase the chances of a successful implementation 
of changes in the organization of care. Discrete choice experimentation, an approach for 
the elicitation of preferences, is widely used in health care and is a useful tool in decision-
making (Ryan, 2004; Ryan & Farrar, 2000; Ryan et al., 2001). 
Our aim was to elicit patient preferences for transferring elements of hearing aid provision 
from the medical sector to private hearing aid dispensers, and to understand the trade-offs 
between these elements of hearing aid provision, using a discrete choice experiment. 
 
 
Methods 
Discrete choice experiments 
Discrete choice experimentation is a form of conjoint analysis. Conjoint analysis is 
developed in mathematical psychology and marketing, and is increasingly used in health 
services research (Ryan & Farrar, 2000; Ryan & Gerard, 2003), including hearing research 
(Meister et al., 2001). Conjoint analysis is grounded in random utility theory and based on 
the principle that complex decisions are not based on a single criterion or factor, but on 
several factors ‘considered jointly’. Any intervention can be described by its attributes, and 
the extent to which an individual values an intervention depends on the levels of these 
attributes (Louviere et al., 2000; Ryan & Farrar, 2000). In conjoint analysis, respondents are 
presented with various alternative descriptions of an intervention, each of which represents 
their attributes at different levels. Respondents are asked to rank the various alternatives 
(ranking), to rate them (rating) or to choose their most preferred (Louviere et al., 2000). The 
latter is referred to as discrete choice experimentation (DCE), and is widely used in health 
care (Ryan, 2004; Ryan & Farrar, 2000; Ryan & Gerard, 2003). Conjoint analysis in terms 
of a ranking experiment has been applied in auditory research to examine the importance 
of hearing aid attributes by Meister et al. (2001). Much of the appeal of conjoint analysis 
lays in that it enables us to understand the trade-offs between attributes. When a cost 
attribute is included, the willingness to pay for a unit change in an attribute can be 
calculated. Each alternative can then be given a monetary value, which allows for use in a 
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cost-benefit analysis, where the costs of a program are compared to its monetary benefits 
(Drummond et al., 2005). Extensive information on discrete choice experiments can be 
found elsewhere (Louviere et al., 2000; Ryan & Farrar, 2000; Ryan & Gerard, 2003). 
 
Questionnaire design 
Twelve possible attributes of interest with regard to hearing aid provision were identified by 
experts. In a preliminary survey using five point Likert scales the following six of these 
attributes were identified by hearing-impaired persons (n=21) as the most important: 1) 
quality of the hearing aid, 2) the performer of the initial assessment to distinguish between 
persons in need of medical care (referred to as patients) and persons not in need of medical 
care (clients), 3) the accuracy of the initial assessment, defined as the probability that 
patients are referred to an ENT-specialist (sensitivity), 4) the duration of the total hearing aid 
provision from the initial assessment until the approval of the hearing aid fitting, 5) the 
follow-up at the ENT-specialist to evaluate the hearing aid fitting, and 6) costs. As the large 
majority of hearing aids in the Netherlands are prescribed and evaluated by an ENT-
specialist (> 85%), we did not mention the AC in the experiment. 
Realistic levels, based on the results of a previous study (AZOS working group, 2006), were 
assigned to each attribute (Table 6.1).  
 
 
 
 
 
 
Table 6.1  Attributes and levels used for discrete choice experiment 
Attributes Levels 
Hearing aid quality: * Good 
Performer & accuracy of initial assessment: * ENT-specialist at hospital 
 * Dispenser at practice, equally accurate 
 * Dispenser at practice, 10% less accurate 
 * Dispenser at practice, 20% less accurate 
Duration: * 2 months 
 * 4 months 
 * 6 months 
 * 8 months 
Follow-up at ENT: * Yes 
 * No 
Savings: * No savings 
 * € 20 
 * € 50 
 * € 100 
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Irrespective of how hearing aid provision is organized, the hearing aid should be of good 
quality. As we expected quality to be a dominant attribute and the study focused on 
organizational aspects, we only assigned the level ‘good’ to this attribute. That is, we made 
sure that for each alternative respondents expected the hearing aid to be of equal quality. 
As we conservatively assumed the private dispenser to be equally or less accurate than the 
ENT-specialist, the attributes performer and accuracy of the initial assessment had levels 
that could not logically be varied independently from each other. Following Louviere et al. 
(2000), these attributes were combined. Duration of the hearing aid provision was assigned 
four levels, ranging from 1 month to 7 months. Two levels (yes and no) were assigned to 
the follow-up at the ENT-specialist.  
We expected most participants to attach less value to direct hearing aid provision by the 
private dispenser, since it restricts access to medical care, and persons often prefer the 
status quo (Salkeld et al., 2000; Walton et al., 2002). Hence, we defined the cost attribute 
as willingness to accept, as savings off of the hearing aid price (Drummond et al., 2005). 
The cost attribute was assigned four levels, equal to two other attributes, to minimize the 
attribute effect (Ratcliffe & Longworth, 2002). The range was based on the answers on an 
open-ended question in the preliminary survey and the levels were based on existing Euro 
bills.A fractional factorial design was used to reduce the number of choices to the smallest 
number necessary for an efficient design (Huber & Zwerina, 1996). We created an 
orthogonal main effects plan, and subsequently determined 16 choice pairs using shifting 
(Street et al., 2005). We ordered the attributes in a chronological order, from initial 
assessment to payment of the hearing aid, to limit the cognitive complexity of the choice 
tasks, and included the option that respondents were indifferent between the alternatives 
(no preference). Appendix 6.1 presents an example of a choice set. 
Additionally we defined a choice set in which one alternative with a higher discount, 
higher accuracy, and all other attribute levels equal unquestionably dominated the other, 
to check whether respondents understood the experiment. The total questionnaire therefore 
consisted of 17 discrete choice questions. 
The questionnaire started with a comprehensive detailed explanation of the attributes and 
levels to ensure that all participants understood the trade-off features as uniformly as 
possible. An example preceded the choice sets, to present the technique to the respondents 
before the beginning of the actual experiment. Three five point Likert scales elicited 
whether respondents found the questionnaire unclear, difficult or long. Additionally, 
demographic variables were collected, as well as whether participants had experienced 
hearing aid provision before. 
 
Survey procedure 
In a pilot study, it was examined whether the participants found all attributes important and 
whether they were willing to trade between the attributes, to check whether the chosen 
attributes and levels were appropriate. It was also examined whether the formulation was 
correct, and whether the participants understood the experiment. The pilot questionnaire, 
completed by 35 participants, was administered face-to-face by a trained interviewer at a 
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private dispenser practice. Based on the results of the pilot study, we slightly adjusted the 
range of the duration attribute. Respondents found one month to be no realistic level for 
the total hearing aid provision, as they assumed a month to be too short to adequately fit a 
hearing aid. Hence, we changed the range of levels for duration to 2 to 8 months. 
Following the pilot study, two trained interviewers conducted face-to-face interviews at 
four private hearing aid dispenser practices, chosen to be representative for the region. 
Participants were persons with hearing complaints visiting the dispenser. As generally all 
hearing aids in the Netherlands are fitted by private hearing aid dispensers, this affords a 
study population representative for the Dutch population seeking help for their hearing 
complaints. 
 
Statistical analysis 
We used a random effects ordered probit model to analyze the data, with choice (A, no 
preference, B) as the ordinal dependent variable (Train, 2003). Explanatory variables were 
the differences between the levels of the two alternatives. The attributes ‘initial assessment 
at ENT-specialist’ and ‘follow-up at ENT-specialist’ were analyzed using dummy coding. 
The levels of the attributes ‘initial assessment accuracy’ and ‘duration’ were treated as 
continuous variables, in correspondence with the chosen levels. Consequently, initial 
assessment accuracy was analyzed per 10% and duration of the hearing aid provision was 
analyzed per 2 months. The levels of the ‘savings’ attribute were also coded continuously, 
and the attribute was analyzed per Euro. 
Two regression models were estimated. One included the main attributes only, the second 
model examined how preferences were influenced by participants’ characteristics (age, 
sex, experience with hearing aid provision, and income). For the second model we first 
included each interaction term in the main attributes model separately. Next, all interaction 
terms with a statistically significant regression coefficient were included in the model 
simultaneously. We used a stepwise backward procedure and variables with the highest p-
value (> 0.05) were excluded from the model one at a time. 
The monetary valuation of each attribute was calculated by dividing the regression 
coefficient of each attribute by the regression coefficient of the cost attribute. This resulted 
in the marginal willingness to accept compensation for a change in the level of a certain 
attribute. Confidence intervals for willingness to accept were calculated using the delta 
method (Hanemann & Kanninen, 1998). 
Additionally we calculated monetary values for three conservative alternative scenarios of 
hearing aid provision, as opposed to the current situation. In the Netherlands, hearing aid 
provision currently includes both an initial assessment and a follow-up at the ENT-
specialist at a duration of six months. The first scenario, full direct hearing aid provision by 
the private dispenser, was defined as having both a 10% less accurate initial assessment 
and a follow-up at the private dispenser, with a duration of two months. The second 
scenario had a 10% less accurate initial assessment at the private dispenser, a duration of 
four months, and a follow-up at the ENT-specialist. The third scenario had an initial 
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assessment at the ENT-specialist, a duration of four months, and a follow-up at the private 
dispenser. 
Data were managed in SPSS 12.0.1 and analyzed using STATA 9. 
 
 
Results 
Respondents 
Between August and December 2006, 201 persons were invited to participate in the 
survey. Of them, 150 (75%) agreed to be interviewed. Table 6.2 shows the characteristics 
of the participants. Four participants (3%) did not answer the dominant pair correctly and 
were therefore excluded from the analysis. Ten participants (7%) found the information in 
the questionnaire unclear. Twenty-four participants (16%) found the questionnaire difficult, 
and 67 participants (46%) found that the questionnaire consisted of (too) many questions. 
 
 
 
Table 6.2  Characteristics of participants (n=150). Values are numbers (percentages) unless stated 
 otherwise 
Characteristic Descriptive statistic 
Age 
 
Mean (standard deviation) 
Range 
71.0 (10.7) 
18 - 95 
years 
years 
Male 85 (56.7 %) 
Marital status 
 
Married 
Widow/ widower 
Not married 
Living together 
97 
37 
11 
5 
(64.7 %) 
(24.7 %) 
(7.3 %) 
(3.3 %) 
Education 
 
No education / primary school 
Lower education 
Junior general secondary education (MAVO) 
Senior secondary vocational education (MBO) 
Senior general secondary education (HAVO / VWO) 
Higher professional education (HBO) / university 
37 
32 
33 
15 
13 
20 
(24.7 %) 
(21.3 %) 
(22.0 %) 
(10.0 %) 
(8.7 %) 
(13.3 %) 
Family income 
 
€ 450 - 1100 
€ 1100 - 1600 
€ 1600 - 2000 
€ 2000 - 3000 
> € 3000 
Don’t know 
Not willing to answer 
18 
28 
22 
24 
17 
14 
27 
(12.0 %) 
(18.7 %) 
(14.7 %) 
(16.0 %) 
(11.3 %) 
(9.3 %) 
(18.0 %) 
Previously experienced hearing aid provision  98 (65.3 %) 
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Preferences 
The final sample for analysis consisted of 146 participants, resulting in 2336 choice 
observations. The coefficients for the attributes were all statistically significantly different 
from zero (Table 6.3). The signs of the coefficients were positive for all attributes, except for 
the initial assessment at the ENT-specialist and duration. Duration seemed to be the least 
important attribute, as a two months longer duration of the hearing aid provision was 
accepted if the participants would be compensated with at least € 17. Participants preferred 
the initial assessment at a private dispenser and were willing to accept an initial assessment 
at the ENT-specialist if they would be compensated with at least € 54. For a 10% loss in 
accuracy participants requested compensation of at least € 119. Participants preferred the 
follow-up at the ENT-specialist and requested compensation of at least € 227 to forgo this 
follow-up. 
 
 
Table 6.3  Results of the random effects ordered probit regression* with main attributes only 
Attribute Regression 
coefficient
(95% Cl) P-value Marginal willingness
to accept  
(95% CI) 
Initial assessment at ENT1 -0.110 (-0.018 to -0.201) 0.019 € 54 for assessment  
at ENT-specialist 
(€ 3 to € 106) 
10% gain in accuracy2 0.239 (0.186 to 0.292) 0.000 € 119 per 10%  
less accuracy 
(€ 59 to € 178) 
2 months longer duration2 -0.034 (-0.064 to -0.004) 0.029 € 17 per 2 months  
extra duration 
(€ 0 to € 34) 
Follow-up at ENT1 0.456 (0.403 to 0.509) 0.000 € 227 for no  
follow-up at ENT 
(€ 122 to 331) 
€ 1 more savings2 0.002 (0.001 to 0.003) 0.000 Not applicable  
Abbreviations: CI = Confidence Interval 
* Random effects ordered probit model with choice (A, no preference, B) as the ordinal dependent 
variable 
1Dummy coding with 0=no and 1=yes 
2Continuous coding in correspondence with the chosen levels (initial assessment accuracy per 10%, 
duration of the hearing aid provision per 2 months, and savings per Euro) 
 
 
 
 
Participants would accept implementation of full direct hearing aid provision by the private 
dispenser (scenario 1) when they would be compensated with at least € 258 (Table 6.4). 
For scenario 2 (an initial assessment at the private dispenser, a follow-up at the ENT-
specialist and a duration of two months less) they requested compensation of at least € 48. 
For the final scenario of an initial assessment at the ENT-specialist, a follow-up at the 
dispenser and two months less duration, they wanted to be compensated with at least        
€ 210. 
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Table 6.4  Willingness to accept for three possible scenarios of hearing aid provision 
Attribute Current 
situation 
Scenario 1 Scenario 2 Scenario 3 
Quality of the hearing aid good good good good 
Performer &  
accuracy of initial assessment
ENT-specialist private dispenser,
10% less accurate
private dispenser,
10% less accurate
ENT-specialist 
Duration  6 months 2 months 4 months 4 months 
Follow-up at ENT-specialist  yes no yes no 
Willingness to accept - € 258 € 48 € 210 
 
Influence of participant characteristics 
There were 27% missing values on family income (Table 6.2). When analyzing whether 
preferences were dependent on income, this would result in a strongly reduced number of 
usable observations. As missing value imputation by using the regression method resulted 
in a large standard error, we decided not to use income in the interaction model. 
Alternatively, we examined whether preferences were influenced by a participant’s 
educational level, which was correlated with income (Spearman’s Rho 0.62, p-value < 
0.001), and had no missing values. 
Preferences were influenced by age, sex, educational level, and experience with hearing 
aid provision (Table 6.5). Older participants preferred the initial assessment at the dispenser 
more strongly and placed less weight on the savings. Women showed a stronger preference 
for the initial assessment at the dispenser and a weaker preference for the follow-up at the 
ENT-specialist than men. Participants with a higher educational level placed less weight on 
the savings, and persons who had previous experience with hearing aid provision preferred 
the initial assessment at the dispenser more strongly. 
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Table 6.5  Results of the random effects ordered probit regression* with main attributes and 
 interactions 
Attribute Regression 
coefficient
(95% Confidence 
Interval) 
P-
value 
Initial assessment at ENT-specialist1 0.702 (0.166 to 1.238) 0.010 
10% gain in initial assessment accuracy2 0.243 (0.190 to 0.297) 0.000 
2 months longer duration of hearing aid provision2 -0.034 (-0.064 to -0.003) 0.031 
Follow-up at ENT-specialist1 0.545 (0.474 to 0.616) 0.000 
€ 1 more savings2 0.014 (0.007 to 0.021) 0.000 
Age2 * initial assessment at dispenser1 0.007 (0.000 to 0.148) 0.043 
Age2 * savings2 -0.0001 (-0.0002 to -0.0000)  0.006 
Sex3 * initial assessment at dispenser1 0.210 (0.058 to 0.363) 0.007 
Sex3 * follow-up at ENT-specialist1 -0.187 (-0.294 to -0.080) 0.001 
Educational level4 * savings2 -0.001 (-0.002 to -0.001) 0.000 
Experience1 * initial assessment at dispenser1 0.281 (0.121 to 0.440) 0.001 
* Random effects ordered probit model with choice (A, no preference, B) as the ordinal dependent 
variable 
1Dummy coding with 0=no and 1=yes 
2Continuous coding in correspondence with the chosen levels (initial assessment accuracy per 10%, 
duration of the hearing aid provision per 2 months, savings per Euro, and age in years) 
3Dummy coding with 0=male and 1=female 
4Categories with higher number representing higher education 
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Discussion 
To our knowledge, this is the first study regarding patients’ preferences for the organization 
of hearing aid provision. In general, participants preferred hearing aid provision with an 
initial assessment at the hearing aid dispenser with the same accuracy as at the ENT-
specialist, a duration of two months, and a follow-up at the ENT-specialist. They requested 
compensation of at least € 17 for two months extra duration. For an initial assessment at 
the ENT-specialist participants requested compensation of at least € 54. A 10% decrease in 
accuracy was accepted when they would receive compensation of at least € 119. 
Participants requested compensation of at least € 227 to forgo the follow-up at the ENT-
specialist. Preferences were influenced by sex, age, educational level, and experience with 
hearing aid provision. 
 
Limitations 
Discrete choice experiments are cognitively challenging (Louviere et al., 2000). As our 
study population was on average 71 years old we were aware of the risk that participants 
might not understand the questionnaire, causing invalid preferences. The questionnaires 
were therefore administered in face-to-face interviews, and a validity check was added. 
Four participants (3%) answered the dominant pair question incorrectly, indicating invalid 
preferences, and were therefore excluded from the analysis. We found no evidence that the 
remaining 146 participants had invalid preferences. To limit the cognitive demand of the 
experiment, we ordered the attributes chronologically, thus reflecting the normal process of 
hearing aid provision. Although Kjaer et al. (2006) recently suggested that an ordering 
effect of the attributes exists, we expected that when ordering the attributes randomly, the 
increase in cognitive demand would outweigh the advantages of minimizing the ordering 
effect. 
Although there is no consensus on the maximum number of choice sets a respondent can 
cope with, the 18 sets we defined might be perceived as a lot. This is emphasized by the 
fact that almost half of the participants (46%) found that the questionnaire consisted of (too) 
many questions. There were no missing values however, probably due to the face-to-face 
interview administration. 
Although the questionnaire started with a comprehensive detailed explanation of the 
attributes, we are aware that accuracy may have been a difficult concept for the 
respondents to understand. That is, it is difficult to fully understand the consequences of 
mistakenly identifying a patient as a client, withholding him medical care. The importance 
of the accuracy attribute might therefore be over- or underestimated. However, as the 
confidence interval surrounding the regression coefficient of the accuracy attribute is not 
very large, there is no indication that the concept of accuracy was actually misunderstood. 
Finally, we included non-traders in the analysis. Respondents were classified as not willing 
to trade when they consequently chose an alternative in terms of one attribute, irrespective 
of the levels of the other attribute. In other studies non-traders are often excluded (Ratcliffe 
& Buxton, 1999; Ryan & Farrar, 2000; Ryan & Hughes, 1997), but Lancsar and Louviere 
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(2006) recently advocated not to remove them, as non-traders are of particular interest to 
decision makers and random utility theory can cope with these preferences. We did 
estimate an additional regression model without the seventeen non-traders (12%), and 
found similar results. 
 
Implications 
Participants preferred hearing aid provision with a shorter duration. Direct hearing aid 
provision by private dispensers could lead to a decrease in patient waits and a reduction in 
the number of consultations, resulting in a shorter duration. 
The participants also preferred to initially visit a dispenser instead of going to an ENT-
specialist in the hospital. However, they value the initial assessment at the dispenser similar 
to a 5% gain in accuracy of that initial assessment. This indicates that hearing-impaired 
persons only prefer to initially visit a private dispenser when he is at least 95% as accurate 
as the ENT-specialist. To enhance the accuracy of the private hearing aid dispenser, a set of 
referral criteria was developed (Veldhuizen et al., 2002). Additionally a training program, 
corresponding to the referral criteria, was especially designed for the purpose of the initial 
assessment. The main topics of the training program are audiometry and otoscopy. 
However, until now this training program has only been applied in an evaluative context. 
More research is needed to determine whether private dispensers are able to accurately 
distinguish between patients and clients, and which skills they require for this purpose. 
Since private dispenser practices are often more accessible than hospitals, hearing-
impaired persons may seek amplification sooner when they do not need to visit a hospital. 
This is emphasized by the fact that older persons preferred the initial assessment at the 
dispenser more strongly. Participants who had previously experienced hearing aid 
provision also had stronger preferences for the initial assessment at the dispenser. 
Apparently persons attach less value to consulting a medical specialist for the initial 
assessment once they have had a medical examination for their hearing problems before. 
Our results suggest that hearing impaired persons find the follow-up at the ENT-specialist 
very important, as they request high compensation to forgo this follow-up. They even 
request a higher compensation (€ 227) than the actual cost of a follow-up at the ENT-
specialist (at maximum € 104) (Oostenbrink et al., 2004). A possible disadvantage of direct 
hearing aid provision by private dispensers is that the prescriber of the hearing aid 
financially benefits from selling hearing aids. This may result in over-provision of hearing 
aids. This disadvantage may possibly be cancelled out when an independent evaluation of 
the hearing aid remains available. In the UK it was experienced that persons prefer a 
telephone follow-up rather than a clinical face-to-face follow-up in some categories. More 
research is needed on whether this is a safe and feasible alternative. 
Participants requested the least compensation for a scenario of hearing aid provision with a 
10% less accurate initial assessment at the private dispenser and a follow-up at the ENT-
specialist. When the assessment would be only 5% less accurate than at the ENT-specialist, 
they would even request no compensation. This indicates that from a patient perspective 
one should strive for implementation of hearing aid provision with a follow-up at the ENT-
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specialist and an initial assessment at the private dispenser, if possible with accuracy 
similar to that of the current hearing aid provision. 
 
 
Conclusion 
The possibility of direct hearing aid provision by private dispensers may save costs, 
decrease patient waits, and may even break down barriers delaying hearing-impaired 
persons to seek help. This has certainly been the case in England, but there were concerns 
about the quality of the hearing aid provision. 
Discrete choice experimentation seems to be a feasible instrument to measure preferences 
in an elderly population. Besides patient preferences, safety and efficiency are important 
issues to consider when changing the organization of hearing aid provision. From the 
present study however we conclude that Dutch hearing-impaired persons are receptive to 
transferring elements of hearing aid provision from the medical sector to private hearing aid 
dispensers. Whether they prefer the initial assessment at the private dispenser or at the 
ENT-specialist depends on the accuracy of the dispenser to distinguish between patients 
and clients. Participants prefer a private dispenser when he is at least 95% as accurate as 
the ENT-specialist, prefer a follow-up at the ENT-specialist, and request a higher 
compensation to forgo this follow-up than its actual costs. 
 Patient preferences for direct hearing aid provision 
113 
Appendix 6.1   Example of a discrete choice question 
 
Attribute Alternative A Alternative B 
Quality of the hearing aid Good Good 
Performer and accuracy of the initial 
assessment 
ENT-specialist at 
hospital 
Dispenser at practice, equally 
accurate 
Duration of hearing aid provision 2 months 4 months 
Follow-up at ENT-specialist  Follow-up at ENT-
specialist 
No follow-up at ENT-
specialist 
Savings € 20 € 50 
   
Which alternative would you choose?  A  B 
   I have no preference 
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Abstract 
Objective 
To examine the long-term cost-effectiveness of, and inform the research agenda on, 
alternative forms of shared care in hearing aid provision. 
Study setting/data sources 
Available evidence from a prospective study, a patient cohort study, published literature 
and expert opinion was synthesized. 
Study design 
A probabilistic decision-analytic Markov model with health states based on hearing aid use 
and pathology was constructed. 
Data collection/extraction methods 
We modeled the long-term cost-effectiveness of (different forms of) shared care as opposed 
to the current organization of hearing aid provision, for persons aged 50+. Additionally we 
assessed the value of additional research, and for which topics further research is most 
valuable. 
Principal findings 
The current organization of hearing aid provision as compared to shared care is more 
effective, and had a higher probability of being cost-effective (54%). It is however 
worthwhile to perform additional research, especially on whether persons seek help for 
their hearing complaints sooner in a shared care pathway and whether the dispenser is 
capable of detecting pathology. 
Conclusions 
Based on the current evidence shared care, in any form, should not be implemented just 
yet, and it is worthwhile to perform additional research to reduce uncertainty surrounding 
this decision. 
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Introduction 
In several health care sectors tasks of medical specialist are transferred to other professions, 
sometimes even outside the medical sector (Adams, 2004; Nancarrow & Borthwick, 2005; 
Norris, 2001; Stevens et al., 2007). This paper illustrates how decision-analytic modeling 
can assist decision-making in such organizational innovations. As a case, we examined 
shared care in hearing aid provision. 
Until recently, all hearing-impaired persons in the Netherlands needed a prescription and 
approval of their hearing aid by an Ear Nose and Throat (ENT) specialist or Audiological 
Centre (AC). The hearing aid was generally fitted by a private hearing aid dispenser. As 
only a small proportion of hearing-impaired adults require management other than hearing 
aids, it is advocated that not all persons with hearing complaints need to be examined by 
an ENT-specialist or AC (Swan & Browning, 1994). Also, the ageing of the population 
increases the costs associated with hearing rehabilitation, and significant patient waits exist 
in for example the UK (British Academy of Audiology, 2006). Hence, increasing attention is 
currently paid to shared care initiatives in hearing aid provision. These initiatives include 
direct hearing aid provision by private dispensers without prescription or approval. 
However, the problem is that little evidence exists regarding shared care in hearing aid 
provision. It is unsure whether private dispensers are capable of identifying the subgroup of 
persons who do require medical care (safety). Also, it is unclear whether the transfer of 
tasks will reduce costs while maintaining the quality of the hearing aid fitting (efficiency). 
Especially in an early stage, organizational innovation can be designed in various 
alternative ways, which makes it difficult to perform trials to assess safety and efficiency. 
However, the lack of evidence did not mean that decisions were postponed. In fact, some 
health insurance companies in the Netherlands already allow private dispensers to take 
over tasks from ENT-specialists and ACs. 
It is better to inform a decision with the available evidence than without any evidence at all 
(Weinstein et al., 2003). Decision-analytic modeling is a useful tool to synthesize available 
evidence, and is increasingly used to estimate the safety and efficiency of health care 
interventions (Weinstein et al., 2003). It is not intended to reveal scientific truth (Weinstein, 
2006), but to guide decision-making. Data from different sources can be combined to 
inform decision making under conditions of uncertainty (Briggs et al., 2006; Fenwick et al., 
2006). Additionally, one can assess the value of additional research, and specifically what 
type of additional evidence would be most valuable. It can therefore assist in making a 
twofold decision: 1) whether or not an intervention should be implemented, given the 
current evidence, and 2) whether it is worthwhile to perform additional research to reduce 
the uncertainty surrounding the first decision (Claxton et al., 2002). 
The current paper aims to examine the long-term cost-effectiveness of (different forms of) 
shared care as opposed to the current organization of hearing aid provision, for persons 
aged 50 years and older. Additionally, we assessed the value of additional research, and for 
which topics further research is most valuable on this subject. 
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Methods 
Model description 
A Markov model was constructed with mutually exclusive health states. The model 
simulated the course of events in a hypothetical cohort of persons with hearing complaints, 
aged 50 years or older. In the model, as time progresses, persons move between the 
different health states according to a set of transition probabilities. The cycle length of the 
model was set to one year, with a lifetime time horizon. 
The model was constructed to compare the expected lifetime costs and effects of shared 
care alternatives with the lifetime costs and effects of the current organization of hearing 
aid provision in the Netherlands. The current organization, where persons seek help with 
the general practitioner (GP) and ENT-specialist or AC, and all persons fitted with a hearing 
aid have an evaluation of their hearing aid fitting at the ENT-specialist or AC, is referred to 
as the ‘current pathway’ (Table 7.1). We defined three shared care pathways: a ‘total direct 
pathway’, a ‘triage pathway’ and a ‘follow-up pathway’. In the ‘total direct pathway’ 
persons seek help with a private dispenser. The private dispenser uses a checklist with 
referral criteria to perform a triage to distinguish between patients (suspected of pathology) 
and clients (no pathology). For clients, as opposed to patients, there is no need to visit the 
ENT-specialist or AC. In the ‘triage pathway’ persons seek help with the private dispenser, 
but all persons fitted with hearing aids have an evaluation at the ENT-specialist or AC. In 
the follow-up pathway persons always seek help with their GP, but for clients there is no 
need for an evaluation of the hearing aid fitting by the ENT-specialist or AC. 
The analysis was performed from the societal perspective, and all costs were reported in 
Euros (€ 1 is US $ 1.25, average 2006 conversion rate). Future costs and effects were 
discounted to their present value by a rate of 4% and 1.5% respectively, according to 
Dutch guidelines (Health Care Insurance Board, 2006). Data sources for the parameters in 
the model were a prospective study (valid n=269), a patient cohort study (n=1000), 
published literature and, if no other source was available, expert opinion. Unless stated 
otherwise, expert opinion was provided by the authors through an informal process. 
 
 
 
 
 
 
Table 7.1 Alternative pathways of hearing aid provision 
Alternative Initial assessment Follow-up at ENT-specialist 
Current pathway GP & ENT-specialist / AC Always 
Total direct pathway Private dispenser Only for patients 
Triage pathway Private dispenser Always 
Follow-up pathway GP & ENT-specialist / AC Only for patients 
Abbreviations: GP = General Practitioner; ENT = Ear, Nose and Throat; AC = Audiological Centre 
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Model construction 
Health states 
Health states were based on two aspects, being hearing aid use and pathology. For the first 
aspect health states were ‘no hearing aid user’, ‘hearing aid user’ and ‘ex hearing aid user’. 
Hearing aid users were subdivided into two health states: good quality hearing aid fitting 
and poor quality hearing aid fitting. For the second aspect, we first identified pathology that 
was associated with hearing loss: acoustic neuroma, chronic otitis media, otosclerosis, 
otitis externa, Ménière’s disease, genetic hearing loss and psychosocial problems. We then 
excluded pathology with symptoms of such nature that they would not be missed by the 
dispenser or by the patients themselves (otitis externa, Ménière’s disease). Subsequently we 
excluded pathology where no direct health consequences from missed treatment as a result 
of a missed diagnosis were expected (genetic hearing loss). Finally, we included the 
following pathology health states in the model: ‘chronic otitis media’, ‘acoustic neuroma’, 
‘otosclerosis’, and ‘psychosocial problems’ (Figure 7.1). Pathology states were either 
detected or undetected. For detected acoustic neuroma we included an ‘after treatment’ 
(either surgery or radiotherapy) health state. The final absorbing state was ‘death’. 
 
 
 
Figure 7.1  Simplified schematic diagram of the Markov model* 
*All health states except detected otitis media are further divided into hearing aid users 
and non-users (and ex-users in the no pathology state). For detected acoustic neuroma 
before and after treatment states are distinguished. 
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Model assumptions 
We assumed that in the total direct pathway and triage pathway all persons with hearing 
complaints would seek help with the private dispenser. Also, we assumed that in the total 
direct pathway and follow-up pathway no dispensers would refer persons without 
pathology (clients) to an ENT-specialist or AC for evaluation of the hearing aid fitting. This 
means that we assumed perfect adherence to the shared care pathways, or perfect 
implementation. Another model assumption was that all persons with pathology (patients) 
would seek help, and that the GP would refer all patients to an ENT-specialist, so that in 
the current pathway there would be no undetected pathology. Also, we expected the GP to 
refer all clients who were potential hearing aid candidates to the ENT-specialist. Finally, we 
expected hearing aid fittings to be of good quality when they were evaluated by an ENT-
specialist or AC. 
 
Probabilities 
All probabilities are listed in Table 7.2. Age-specific incidence figures were found only for 
acoustic neuroma (Propp et al., 2006). For chronic otitis media and otosclerosis we used 
incidence figures of the general population (Cummings, 2005). As the typical age of onset 
of the hearing loss associated with otosclerosis is between 30 and 40 years (Cummings, 
2005), we assumed that the incidence after the age of 50 would be at maximum one third 
of the incidence of the general population (expert opinion). We found no published 
literature on the incidence of psychosocial problems, and therefore used a database of 
1000 randomly selected patients consulting for hearing problems with an ENT-specialist in 
a community hospital in the Netherlands in 2002 (Duijvestijn et al, unpublished data). Of 
the 744 persons aged 50 years and older, 13 (1.7%) were referred to an AC for specialized 
psychosocial care. 
Shared care in hearing aid provision might lower barriers to help-seeking for hearing 
complaints. In a survey, 24% of the persons with hearing complaints reported that they 
would be inclined to obtain a hearing aid sooner when they did not have to visit their GP, 
an ENT-specialist or AC first (Grutters et al., 2007b). Based on expert opinion, we made a 
conservative estimation of 10% extra help-seeking in the total direct and triage pathway. 
Probabilities to start a hearing aid trial, to have a follow-up and to have a successful 
hearing aid fitting were derived from a multi-centre non-controlled prospective evaluation 
study examining the shared care pathway versus the current pathway (AZOS working 
group, 2006). Participants, being persons with hearing complaints aged 50 years and older 
(valid n=269), first visited the hearing aid dispenser for a triage visit, where the dispenser 
examined whether the participant was in need of medical or specialized audiological care 
or not and hence should be defined as a patient or client respectively. All participants 
subsequently visited the ENT-specialist and AC to evaluate whether the dispenser had 
correctly defined them as a patient or a client. In cases where the participant was fitted 
with hearing aids he returned to the AC for a follow-up visit, to evaluate the quality of the 
hearing aid fitting. 
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Because of the low incidence of pathology the study population of the prospective study 
was too small to obtain valid estimates of sensitivity and specificity of the private dispenser. 
Based on expert opinion we expected the probability of a private dispenser to refer patients 
to an ENT-specialist (sensitivity) to be at least as good as chance (0.5) and at maximum 
perfect (1), with a mean value of 0.75. The probability of a private dispenser not to refer 
clients to an ENT-specialist (specificity) was estimated to be between 0 and 1, with a mean 
value of 0.5. Hearing aid users are possibly more aware of their hearing problems and are 
more likely to seek help when their symptoms worsen. We therefore estimated the 
probability of undetected pathology to be detected to be higher for hearing aid users (0.2) 
than for non-users (0.1). 
Quality of the hearing aid fitting was based on a multi criteria evaluation instrument, of 
which details can be found elsewhere (AZOS working group, 2006). The probability to 
have a good quality hearing aid fitting under responsibility of the dispenser was 0.85, as 
found in the prospective study. We assumed that for undetected acoustic neuroma, 
undetected otosclerosis and undetected psychosocial problems the hearing aid fitting 
would always be of poor quality, as these pathologies should have been considered in the 
hearing aid fitting. We estimated the probability to become an ex-user to be 50% higher for 
hearing aid users with a poor quality hearing aid fitting (0.18) than with a good quality 
hearing aid fitting (0.12). 
We used age-specific mortality rates for five year age groups (Central Bureau for Statistics, 
2007). 
 
Effects 
Health-related quality of life was used as outcome measure in the model. Health-related 
quality of life was considered as single index utility, on a scale from 0 to 1, where 0 
represents death and 1 represents perfect health. The use of utility scores allows the 
calculation of Quality Adjusted Life Years (QALYs) and cost per QALY ratios. Utility scores 
were derived with the HUI3, a measure responsive to change in health state utility after 
hearing aid fitting (Barton et al., 2004; Grutters et al., 2007a). For persons without 
pathology, we used the utility scores of participants in the prospective study, with and 
without hearing aid fitting (Table 7.2). We assumed ex hearing aid users to have the same 
level of utility as persons without hearing aid fitting. Based on expert opinion we derived 
HUI3 utility scores for persons with pathology. We estimated that persons with chronic 
otitis media and otosclerosis had more hearing complaints than persons without pathology, 
and that persons with chronic otitis media had more pain than persons with otoslerosis. 
Undetected psychosocial problems were associated with more problems on the emotional 
level. An acoustic neuroma was associated with more pain and more hearing loss than no 
pathology. We estimated that quality of the hearing aid fitting did not influence utility, as 
we did not find a relation between the two in the prospective study. 
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Costs 
All costs were in Euro and price indices were used to convert costs to a 2006 price level 
(Central Bureau for Statistics, 2007). Costs were estimated for health states as well as 
transitions. Wherever possible, costs were based on the Dutch manual for cost research 
(Oostenbrink et al., 2004). Alternatively, hospital prices were used. Productivity costs were 
not included because they were not expected to be relevant in a population with hearing 
complaints aged 50 years and older (Joore et al., 2003b). 
Costs of the triage and follow-up visit at the private dispenser were calculated using a 
micro-costing approach. We repeatedly (n=9) measured the exact time that was needed to 
perform both the triage and the follow-up visit, at three different dispensers participating in 
the study. This resulted in a mean duration and standard error, which was multiplied by the 
average labor costs of a private dispenser, including rent, depreciation of equipment, 
energy, taxation and maintenance. All costs are listed in Table 7.2. 
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Table 7.2  List of input parameters 
Input parameters Estimated
value 
SE Distribution Source 
Transition probabilities     
Incidence   
Acoustic neuroma 0.0001 0.0001 dirichlet 1 
Chronic otitis media 0.0013 0.0003 dirichlet 2 
Otosclerosis 0.0001 0.0001 dirichlet 2, EO 
Psychosocial problems 0.0175 0.0009 dirichlet 3 
Help-seeking for hearing complaints   
Seeking help 0.16 fixed  4 
Increase in help-seeking in total direct and triage pathways 0.10 * beta EO 
Process of hearing aid (HA)  fitting for patients with pathology   
Having HA with acoustic neuroma, otitis media, 
otosclerosis 
0.75 0.03 beta EO 
Having HA with psychosocial problems 0.90 0.02 beta EO 
Getting treatment for acoustic neuroma 0.20 0.06 beta EO 
Being successfully treated for otitis media first 4 years 0.80 0.06 beta EO 
Being successfully treated for otitis media after 4 years 1 fixed  EO 
Being successfully treated for psychosocial problems 0.50 0.29 beta EO 
Process of hearing aid (HA) fitting for persons without pathology   
GP to refer to ENT-specialist 0.69 fixed  5 
Starting hearing aid fitting 0.58 0.03 beta OS 
Having a follow-up without pathology 0.90 0.02 beta OS 
Having a hearing aid after follow-up 0.98 0.01 beta OS 
Sensitivity   
Dispenser to refer pathology to ENT-specialist 0.75 0.14 beta EO 
Specificity   
Dispenser not referring no pathology to ENT 0.50 0.29 beta EO 
Detecting undetected pathology   
Detecting undetected pathology in HA users 0.20 uniform 0-1 EO 
Detecting undetected pathology in non HA users 0.10  uniform 0-1 EO 
Quality hearing aid fitting   
Having a good quality HA fitting after follow-up dispenser 0.85 0.07 beta OS 
Becoming ex user   
Becoming ex user with poor quality HA fitting 0.18 0.01 beta 6, EO 
Becoming ex user with good quality HA fitting 0.12 0.01 beta 6, EO 
   
Utility scores   
No pathology, no hearing aid / ex user 0.63 0.02 beta OS 
No pathology, hearing aid user 0.70 0.02 beta OS 
Acoustic neuroma detected, no hearing aid 0.42 0.02 beta EO 
Acoustic neuroma detected, hearing aid user 0.51 0.02 beta EO 
Acoustic neuroma detected, after treatment 0.23 0.02  beta EO 
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Table 7.2 List of input parameters (continued)   
   
Input parameters Estimated
value
SE Distribution Source 
Acoustic neuroma undetected, no hearing aid 0.35 0.02 beta EO 
Acoustic neuroma undetected, hearing aid user 0.41 0.02 beta EO 
Otitis media detected 0.52 0.02 beta EO 
Otitis media undetected, no hearing aid 0.52 0.02 beta EO 
Otitis media undetected, hearing aid user 0.56 0.02 beta EO 
Otosclerosis detected, no hearing aid 0.58 0.02 beta EO 
Otosclerosis detected, hearing aid user 0.62 0.02 beta EO 
Otosclerosis undetected, no hearing aid 0.31 0.02 beta EO 
Otosclerosis undetected, hearing aid user 0.45 0.02 beta EO 
Psychosocial problems detected, no hearing aid 0.63 0.02 beta EO 
Psychosocial problems detected, hearing aid user 0.70 0.02 beta EO 
Psychosocial problems undetected, no hearing aid 0.54 0.02 beta EO 
Psychosocial problems undetected, hearing aid user 0.59 0.02 beta EO 
   
Costs   
Ratio of surgery versus radiotherapy as treatment for 
acoustic neuroma 
0.50 0.03 beta EO 
Probability of CT scan in diagnosing chronic otitis media 
and otosclerosis 
0.50 0.29 beta EO 
Costs of extra procedures at ENT/AC for no pathology 
when referred by GP or when referred by dispenser if 
specificity < 0.75 ** 
68 10 gamma 7, OS 
Costs of extra procedures at ENT/AC for no pathology 
when referred by dispenser and specificity ≥ 0.75 ** 
138 24 gamma 7, OS 
Annual costs of batteries and maintenance, per hearing aid 52 fixed  PC 
Annual cost of hearing aid repair 28 fixed  PC 
Resource use   
Number of hearing aids fitted per person 1.78 0.04 beta OS 
MRI in acoustic neuroma wait & scan state 1 fixed  EO 
MRI after radiotherapy treatment for acoustic neuroma 1 fixed  EO 
ENT consults in acoustic neuroma wait & scan state 1.50 0.29 beta EO 
ENT consults in acoustic neuroma after treatment state 2.00 0.50 gamma EO 
ENT consults in detected otitis media state 4.00 1.00 gamma EO 
Treatments (tympanoplasty) in detected otitis media state 1 fixed  EO 
Combined ENT/AC consults in detected otosclerosis state 1.00 0.25 gamma EO 
Clinical audiologist / AC consults in detected psychosocial 
problems state 
4.00 1.00 gamma EO 
Initial assessments at dispenser 1 fixed  EO 
GP visits when seeking help with GP 1 fixed  EO 
Combined ENT/AC consults when referred to ENT/AC 1 fixed  EO 
Combined ENT/AC follow-up visits to evaluate hearing aid 
fitting 
1.22 0.04 beta OS 
Follow-up visits at dispenser 1 fixed  EO 
BERA when diagnosing acoustic neuroma 1 fixed  EO 
MRI when diagnosing acoustic neuroma 1 fixed  EO 
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 * A skewed distribution between 0 and 1 was fitted with a mean of 0.1, and α=1, β=9.  
** For the calculation of average costs of procedures at ENT for persons without pathology we 
assumed the average costs to be higher when specificity was higher. For specificity higher than 0.75 
we assumed that the dispenser would refer the subpopulation (25%) who received further diagnostics 
in the observational study and thus had higher costs. 
*** A skewed distribution between 0 and 1 was fitted with a mean of 0.2, and α=1, β=4, as the 
probability that the stapedectomy was not performed on both ears, and was then subtracted from 2 to 
obtain the number of stapedectomies. 
Abbreviations: OS = observational study; EO = expert opinion; PC = personal communication with H. 
Streukens; HC = hospital costs; HA = hearing aid; SE = standard error; AC = audiological centre 
References: 1 (Propp et al., 2006); 2 (Cummings, 2005); 3 Duijvestijn et al, unpublished data; 4 
(Chorus et al., 1995); 5 (Duijvestijn et al., 1999); 6 (Joore et al., 2003b) 7  (Oostenbrink et al., 2004); 8 
(Ziekenfondsraad, 1994)  
Table 7.2 List of input parameters (continued)   
   
Input parameters Estimated
value
SE Distribution Source 
ENT consults when diagnosing acoustic neuroma 2 fixed  EO 
Tympanometry when diagnosing chronic otitis media 1 fixed  EO 
Tympanometry when diagnosing otosclerosis 1 fixed  EO 
Stapedectomy when having otosclerosis 1.80 *** beta EO 
Clinical audiologist consults when diagnosing 
psychosocial problems
1 fixed   
ENT consults related to treatment for acoustic neuroma 1 fixed  EO 
MRI related to treatment for acoustic neuroma 1 fixed  EO 
Unit costs (€)   
Hearing aid fitting, per hearing aid 332 fixed  8, OS 
Hearing aid, without fitting, per hearing aid 519 fixed  8, OS 
GP visit 21 fixed  7 
Initial assessment at dispenser 42 3 gamma OS 
ENT consult 65 fixed  7 
Consult with clinical audiologist / audiological centre (AC) 107 fixed  HC 
Combined ENT/AC consult 162 fixed  7 
Combined ENT/AC follow-up to evaluate hearing aid fitting 72 fixed  7 
Follow-up at dispenser 41 3 gamma OS 
MRI 251 fixed  7 
BERA 338 fixed  HC 
CT scan 276 fixed  7 
Tympanometry 64 fixed  HC 
Stapedectomy 1352 fixed  7 
Surgery as treatment for acoustic neuroma 4120 fixed  7 
Radiotherapy as treatment for acoustic neuroma 9958 fixed  7 
Treatment for chronic otitis media (tympanoplasty) 1640 fixed  7 
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Analysis 
We compared the cost-effectiveness of the total direct pathway, the triage pathway, the 
follow-up pathway and the current pathway. Incremental cost-effectiveness ratios (ICERs) 
were calculated, dividing the incremental costs by the incremental QALYs. ICERs were 
calculated by comparing each pathway with the next most effective pathway. Whether a 
pathway is deemed efficient depends on how much society is willing to pay for a gain in 
effect, which is referred to as the ceiling ratio. In the Netherlands an informal ceiling ratio 
of € 80 000 per QALY exists (Council for Public Health and Health Care, 2006). This is 
however a maximum ceiling ratio which applies when there is a high burden of disease, 
and is therefore not likely to apply to shared care in hearing aid provision. The National 
Institute for Health and Clinical Excellence in the United Kingdom uses a ceiling ratio 
between £ 20 000 and £ 30 000 per QALY (Buxton, 2006), which is roughly € 40 000. 
Uncertainty surrounding the ICERs was handled probabilistically. This means that we 
assigned distributions to the model parameters, to reflect the second-order uncertainty in 
the estimation of that parameter (Weinstein, 2006). Measures of variance were retrieved 
from the prospective study, the patient cohort or published literature and, if no other source 
was available, from expert opinion. See Table 7.2 for the assigned distributions. Parameter 
values were drawn at random from the assigned distributions, using Monte Carlo 
simulation with 10 000 iterations. To illustrate the results of the simulation, cost-
effectiveness acceptability curves (CEACs) were calculated (Fenwick et al., 2001; Van Hout 
et al., 1994). For different ceiling ratios, the net monetary benefit was calculated for each 
pathway by subtracting the costs from the effects, multiplied by the ceiling ratio. CEACs 
show the probability that a pathway has the highest net monetary benefit, and thus is 
deemed cost-effective, given different ceiling ratios. 
In the base case analysis, age was set at 70 years, as this was the median age of participants 
in the prospective study, and was estimated to be the median age for persons seeking help 
for their hearing complaints. In a subgroup analysis, we varied age to 50 and 85 years. 
As uncertainty exists, there is always a chance that the ‘wrong’ decision will be made 
(Briggs et al., 2006). The expected value of perfect information (EVPI) is a measure of the 
worth of acquiring additional information, through further research (Claxton & Posnett, 
1996). The EVPI is the expected value of obtaining perfect knowledge of the ‘true’ values of 
all parameters. We calculated the total EVPI by subtracting the net monetary benefit of the 
pathway we would choose under conditions of uncertainty, from the net monetary benefit 
of the optimal decision we would make if we knew the ‘true’ parameter values. Finally, we 
calculated the EVPI for (groups of) parameters, for a ceiling ratio of € 40 000 per QALY, to 
examine for which parameters further research is the most valuable (Felli & Hazen, 1998). 
We calculated this partial EVPI by subtracting the net monetary benefit of the pathway we 
would choose under conditions of uncertainty for a given parameter (group), from the net 
monetary benefit of the optimal decision we would make if we knew the ‘true’ value of that 
parameter (group) (Groot Koerkamp et al., 2006). 
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Results 
Base case analysis 
The current pathway yielded the most QALYs (on average 7.659; Table 7.3), followed by 
the follow-up pathway. The follow-up pathway was associated with a slight QALY loss of 
0.005 and cost savings of € 40, resulting in a mean ICER of € 8 381 saved per QALY lost. 
As both the triage pathway and the total direct pathway were somewhat more expensive 
than the follow-up pathway and associated with a loss in QALYs, these pathways were 
judged inferior. 
 
 
Table 7.3  Base case results and one-way sensitivity analyses 
Pathway Expected costs in € 
(95% CI) 
Expected QALYs 
(95% CI)
Comparison ICER  
(€ saved per 
QALY lost) 
70 years (base case analysis)   
Current pathway 1486 (1345 - 1804) 7.659 (7.34 - 7.96)   
Follow-up pathway 1447 (1314 - 1766) 7.654 (7.33 - 7.96) Current pathway 8381 
Triage pathway 1491 (1283 - 1815) 7.646 (7.34 - 7.95) Follow-up pathway inferior 
Total direct pathway 1449 (1250 - 1772) 7.641 (7.34 - 7.95) Follow-up pathway inferior 
50 years    
Current pathway 2359 (2089 - 3161) 15.120 (14.48 - 15.72)   
Follow-up pathway 2286 (2035 - 3090) 15.109 (14.47 - 15.71) Current pathway 6453 
Triage pathway 2304 (2013 - 3127) 15.042 (14.48 - 15.70) Follow-up pathway inferior 
Total direct pathway 2228 (1955 - 3053) 15.031 (14.46 - 15.69) Follow-up pathway 743 
85 years    
Current pathway 664 (611 - 748) 3.104 (2.97 - 3.23)   
Follow-up pathway 651 (599 - 734) 3.103 (2.97 - 3.23) Current pathway 13 148 
Triage pathway 671 (567 - 774) 3.101 (2.97 - 3.23) Follow-up pathway inferior 
Total direct pathway 656 (554 - 757) 3.100 (2.97 - 3.22) Follow-up pathway inferior 
95% Confidence Intervals (CI) are based on probabilistic analysis 
 
 
In Figure 7.2 the cost-effectiveness acceptability curves show that considerable uncertainty 
surrounds the decision which pathway is deemed cost-effective. Given a ceiling ratio of     
€ 40 000, the current pathway had the highest probability of being cost-effective (54%), 
followed by the triage pathway (40%), the follow-up pathway (4%) and the total direct 
pathway (2%). 
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Figure 7.2 Cost-effectiveness acceptability curves for the four pathways 
 
Subgroup analysis for age 
To examine whether age influenced the results of the cost-effectiveness analysis, we varied 
age to 50 and 85 years (Table 7.3). For persons aged 50, the current pathway yielded the 
most QALYs (15.120), followed by the follow-up pathway. The follow-up pathway resulted 
in a QALY loss of 0.011, cost savings of € 73, and hence an ICER of € 6 453 saved per 
QALY lost. The triage pathway was more expensive and less effective than the follow-up 
pathway, so this pathway was inferior. The total direct pathway was less expensive and less 
effective than the follow-up pathway, resulting in an ICER of € 641 saved per QALY lost. 
Given a ceiling ratio of € 40 000 the current pathway, follow-up pathway, triage pathway 
and total direct pathway had a probability of being cost-effective of 61%, 3%, 35% and 1% 
respectively. 
For persons aged 85, the current pathway also yielded the most QALYs (3.104), followed 
by the follow-up pathway. The follow-up pathway resulted in cost savings of € 14 and a 
QALY loss of 0.001, and hence an ICER of € 13 148 saved per QALY lost. Both the total 
direct pathway and the triage pathway were more expensive and less effective than the 
follow-up pathway, and thus inferior. The current, follow-up, triage and total direct 
pathway had a 46%, 10%, 38% and 6% probability of being cost-effective respectively, 
given a ceiling ratio of € 40 000. 
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Expected value of perfect information 
For the base case analysis the uncertainty surrounding the decision whether or not to 
implement shared care resulted in an EVPI of € 193 per person, given a ceiling ratio of       
€ 40 000. Implementing shared care affects all persons with hearing complaints of 50 years 
and older without a hearing aid, being a total of 1 142 835 persons in the Netherlands in 
the next 10 years (Central Bureau for Statistics, 2007). This makes the population EVPI       
€ 110 million, meaning that perfect information on this topic is worth € 110 million. The 
population EVPI for different ceiling ratios is presented in Figure 7.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Population expected value of perfect information curve 
 
 
Additionally, the EVPI for parameters was calculated. The parameter most valuable for 
further research was whether persons with hearing complaints would seek help sooner 
when they can do so directly with the private dispenser (Figure 7.4). Another valuable 
parameter for further research was the probability that the private dispenser refers patients 
to the ENT-specialist (sensitivity), followed by the probability that undetected pathology 
will be detected, and the utility scores. 
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Figure 7.4  Expected value of perfect information for (groups of) parameters 
 
 
Discussion 
Using decision-analytic modeling, we found that the differences in costs and effects 
between the pathways were small. The current pathway was slightly more effective than 
the shared care pathways. The follow-up pathway was both somewhat less expensive and 
less effective than the current pathway, resulting in an ICER of € 8 381 saved per QALY 
lost. The results indicate that none of the alternative shared care pathways would be 
deemed cost-effective, especially the total direct pathway and the triage pathway as they 
were more expensive and less effective than the follow-up pathway. However, the ICERs 
are surrounded by considerable uncertainty. Given a ceiling ratio of € 40 000, the current 
pathway had the highest probability of being cost-effective (54%), followed by the triage 
pathway (40%), the follow-up pathway (4%) and the total direct pathway (2%). Subgroup 
analyses showed that shared care became more favorable with increasing age, although the 
uncertainty remained high. The value of totally eliminating uncertainty was € 110 million 
in the base case analysis, for a ceiling ratio of € 40 000. 
Given the present results, implementing any form of shared care in hearing aid provision at 
this stage is not recommended. Further research is needed to reduce the uncertainty. 
Although some uncertainty will always remain and hence perfect information is unfeasible, 
the population EVPI showed that the value of further research on this topic greatly 
outweighs its costs. One of the most valuable topics for further research was the sensitivity 
of the private dispenser to recognize pathology. More research is needed on whether the 
dispensers are capable of identifying the subgroup of persons who require medical care. 
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Another important topic is the probability that a person with hearing complaints will seek 
help for his complaints. The results from a survey indicated that a quarter of the 
participants considered the visits to GP, ENT-specialist and AC as a barrier for hearing aid 
fitting (Grutters et al., 2007b). However, we are unsure whether more persons will actually 
seek help in the shared care pathway, and how much more. Probably, shared care will 
only result in health gain when barriers are lowered and more hearing-impaired persons 
are adequately fitted with hearing aids. Otherwise, there will be no health benefit but only 
a health loss for a small cost reduction. It is doubtful whether the latter would be deemed 
desirable by society. More research is therefore needed on whether shared care will 
actually lower barriers to seek help for hearing complaints. A possible disadvantage of 
shared care is that the prescriber of the hearing aid financially benefits from selling hearing 
aids. This may result in over-provision of hearing aids, and a higher probability of 
becoming an ex user. Although over-provision was beyond the scope of the present paper, 
it should be considered if in a later stage shared care is found to be cost-effective and may 
be implemented, especially when it is found that shared care actually lowers barriers to 
help-seeking. 
The current paper demonstrates the use and usefulness of decision-analytic modeling in 
health services research. Some years ago Hadley presented two major issues in health 
services research: 1) there is not enough data to answer questions with enough precision 
for people to use in making decisions, and 2) collecting data is expensive, and health 
services research does not have enough budget to provide helpful answers (Hadley, 2000). 
Decision-analytic modeling can assist in both these issues. First, all available evidence can 
be synthesized in a model to guide decision-making. Next, value of information analyses 
can help to allocate research budgets in the most efficient way. This will obviously not 
answer all questions that exist in health services research, but will at least help to choose 
the most valuable topics for future research. 
There are a number of limitations of the present study that need to be addressed. First, we 
only incorporated four types of pathology, while also other types may affect hearing and 
may be missed by dispensers. However, modeling is always a simplification of a complex 
reality, and we feel that we included the most important types of pathology in this study, as 
they most frequently occur in this population and are most likely to be missed by 
dispensers. Although hearing loss can result from Lyme disease, we could not find a strong 
association between Lyme disease and hearing loss in the literature (Cummings, 2005; 
Gagnebin & Maire, 2002). We therefore left Lyme disease out of the model, although we 
are aware that it is, and will probably increase to be, a possible cause of hearing loss, due 
to the increasing number of ticks infected with Borrelia burgdorferi (Hofhuis et al., 2006). 
Another limitation may be that many uncertain parameters were included in the model, 
based on expert opinion or small study populations. However, a model should not be 
faulted because existing data fall short of ideal standards of scientific rigor (Weinstein et al., 
2003). That is, decisions will be made, so it is better to inform the decision with the 
available evidence than without any evidence at all. Using decision-analytic modeling we 
were able to incorporate this uncertainty in the model, and results were shown with 
surrounding uncertainty. We did assume ‘perfect implementation’, though. Less than 
Chapter 7  
134 
perfect implementation reduces efficiency, for example when help-seeking with the 
dispenser is possible but hearing-impaired persons would continue to seek help with their 
GP. It is unclear whether patients and professionals will change their behavior if shared 
care would be implemented. If shared care in hearing aid provision would be deemed 
efficient, it would therefore be interesting to examine the value of perfect information. This 
would allow for a trade-off between the costs and benefits of implementation strategies 
(Fenwick et al., 2007; Hoomans et al., 2007). 
A final limitation is that decision-analytic modeling is rather computer intensive. Especially 
for the partial EVPI, many iterations need to be drawn. In the present study, we ran 200 
Monte Carlo simulations by 200 draws for the parameter (group) of interest. When 
repeatedly running our partial EVPI analysis the ordering of which (groups of) parameters 
were most valuable for further research remained stable. Thus, we could accurately 
estimate which (groups of) parameters are more and less valuable for further research. One 
should however be aware that, to answer the question how valuable obtaining perfect 
information for each parameter (group) exactly is, many more iterations would be required. 
 
 
Conclusion 
We can conclude that, based on the available evidence, at this stage implementation of 
shared care in hearing aid provision, in any form, is not recommended. This contradicts the 
current situation in the Netherlands, where shared care models are implemented. 
Furthermore, the results show that it is worthwhile to perform additional research to reduce 
uncertainty surrounding the decision whether or not to implement shared care. Additional 
research on whether shared care will lower barriers to help-seeking and whether dispensers 
are capable of identifying the subgroup that requires medical care is most valuable. 
Overall, this study shows that decision-analytic modeling in an early stage of 
organizational innovation is a valuable tool to come to evidence-based decision making. 
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The objective of this thesis was to use health technology assessment to evaluate whether an 
organizational innovation, shared care in hearing aid provision, benefits the care for 
hearing-impaired persons. In this final chapter, the main findings regarding the research 
questions are summarized and discussed, followed by the methodological considerations. 
Subsequently, recommendations for policy and practice are described, and areas for future 
research are identified. 
 
 
Main findings 
The first research question addressed the expectations and potential barriers and facilitators 
towards shared care in hearing aid provision, of both patients and professionals. Hearing 
aid dispensers and general practitioners (GPs) had on average positive expectations 
towards the direct pathway, while the Ear Nose and Throat (ENT) specialists and clinical 
audiologists had on average negative expectations and were somewhat more reluctant 
towards implementation. This has also been observed in other health care settings where 
established professions develop strategies to protect their boundaries, while encroaching 
professions try to expand their work areas (Adams, 2004; Nancarrow & Borthwick, 2005; 
Norris, 2001; Stevens et al., 2007). Despite these differences, most professionals either 
supported implementation of the shared care model, provided that a number of conditions 
are satisfied, or did not support implementation, unless roughly the same conditions are 
satisfied. These conditions were to arrange good communication between the professionals 
involved in the shared care model, to include adequate training for the hearing aid 
dispensers, to frequently evaluate the shared care model, to formulate clear criteria for 
referral, to define a clear division of tasks, to have a second opinion possibility, and to 
provide a complaints service. Patients evaluated the referral and shared care pathway 
equally and had confidence in the hearing aid dispenser. Many, especially older, 
participants however stated that they would still visit the GP and ENT-specialist, even when 
this would not be necessary for reimbursement, and found it important that the ENT-
specialist or audiological centre (AC) evaluated their hearing aid fitting. This indicates that 
older persons are more attached to the opinion of the medical specialist. 
 
The second research question focused on how to measure outcome in shared care in 
hearing aid provision. With regard to measuring utility, both the EuroQol 5D (EQ-5D) and 
the Health Utilities Index mark III (HUI3) seemed to be practical and valid. Only moderate 
to poor agreement was found between the measures. The HUI3 and the HUI mark II were 
more responsive to change after hearing aid fitting than the EQ-5D, and hence resulted in 
lower incremental cost-effectiveness ratios (ICERs) for hearing aid fitting. The results 
confirm other studies that found that different utility measures lead to different utility scores 
(Bosch & Hunink, 2000; Brazier et al., 2004; Conner-Spady & Suarez-Almazor, 2003; 
Espallargues et al., 2005; Feeny et al., 2004; Kaplan et al., 2005; Kopec & Willison, 2003; 
Longworth & Bryan, 2003; Marra et al., 2004; Marra et al., 2005; O'Brien et al., 2003; 
Oostenbrink et al., 2002; Petrou & Hockley, 2005). With respect to the study population, 
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our results confirm those of Barton et al. (2005; 2004), who compared the EQ-5D and the 
HUI3 before and after hearing aid fitting in a British sample. The lower utility scores and 
higher responsiveness of the HUI3 as opposed to the EQ-5D were also found in a 
population with visual impairment (Espallargues et al., 2005). 
In the contingent valuation study we found no statistically significant difference, and a 
strong association between the results of the open-ended and the payment scale question. 
The payment scale and the open-ended format both showed good criterion validity, though 
the open-ended willingness to pay (WTP) question showed a stronger association with the 
gold standard, the actual payment. Moreover, the open-ended WTP question showed better 
construct validity, since it was consistent with the theoretical construct of positive income 
elasticity. Although the open-ended format is often thought to be less valid than the 
payment scale format (Arrow, Solow, Portney, Leamer, Radner, & Schuman, 1993; 
Donaldson, Thomas, & Torgerson, 1997; Ryan, Scott, & Donaldson, 2004), these results 
point towards the opposite. This may well be the result of the composition of our study 
population, as our study population consisted of hearing aid users who were familiar with 
payment for their hearing aid. 
In the discrete choice experiment (DCE) we found that willingness to accept (WTA) 
exceeded willingness to pay, similar to what was found in contingent valuation studies on 
a variety of subjects (Horowitz & McConnell, 2002; O'Brien et al., 2002). The disparity 
between WTA and WTP was of a magnitude to alter policy recommendations, as omitting 
the follow-up at the ENT-specialist would only be recommended when using a WTP format 
to elicit monetary valuations, and would not be recommended when using a WTA format 
for losers and a WTP format for gainers or only a WTA format. 
From the discrete choice experiment it was found that Dutch hearing-impaired persons are 
receptive to transferring elements of hearing aid provision from the medical sector to 
private hearing aid dispensers. In general, participants preferred that hearing aids would be 
provided with an initial assessment at the hearing aid dispenser with the same accuracy as 
at the ENT-specialist, a duration of two months, and a follow-up at the ENT-specialist to 
evaluate the hearing aid fitting. 
 
The third research question focused on whether shared care in hearing aid provision is 
efficient. We found that shared care in hearing aid provision results in both a cost 
reduction and a loss of quality adjusted life years (QALYs). Shared care becomes more 
favorable with increasing age, but for persons aged 85 there is still less than € 40 000 saved 
per QALY lost, which indicates that shared care is not cost-effective. However, 
considerable uncertainty surrounded the incremental cost-effectiveness ratios (ICERs). 
Given a ceiling ratio of € 40 000, there was a 54% probability that the referral pathway 
would be deemed cost-effective. Of the alternative shared care models, the triage pathway 
had the highest probability of being cost-effective (40%). It was found to be most valuable 
to perform additional research on whether shared care in hearing aid provision will lower 
barriers for help-seeking, and whether hearing aid dispensers are capable of distinguishing 
patients from clients. 
 
 General discussion 
139 
From the survey we found that persons aged 70 years and older, compared to persons 
under the age of 70, were more inclined to still visit the ENT-specialist or AC, even if this 
was not necessary for reimbursement of the hearing aid. This seems to contradict the 
findings of the discrete choice experiment, where older persons were found to have a 
stronger preference for the initial assessment at the dispenser as opposed to at the ENT-
specialist. This contradiction may result from the fact that the youngest participant in the 
discrete choice experiment was 18, while the youngest participant in the survey was 50 
years of age. Persons with hearing complaints who are under the age of 50 always need to 
see an ENT-specialist or AC, as their hearing loss is not only age-related and may be a 
symptom of a (treatable) medical condition. It is therefore not surprising that persons under 
the age of 50 stated that they wish to be examined by an ENT-specialist. Another possible 
explanation is the difference in question designs. In the survey respondents stated on a 
Likert scale whether they would still visit the ENT-specialist or AC, with no strings attached. 
On a Likert scale respondents make a choice that is not constrained, which may cause 
respondents to overstate their preferences (Ryan et al., 2001). In a discrete choice 
experiment the choice is constrained, as respondents make trade-offs between different 
attributes, which may well lead to different answers. It has been suggested that Likert scales 
are a useful technique for eliciting attitudes, but that conjoint analysis should be used to 
measure preferences (Phillips et al., 2002; Ryan et al., 2001). 
 
We can combine the results of the DCE and the cost-effectiveness analysis to do a 
straightforward cost-benefit analysis. Monetary values for the three alternative pathways of 
shared care in hearing aid provision in the cost-effectiveness analysis can be estimated with 
the results of the DCE. For the total direct pathway, assuming a four months shorter 
duration, hearing-impaired persons requested compensation of at least € 437, while it was 
found to save only € 37 per person as opposed to the current pathway. For the triage 
pathway, assuming a two months shorter duration, minimum compensation of € 227 was 
requested, while it was found to be € 5 more expensive than the current pathway. For the 
follow-up pathway, also assuming a two months shorter duration, compensation of at least 
€ 210 was requested, while saving only € 39 per person. As the resulting net benefits 
(benefits minus costs) are negative for all pathways, none should be implemented from a 
cost-benefit perspective. However, we need to emphasize that considerable uncertainty 
surrounded these costs. Besides, the cost-effectiveness analysis was based on the total 
population with hearing complaints, while the DCE included only the subpopulation of 
persons who seek help for their hearing complaints.  
An interesting finding when comparing the results of the DCE and the cost-effectiveness 
analysis is that the triage pathway, with only introducing the triage at the dispenser but 
maintaining the evaluation of the hearing aid fitting at the ENT-specialist or AC, is the 
pathway that is preferred by the patients as well as the shared care model that is most likely 
to be cost-effective.   
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Methodological considerations 
Some methodological considerations arise from the use of health technology assessment in 
evaluating shared care in hearing aid provision. 
First, it is questionable whether the Technology Assessment Iterative Loop (TAIL) is readily 
applicable to organizational innovations such as shared care in hearing aid provision. For 
example, organizational innovations need to be implemented in order to evaluate them. 
However, according to the loop a technology is not implemented until efficacy, 
community effectiveness and efficiency are proven. Also, according to the loop a trade-off 
between costs and consequences takes places only when efficacy and community 
effectiveness are proven. However, the use of decision-analytic modeling provides 
valuable information on the potential cost-effectiveness of the innovation, on how the 
innovation should be designed, and on which topics are most valuable for further research. 
Decision-analytical modeling therefore is a useful tool to examine efficiency in a very early 
stage, even before conclusive evidence on efficacy is available. 
As organizational innovations require agreements and cooperation among health care 
professionals, randomized trials are often not appropriate or even possible (Winkens & 
Klazinga, 2000). Pragmatic trials are probably more appropriate, as they allow for 
involvement of all parties and adjustments during the trial. However, this also involves 
some limitations. In our prospective study patients received usual care, with only an extra 
visit to the dispenser before the initial assessment at the ENT-specialist and AC. As patients 
were not randomized to separate arms and were not forced to a certain care pathway, a 
number of patients had their hearing aid fitted at dispensers not participating in the study, 
and were therefore lost to follow-up. Also, a number of patients had not finished their 
hearing aid trial before the end of the study. A less controlled study population results in a 
higher number of missing values and a more heterogenic study population. These 
limitations are among the risks of performing pragmatic research, but the advantage is that 
outcomes are probably more representative for the real world. 
Also, in evaluating organizational innovation researchers tend to play a double role, as 
they both evaluate and implement the innovation. This has limitations, as they may be 
biased towards the innovation, or towards professionals, but also has advantages, as they 
are involved in the innovation process and can directly take up practice and quickly adjust 
to events. While the latter is not important in traditional health technology assessment 
(HTA), it may be when using HTA in organizational innovations. This again indicates that 
the traditional form of HTA may be less appropriate to organizational innovation than it is 
to for example pharmaceutical research. Possibly aspects of constructive technology 
assessment could be used to adapt the traditional HTA to organizational innovation. One 
of the key aspects of constructive technology assessment is to shift the focus of TA away 
from assessing fully developed technologies, and introduce anticipation of technology 
impacts at an early stage in the development (Rip et al., 1995). Also, a key aspect of 
constructive TA is to provide a continuous dialogue between ‘potential or actual users of 
the technology, those who are affected by the technology and those who design and 
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promote the technology’. Possibly these aspects of constructive TA may well apply to HTA 
in organizational innovation. 
Modeling is always a simplification of a complex reality. Therefore, model assumptions 
need to be made. However, one should keep in mind that decision-analytic models are not 
intended to reveal scientific truth (Weinstein, 2006), but to guide decision-making. In 
modeling the efficiency of shared care in hearing aid provision, we assumed perfect 
implementation. It is however unclear whether patients and professionals will change their 
behavior if shared care in hearing aid provision would be implemented. Less than perfect 
implementation would reduce efficiency. Recently there has been growing interest in the 
value of investing in strategies to improve implementation, and whether one should invest 
in strategies to improve behavioral change. If shared care in hearing aid provision would 
be deemed efficient, it would be interesting to examine the value of perfect information, 
allowing for a trade-off between the costs and benefits of implementation strategies. 
Recently, frameworks were developed to calculate this value of perfect implementation 
(Fenwick et al., 2007; Hoomans et al., 2007). However, simply incorporating 
implementation parameters in the decision-analytic model may be a practicable alternative 
to separate frameworks in assessing the value of perfect implementation. 
Finally, monetary valuation is able to encompass much more than the traditional QALY. 
That is, underlying preferences not directly related to health, such as accessibility or 
satisfaction, are incorporated in the monetary value, while they are not incorporated in the 
QALY. Aspects of accessibility and satisfaction are important in organizational innovations, 
and the trade-off between these outcomes and the clinical outcome is interesting. 
Therefore, monetary valuation and the cost-benefit analysis may be more appropriate than 
cost-utility analysis in this field. As respondents are often not familiar with the innovation, 
and several alternative designs of the innovation exist, DCE may well be more appropriate 
than contingent valuation. That is, in a DCE respondents are not directly asked to state an 
amount of money, and monetary values can be calculated for various configurations of 
levels. However, a lot of controversy remains on whether and how a cost attribute should 
be included in a DCE to calculate monetary values for use in a cost-benefit analysis 
(Hanley et al., 2003; McIntosh, 2006; Ratcliffe, 2000; Slothuus Skjoldborg & Gyrd-Hansen, 
2003). 
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Recommendations 
Shared care in hearing aid provision is not yet broadly based among professionals who are 
involved in the care for hearing-impaired persons. Especially ENT-specialists and clinical 
audiologists stated potential risks and were somewhat reluctant to implement a shared care 
model. Their concerns regarding safety and efficiency are supported by the cost-
effectiveness analysis, which showed that more evidence is needed on whether private 
dispensers are capable of detecting pathology. The professionals are united in the 
conditions that need to be fulfilled for a successful implementation of shared care in 
hearing aid provision. It is important that these conditions are addressed in the design or 
implementation process of shared care in hearing aid provision. Another important aspect 
is that all parties should be involved in the design and implementation process of the 
innovation. In small regions it possibly is less difficult to create a basis of trust among the 
professionals involved. When the professionals and hearing-impaired persons make 
agreements on a regional level, they will get to know each other better. As a result this 
might improve their communication and their confidence in the other professionals’ 
capabilities. Implementation of shared care in hearing aid provision on a regional level is 
therefore recommended to best satisfy the stated conditions. 
Regarding outcome measurement, it is clear that health state utility scores heavily depend 
on the measure that is used to elicit them. The use of QALYs is often recommended in 
economic evaluations as it allows for comparison across different interventions and health 
care sectors (Drummond et al., 2005). However, the impact of different utility measures on 
the ICER for hearing aid fitting is of a magnitude that can alter policy decisions. Hence, 
comparisons of QALYs across studies and interventions should be interpreted with caution. 
We recommend that the HUI3 is the instrument of first choice when measuring utility in a 
population with hearing complaints, but we emphasize the importance of a clear notion of 
what constitutes utility with regard to economic analyses in health care. This seems to be 
especially important for organizational innovations, where health is not always the most 
obvious maximand. From the comparison of different question formats in contingent 
valuation, we recommend that in future WTP studies on hearing aids the open-ended 
question is used to directly elicit WTP values. This recommendation may also apply to 
other study settings where respondents are familiar with costs or payments for the 
intervention under evaluation. When eliciting monetary values in a DCE we recommend 
that a normative decision is made on whether the cost attribute should be defined as a 
payment or a discount to elicit monetary values. Until this normative decision is made, we 
recommend to choose the most conservative format, which is a payment (WTP) if (the 
majority of) respondents are potential gainers, and a discount (WTA) if (the majority of) 
respondents are potential losers. However, this may affect the flexibility of discrete choice 
experiments to calculate monetary values for different configurations of interest within a 
cost-benefit analysis. 
With regard to shared care in hearing aid provision, we do not recommend to implement 
shared care, in any form, just yet. As the value of further research on this topic greatly 
outweighs its costs, we recommend to first reduce some uncertainty, especially with regard 
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to whether shared care in hearing aid provision will increase help-seeking among persons 
with hearing complaints, and whether dispensers are capable of detecting pathology. 
Subgroup analyses showed that shared care in hearing aid provision becomes more 
efficient with increasing age. This corresponds to the fact that in the DCE older persons had 
a stronger preference for the initial assessment at the hearing aid dispenser. However, as 
the results of the survey indicated that older persons were more attached to the opinion of 
the medical specialist, shared care should not just be recommended for a subgroup of older 
persons without taking into account their preferences. 
 
Despite these recommendations, it is important to realize that in some regions of the 
Netherlands, a number of health insurance companies already permit a form of direct 
hearing aid provision by selected private dispensers. For example, some insurance 
companies and dispenser practices have made agreements that an evaluation of the 
hearing aid fitting by an ENT-specialist or AC is no longer needed for reimbursement. A 
few years ago policy makers in the Netherlands decided that the provision of medical aids 
should be deregulated. This would give insurance companies room for competition and 
would give patients room for choice by comparing the insurance companies. In the case of 
hearing aid provision, the insurance companies make use of the free rein they were given, 
by making agreements with hearing aid dispenser practices. It is however doubtful whether 
this benefits the care for hearing-impaired persons. The results of this thesis indicate that it 
is unlikely that the agreements that are currently being made are efficient, and hence 
market regulation seems to fail. However, agreements have been made and will probably 
not become undone. It is important that policy makers become aware of this consequence 
of the deregulation. They should attend to caution in the provision of hearing aids, and to 
quality standards with regard to existing and future agreements and careful evaluation of 
the agreements. 
 
Private hearing aid dispensers are not a legally protected professional group in the 
Netherlands. This means that anyone can call himself a private dispenser. When dispensers 
are going to be included in the shared care pathway, it is highly recommended that they 
develop a code of conduct, which should be guaranteed by a supervisory board and a 
conciliation board. The Dutch register foundation of hearing aid dispensers (Stichting 
Audicienregister, StAr) has formulated quality standards and keeps a register of hearing aid 
dispensers that fulfill these standards. Also, since January 2007 the foundation provides 
hearing aid dispenser practices that work according to the standards with a quality mark. In 
addition, the Comité Européen de Normalisation (CEN) has recently decided to formulate 
European quality standards to the work area and professional practice of hearing aid 
dispensers. These initiatives are important for the private dispensers to become a serious 
partner and to gain responsibility in the process of hearing aid provision. Moreover, such 
initiatives are needed to guarantee the quality and safety of shared care models in hearing 
aid provision. 
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In general, we believe that in the process of organizational innovations in health care, 
health technology assessment should occupy a more important place. It is rather surprising 
that the stringent rules for pharmaco-economic research do not apply to health services 
research. Each new drug needs conclusive evidence before it can be introduced to the 
market. In contrast, organizational innovations can be implemented without formal 
evidence, except with regard to tasks which are reserved to specific health care 
professionals by law. We believe that decision-making with regard to organizational 
innovation in health care should be based more on thorough evaluation by means of health 
technology assessment, thus facilitating evidence-based decision-making. This thesis 
provides a practical example of how this can be done. However, more work is needed to 
adapt health technology assessment to the field of organizational innovation. Possibly 
adapting some of the key issues of constructive technology assessment, such as a 
continuous dialogue between involved parties and assessment at an early stage, would 
make HTA more appropriate to organizational innovation. 
 
In conclusion, we recommend that in organizational innovations HTA should be applied 
from a very early stage. Decision-analytic modeling can be used to integrate all available 
evidence to inform the design process and the topics most valuable for further research. 
Also, all parties involved in the innovation, patients as well as professionals, should be 
involved in a very early stage to understand the important issues in the field and to involve 
them in the design process. Involvement in the design of the innovation will probably 
enhance the chances that the parties support the innovation and that the innovation fits the 
needs of these parties. Hence, early involvement facilitates the will of the parties to change 
their behavior when the innovation is implemented. Finally, the evidence that is obtained 
from health technology assessment should be used in decision-making with regard to 
organizational innovation, as is already practice for pharmaceutical and other strictly 
medical innovations. In order to make organizational innovations such as shared care in 
hearing aid provision beneficial to the care for hearing-impaired persons, it is important 
that they are evaluated appropriately. 
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Areas for future research 
Regarding outcome measurement, we emphasized the importance of a clear notion of what 
constitutes utility in economic evaluations in health care. An important area for future 
research is whether societies wish to, or should, maximize life expectancy corrected for 
health-related quality of life from a more functional perspective as in the EQ-5D, or from a 
‘within-the-skin’ perspective as in the HUI. Moreover, there is need for consensus with 
regard to the content of the evaluative space in economic evaluations in broader terms. 
Should QALYs remain the recommended outcome measure, or should we look broader 
than health outcomes alone, for example by using monetary values? The results from the 
contingent valuation study add to the limited evidence on the validity of direct willingness 
to pay measures to elicit monetary values. However, more evidence is needed on the 
validity of directly measuring willingness to pay and its elicitation formats. As patient 
preferences gain increasing attention in decision making (Bridges & Jones, 2007; Ryan, 
2004), and cost-benefit analyses may be more appropriate when evaluating organizational 
innovation, discrete choice experiments will probably become increasingly important in 
health services research. Discrete choice experimentation seems to be a feasible instrument 
to measure monetary values. However, more research is needed to address methodological 
issues regarding the inclusion of a cost attribute to elicit monetary valuations with a 
discrete choice experiment (Hanley et al., 2003; McIntosh, 2006; Ratcliffe, 2000; Slothuus 
Skjoldborg & Gyrd-Hansen, 2003). Specifically, more research is needed on why the 
disparity between WTA and WTP occurs in a discrete choice experiment, and on when to 
use a payment or a discount in the cost attribute. 
With regard to the safety and efficiency of shared care in hearing aid provision, more 
research is needed on whether hearing aid dispensers are capable of distinguishing 
between patients and clients. But even when it is found to be safe, shared care in hearing 
aid provision may only benefit the care for hearing-impaired persons when barriers towards 
help-seeking are lowered and, as a result, more hearing-impaired persons are appropriately 
fitted with hearing aids. Otherwise, there will be no health benefit but only a health loss for 
a small cost reduction. It is doubtful whether the latter would be deemed desirable by 
society. More research is therefore needed on whether shared care in hearing aid provision 
will actually cause persons to seek help for their hearing complaints sooner. 
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The increasing burden of chronic diseases on today’s health care system has resulted in an 
increased importance of redesigning health care to patient-centered care, and of attuning 
the tasks of health care professionals. With regard to hearing aid provision, the current 
growth of the ageing population causes a proportional growth of the population with 
hearing impairment. This raises the burden of disease and the medical consumption for 
hearing impairment and, as a consequence, increases the costs of hearing rehabilitation. 
Increasing attention is therefore paid to attuning the tasks of all professionals involved in 
the care for hearing-impaired persons. This has resulted in shared care initiatives in hearing 
aid provision, where some of the tasks of Ear, Nose and Throat (ENT) specialists and 
Audiological Centres are substituted to hearing aid dispensers. This would allow for direct 
hearing aid provision by dispensers, without prescription or approval of an ENT-specialist 
or Audiological Centre. 
Health technology assessment seeks to inform health policy makers by examining medical, 
social, ethical and economic implications of technologies in health care. Health 
technology assessment is an iterative process, and the assessment needs to continue 
throughout the life of a technology. This iterative process is illustrated by the Technology 
Assessment Iterative Loop. The aim of the thesis is to use health technology assessment to 
evaluate whether an organizational innovation, shared care in hearing aid provision, 
benefits the care for hearing-impaired persons. 
 
 
Part I 
The first part of this thesis focuses on barriers and facilitators with regard to the 
implementation of shared care in hearing aid provision in an early stage of an 
organizational innovation process, to become aware of which issues are of importance in 
the field, and to guide the design process of the innovation.  
In Chapter 2 we examined expectations and potential barriers and facilitators of hearing 
impaired persons and professionals involved in the care for hearing impaired persons, 
using a survey. On average general practitioners and hearing aid dispensers had positive 
expectations towards shared care in hearing aid provision, while ENT-specialists and 
clinical audiologists had negative expectations. Most professionals either supported 
implementation of shared care, provided that a number of conditions were satisfied, or did 
not support implementation, unless roughly the same conditions were satisfied. Persons 
with hearing complaints evaluated the current organization of hearing aid provision and 
shared care equally, and stated to have confidence in the trained hearing aid dispenser. 
Many, especially older, participants stated however that they would still visit the general 
practitioner and ENT-specialist, even when this would not be necessary for reimbursement 
of the hearing aid, and found it important that the ENT-specialist or Audiological Centre 
evaluated their hearing aid. Overall, Chapter 2 identified professional concerns about 
shared care in hearing aid provision. Gaps in expectations exist amongst professions, but 
also amongst hearing impaired persons, especially between age groups and regions. 
Implementation on a regional level is recommended to best satisfy the stated conditions. 
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Part II 
In the second part of this thesis different outcome measures for shared care in hearing aid 
provision are considered, both in terms of health state utilities and monetary valuations. 
In Chapter 3 utility scores were elicited in a population with hearing complaints, before 
and after hearing aid provision. Utility scores were elicited using the preference-based 
utility measures EuroQol 5D (EQ-5D), Health Utilities Index mark II (HUI2) and Health 
Utilities Index mark III (HUI3). These instruments differ in their underlying assumptions 
about what constitutes health state utility. Practicality, construct validity, agreement, 
responsiveness and impact on the incremental cost-effectiveness ratio for hearing aid fitting 
of the different measures were examined. Regarding practicality, all measures were found 
to have high completion rates. Both the EQ-5D and the HUI3 showed some evidence of 
construct validity. The HUI2 and HUI3 scores were found to be lower than the EQ-5D 
scores and agreement was moderate to poor. As to responsiveness, only the HUI2 and the 
HUI3 measured statistically significant improvement after hearing aid fitting, while the EQ-
5D did not capture this effect. The incremental cost-effectiveness ratios for hearing aid 
fitting varied from € 647 209 per Quality Adjusted Life Year (QALY) using the EQ-5D to € 
15 811 per QALY using the HUI3. The results of this study show that utility scores, utility 
gain and incremental cost-effectiveness ratios heavily depend on the measure that is used 
to elicit health state utility. Chapter 3 indicates HUI3 as the instrument of first choice when 
measuring utility in a population with hearing complaints, but emphasizes the importance 
of a clear notion of what constitutes health state utility with regard to economic analyses. 
Chapter 4 examined contingent valuation to elicit monetary values for hearing aid fitting. It 
provides additional evidence on the validity of two willingness to pay (WTP) elicitation 
formats: the open-ended question and the payment scale. We elicited WTP for a hearing 
aid among hearing aid users, using both a payment scale and an open-ended question. We 
compared the results from both formats, and tested criterion validity by comparing both 
formats with the actual out-of-pocket payment. Construct validity was tested by examining 
whether WTP was consistent with positive income elasticity. We found no statistically 
significant difference between the results on the payment scale and open-ended question. 
Both formats showed good criterion validity, although the open-ended question showed a 
stronger association with the actual out-of-pocket payment. The open-ended format 
showed better construct validity, as it was positively influenced by family income. The 
results of Chapter 4 indicate that the open-ended question was more valid than the 
payment scale question. We therefore recommend that in future WTP studies on hearing 
aids the open-ended question is used to directly elicit WTP values. The same 
recommendation may apply to other studies where respondents are familiar with costs or 
payments for the intervention under evaluation. 
Chapter 5 focused on the disparity between willingness to accept (WTA) and WTP in 
discrete choice experiments. Our main objective was to compare WTA and WTP in a 
discrete choice experiment on hearing aid provision. Additionally, income effect and 
endowment effect were explored as possible explanations for the disparity between WTA 
and WTP, and the impact of using a WTA and/or WTP format to elicit monetary valuations 
on the net benefit of shared care in hearing aid provision was examined. Persons with 
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hearing complaints randomly received a WTP (cost attribute defined as extra payment) or 
WTA (cost attribute defined as discount) version of the experiment. In the versions, except 
for the cost attribute, all choice sets were equal. The cost coefficient was found to be 
statistically significantly higher in the WTP format. Marginal WTA was statistically 
significantly higher than marginal WTP for two out of four attributes. The disparity between 
WTA and WTP was higher in the high educational (as proxy for income) group. We did not 
find proof of an experience endowment effect. Implementing a form of shared care in 
hearing aid provision would only be recommended when using WTP. From Chapter 5 it is 
clear that WTA exceeds WTP, also in a discrete choice experiment. As this affects 
monetary valuations, more research on when to use a payment or a discount in the cost 
attribute is needed before discrete choice results can be used in cost-benefit analyses. 
Chapter 6 elicited patient preferences for transferring elements of hearing aid provision 
from the medical sector (ENT-specialists and Audiological Centres) to hearing aid 
dispensers, to understand the trade-offs between different elements of hearing aid 
provision. Participants preferred the initial assessment at the hearing aid dispenser, higher 
accuracy in identifying persons in need of medical care, shorter duration of the total 
hearing aid provision, and a follow-up at the ENT-specialist. They required compensation 
of at least € 17 per two months extra duration, € 54 for an initial assessment at the ENT-
specialist, € 119 per 10% decrease in accuracy, and € 227 to forgo the follow-up at the 
ENT-specialist. Preferences were influenced by sex, age, educational level, and experience 
with hearing aid provision. From Chapter 6 it was found that hearing-impaired persons are 
receptive to transferring elements of hearing aid provision from the medical sector to 
dispensers. In the organization of hearing aid provision hearing-impaired persons prefer an 
initial assessment at a dispenser when the dispenser is at least 95% as accurate as the ENT-
specialist, and prefer a follow-up visit at the ENT-specialist. 
 
 
Part III 
The third part of this thesis integrates all available evidence in a decision-analytic model to 
make a trade-off between the benefits and risks of shared care in hearing aid provision. 
Chapter 7 describes the results of modeling the long-term cost-effectiveness of (different 
forms of) shared care as opposed to the current organization of hearing aid provision, for 
persons aged 50 years and older. The current organization of hearing aid provision as 
compared to shared care is somewhat more effective and somewhat more costly, and had a 
higher probability of being cost-effective (54%). Of the alternative forms of shared care, a 
pathway with an initial assessment at the hearing aid dispenser and a follow-up at the ENT-
specialist or Audiological Centre had the highest probability of being cost-effective (40%).  
It is worthwhile to perform additional research to reduce the uncertainty surrounding these 
results. Additional research is especially worthwhile on whether persons seek help for their 
hearing complaints sooner in a shared care pathway and whether the hearing aid dispenser 
is capable of detecting pathology.  
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In Chapter 8 the main findings of this thesis are summarized and discussed. Additionally, 
some methodological aspects are considered. First, it is questioned whether the 
Technology Assessment Iterative Loop is readily applicable to organizational innovations 
such as shared care in hearing aid provision. That is, organizational innovations often need 
implementation before they can be evaluated. Moreover, decision-analytical modeling 
turned out to be a useful tool to examine efficiency in a very early stage, even before 
conclusive evidence on efficacy is available. Next, randomized trials are rarely applicable 
to organizational innovations. Therefore pragmatic trials, which have limitations as well as 
advantages, are often more appropriate. Also, it is suggested that aspects of constructive 
technology assessment could be used to adapt the traditional health technology assessment 
to organizational innovation. These aspects are for example the introduction of technology 
assessment at a very early stage in the development of a technology, and a continuous 
dialogue between users of the technology. Finally, the fact that modeling is always a 
simplification of a complex reality, as well as the fact that monetary valuation is able to 
encompass much more than traditional quality adjusted life years and might therefore be 
more appropriate in evaluating organizational innovation, are considered.  
Furthermore a number of recommendations are made in Chapter 8. Besides the 
recommendations directly based on the results of the studies, it is recommended that 
hearing aid dispensers develop a code of conduct. Also, it is recommended that health 
technology assessment should occupy a more important place in the process of 
organizational innovation in health care. More specifically, it is recommended that in 
organizational innovations in health care, health technology assessment should be applied 
from a very early stage. 
Finally, areas for future research are discussed. These include consensus with regard to the 
evaluative space in economic evaluations in health care: should quality adjusted life years 
remain the recommended outcome measure, or is a broader view indicated? Additionally, 
more evidence is needed on the validity of directly measuring WTP, as well as on why the 
disparity between WTA and WTP occurs in a discrete choice experiment and when to use 
a discount or a payment in the cost attribute. Also, important areas for future research are 
whether hearing aid dispensers are capable of identifying patients in need of medical care, 
and on whether shared care in hearing aid provision will lower barriers for help-seeking. 
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Chronische ziekten oefenen een toenemende druk uit op het huidige gezondheidszorg-
systeem. Dit heeft ertoe geleid dat steeds meer belang wordt gehecht aan het herontwerpen 
van de gezondheidszorg tot patiëntgerichte zorg, en aan het onderling afstemmen van 
taken van professionals in de gezondheidszorg. De vergrijzing van de bevolking leidt tot 
een groeiend aantal slechthorenden. Dit verhoogt de ziektelast en medische consumptie 
met betrekking tot slechthorendheid, met stijgende kosten van gehoorrevalidatie als gevolg. 
Er wordt daarom steeds meer aandacht besteed aan het onderling afstemmen van de taken 
van alle betrokken beroepsbeoefenaren in de zorg voor slechthorenden. Zo is er steeds 
meer aandacht voor ketenzorg voor oudere slechthorenden, waarbij taken van Keel-, Neus- 
en Oorartsen en Audiologische Centra overgenomen worden door audiciens. Audiciens 
kunnen bij slechthorenden die geen medische zorg nodig hebben dan direct een 
hoortoestel aanpassen. 
Health technology assessment is een manier om nieuwe technologieën in de 
gezondheidszorg (uiteenlopend van medicijnen tot organisatieveranderingen) te evalueren. 
Het onderzoekt de medische, sociale, ethische en economische implicaties van 
technologieën en is gericht op besluitvorming. Health technology assessment is een 
iteratief proces, dat gedurende het gehele leven van een technologie dient te worden 
voortgezet. Dit iteratieve proces wordt geïllustreerd door de Technology Assessment 
Iterative Loop. Het doel van dit proefschrift is om door middel van health technology 
assessment te evalueren of ketenzorg in de hoortoestelverstrekking bevorderlijk is voor de 
zorg voor slechthorenden. 
 
 
Deel I 
Het eerste deel van dit proefschrift richt zich op belemmerende en bevorderende factoren 
bij het implementeren van ketenzorg in de hoortoestelverstrekking. Door deze factoren in 
een vroeg stadium van een organisatievernieuwingsproces te verkennen kan inzicht 
verkregen worden in wat er speelt in het veld, en kan de ontwikkeling van de vernieuwing 
gestuurd worden.  
In Hoofdstuk 2 onderzochten we verwachtingen en potentiële belemmerende en 
bevorderende factoren bij slechthorenden en beroepsbeoefenaren betrokken bij de zorg 
voor slechthorenden, door middel van een survey. Over het algemeen hadden huisartsen 
en audiciens positieve verwachtingen van ketenzorg in de hoortoestelverstrekking, terwijl 
KNO-artsen en audiologen negatieve verwachtingen hadden. De meeste beroeps-
beoefenaren gaven aan wel achter implementatie van de ketenzorg te staan, mits aan 
bepaalde voorwaarden werd voldaan, of niet achter implementatie te staan tenzij aan 
ongeveer dezelfde voorwaarden werd voldaan. Slechthorenden beoordeelden de huidige 
zorg voor slechthorenden en ketenzorg als gelijkwaardig, en gaven aan vertrouwen te 
hebben in de bijgeschoolde audicien. Veel, met name oudere, respondenten gaven echter 
aan dat ze ook naar de huisarts en KNO-arts zouden gaan als dat niet nodig zou zijn voor 
vergoeding van het hoortoestel. Zij vonden het belangrijk dat hun hoortoestelaanpassing 
werd geëvalueerd door een KNO-arts of een Audiologisch Centrum. Uit Hoofdstuk 2 bleek 
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over het algemeen dat er bij de verschillende beroepsgroepen bedenkingen bestaan over 
ketenzorg in de hoortoestelverstrekking. Verschillen in verwachtingen bestaan tussen de 
beroepsgroepen, maar ook tussen de slechthorenden zelf, met name tussen verschillende 
leeftijdsgroepen en regio’s. Implementatie op regionaal niveau wordt aanbevolen om het 
beste aan de genoemde voorwaarden te kunnen voldoen. 
 
 
Deel II 
In het tweede deel van dit proefschrift worden verschillende uitkomstmaten voor ketenzorg 
in de hoortoestelverstrekking in beschouwing genomen, zowel in termen van utiliteiten als 
monetaire waarderingen.  
In Hoofdstuk 3 zijn utiliteitsscores gemeten in een populatie met gehoorklachten, voor en 
na hoortoestelaanpassing. Utiliteitsscores werden gemeten met de utiliteitsinstrumenten 
EuroQol 5D (EQ-5D), Health Utilities Index mark II (HUI2) en Health Utilities Index mark 
III (HUI3). Deze instrumenten verschillen in hun veronderstellingen over hoe een utiliteit 
gevormd wordt. De bruikbaarheid, constructvaliditeit, overeenstemming, responsiviteit en 
de impact op de incrementele kosteneffectiviteitsratio van hoortoestelaanpassing van de 
verschillende meetinstrumenten werd onderzocht. Met betrekking tot de bruikbaarheid 
bleken de meetinstrumenten allemaal goed ingevuld te worden. Zowel de EQ-5D als de 
HUI3 vertoonden tekenen van constructvaliditeit. De HUI2 en HUI3 scores waren lager 
dan de EQ-5D scores, en de overeenstemming was redelijk tot slecht. Wat de responsiviteit 
betreft vonden alleen de HUI2 en HUI3 een statistisch significante verbetering na 
hoortoestelaanpassing, terwijl dit effect met de EQ-5D niet werd gevonden. De 
incrementele kosteneffectiviteitsratio’s varieerden van € 647 209 per voor kwaliteit gecorri-
geerd levensjaar met de EQ-5D tot € 15 811 per voor kwaliteit gecorrigeerd levensjaar met 
de HUI3. De resultaten van deze studie tonen aan dat utiliteitsscores, utiliteitswinst en 
incrementele kosteneffectiviteitsratio’s sterk afhankelijk zijn van het meetinstrument dat 
gebruikt is om de utiliteiten te meten. Hoofdstuk 3 wijst de HUI3 aan als instrument van 
voorkeur voor het meten van utiliteiten in een populatie met gehoorklachten, maar 
benadrukt het belang van een duidelijk begrip over wat, met betrekking tot economische 
analyses, een utiliteit vormt. 
Hoofdstuk 4 onderzocht de contingent valuation methode om monetaire waarderingen te 
meten. Het hoofdstuk verschaft aanvullend bewijs met betrekking tot de validiteit van twee 
manieren om willingness to pay (WTP; bereidheid te betalen) te meten: de open vraag en 
een lijst met geldbedragen, de zogenoemde payment scale. We onderzochten de WTP 
voor een hoortoestel bij hoortoestelgebruikers, met zowel de open vraag als de payment 
scale. We hebben de resultaten van beide methoden vergeleken, en hebben de criterium-
validiteit getest door beide te vergelijken met de eigen bijdrage die hoortoestelgebruikers 
daadwerkelijk voor hun hoortoestel betaald hadden. Constructvaliditeit werd getoetst door 
te onderzoeken of de WTP consistent is met de positieve inkomenselasticiteit. We vonden 
geen statistisch significant verschil tussen de resultaten van de open vraag en de payment 
scale. Beide methoden vertoonden goede criteriumvaliditeit, hoewel de open vraag een 
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sterker verband liet zien met de daadwerkelijke eigen bijdrage. De open vraag had een 
betere constructvaliditeit, aangezien deze positief beïnvloed werd door inkomen. De 
resultaten van Hoofdstuk 4 wijzen erop dat de open vraag meer valide is dan de payment 
scale. Daarom bevelen we aan om in toekomstige WTP-studies naar hoortoestellen de 
open vraag te gebruiken om direct WTP-waarden te meten. Deze aanbeveling zou ook van 
toepassing kunnen zijn op andere studies waar respondenten bekend zijn met kosten of 
betalingen voor de interventie die geëvalueerd wordt. 
Hoofdstuk 5 richtte zich op de ongelijkheid tussen willingness to accept (WTA; bereidheid 
te accepteren) en WTP in keuze-experimenten. Ons belangrijkste doel was het vergelijken 
van WTA en WTP in een keuze-experiment met betrekking tot de hoortoestelverstrekking. 
Daarnaast werden inkomenseffect en bezitsneiging (endowment effect) onderzocht als 
mogelijke verklaringen voor de ongelijkheid tussen WTA en WTP. Ook werd de impact 
van het gebruik van een WTA en/of WTP format om monetaire waarden te verkrijgen op de 
netto baten van ketenzorg in de hoortoestelverstrekking onderzocht. Mensen met klachten 
van slechthorendheid kregen willekeurig een WTA (kostenattribuut gedefinieerd als een 
korting op het hoortoestel) of een WTP (kostenattribuut gedefinieerd als extra kosten voor 
het hoortoestel) versie van het experiment. In de twee versies waren behalve het 
kostenattribuut alle keuzesets gelijk. De regressie-coëfficiënt van het kostenattribuut bleek 
statistisch significant hoger in de WTP versie dan in de WTA versie. Marginale WTA was 
statistisch significant hoger dan marginale WTP voor twee van de vier attributen. Het 
verschil tussen WTA en WTP was groter in de groep mensen met een hoger opleidings-
niveau (als proxy voor inkomen). We vonden geen bewijs voor bezitsneiging in de vorm 
van een ervaringseffect. Het implementeren van ketenzorg in de hoortoestelverstrekking 
zou alleen aanbevolen worden wanneer gebruik gemaakt werd van de resultaten van het 
WTP format. Uit Hoofdstuk 5 blijkt duidelijk dat WTA hoger is dan WTP, ook in keuze-
experimenten. Aangezien dit de monetaire waarderingen beïnvloedt is er meer onderzoek 
nodig naar wanneer kortingen of extra kosten gebruikt moeten worden in het 
kostenattribuut, voordat de resultaten van keuze-experimenten gebruikt kunnen worden in 
kosten-baten analyses. 
Hoofdstuk 6 onderzocht de voorkeuren van patiënten voor het overhevelen van aspecten 
van hoortoestelverstrekking van de medische sector (KNO-artsen en Audiologische Centra) 
naar audiciens, om inzicht te krijgen in de afwegingen van patiënten tussen verschillende 
aspecten van hoortoestelverstrekking. Respondenten hadden een voorkeur voor het eerste 
bezoek (de triage) bij de audicien, een hogere nauwkeurigheid bij het identificeren van 
mensen die medische zorg nodig hebben, een kortere duur van het totale proces van 
hoortoestelverstrekking en een eindcontrole bij de KNO-arts. Ze wilden een compensatie 
van minimaal € 17 per twee maanden langere duur van het proces, € 54 voor het eerste 
bezoek bij de KNO-arts, € 119 per 10% minder nauwkeurigheid en wilden een 
compensatie van € 227 als ze de eindcontrole bij de KNO-arts zouden verliezen. 
Voorkeuren werden beïnvloed door geslacht, leeftijd, opleidingsniveau en ervaring met de 
hoortoestelverstrekking. Uit Hoofdstuk 6 blijkt dat slechthorenden open staan voor het 
overhevelen van aspecten van hoortoestelverstrekking van de medische sector naar 
audiciens. In de organisatie van hoortoestelverstrekking hebben slechthorenden een 
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voorkeur voor een triage bij de audicien als deze minimaal 95% nauwkeurig is, alsmede 
voor een eindcontrole bij de KNO-arts. 
 
 
Deel III 
Het derde deel van dit proefschrift integreert al het beschikbare bewijs in een beslismodel, 
om een afweging te maken tussen de voordelen en risico’s van ketenzorg in de 
hoortoestelverstrekking.  
Hoofdstuk 7 beschrijft de resultaten van het modelleren van de lange termijn 
kosteneffectiviteit van (verschillende vormen van) ketenzorg ten opzichte van de huidige 
organisatie van hoortoestelverstrekking, voor personen van 50 jaar en ouder. 
Hoortoestelverstrekking in de huidige vorm bleek iets effectiever en iets duurder dan 
ketenzorg, en had een grotere kans om kosteneffectief te zijn (54%). Van de alternatieve 
vormen van ketenzorg had een zorgmodel met een triage bij de audicien en een 
eindcontrole bij de KNO-arts of het Audiologisch Centrum de grootste kans om 
kosteneffectief te zijn (40%). Het is lonend om aanvullend onderzoek te doen om de 
onzekerheid omtrent deze resultaten te verminderen. Het is met name waardevol om te 
onderzoeken of mensen eerder hulp zoeken voor hun gehoorklachten als ze daarvoor 
direct bij de audicien terecht kunnen, en of de audicien in staat is om pathologie te 
detecteren. 
 
In Hoofdstuk 8 worden de belangrijkste resultaten van dit proefschrift samengevat en 
bediscussieerd. Daarnaast worden enkele methodologische aspecten in beschouwing 
genomen. Eerst wordt de vraag gesteld of de Technology Assessment Iterative Loop direct 
bruikbaar is bij organisatievernieuwingen zoals ketenzorg in de hoortoestelverstrekking. 
Organisatievernieuwingen dienen namelijk geïmplementeerd te worden om ze te kunnen 
evalueren. Daarnaast bleek het besliskundig modelleren een bruikbaar instrument voor het 
evalueren van doelmatigheid in een zeer vroeg stadium, zelfs voordat overtuigend bewijs 
betreffende de werkzaamheid voorhanden is. Ten tweede zijn gerandomiseerde 
onderzoeken met controlegroep vaak niet toepasbaar bij organisatievernieuwingen. 
Pragmatische onderzoeken, die zowel voordelen als nadelen hebben ten opzichte van 
gerandomiseerde onderzoeken, zijn daarom vaak meer geschikt. Ten derde wordt in 
overweging gegeven dat aspecten van constructive technology assessment gebruikt zouden 
kunnen worden om het traditionele health technology assessment geschikt te maken voor 
organisatievernieuwingen. Deze aspecten zijn bijvoorbeeld het introduceren van 
technology assessment in een zeer vroeg stadium in de ontwikkeling van een technologie, 
en een continue dialoog tussen gebruikers van de technologie. Tenslotte wordt ingegaan 
op het feit dat modelleren altijd een simplificatie van de werkelijkheid is, en dat monetaire 
waarderingen zoveel meer kunnen bevatten dan de traditionele voor kwaliteit 
gecorrigeerde levensjaren, en daarom wel eens geschikter zouden kunnen zijn voor het 
evalueren van organisatievernieuwingen.  
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Vervolgens worden een aantal aanbevelingen gedaan in Hoofdstuk 8. Naast de 
aanbevelingen die direct volgen uit de resultaten van de studies, wordt aanbevolen dat 
audiciens een gedragscode ontwikkelen. Ook wordt aanbevolen dat health technology 
assessment een meer prominente plek inneemt in het proces van organisatievernieuwing in 
de gezondheidszorg. Meer specifiek wordt aanbevolen dat bij organisatievernieuwingen in 
de gezondheidszorg health technology assessment al in een zeer vroeg stadium ingezet 
wordt. 
Tenslotte worden aanbevelingen gedaan voor toekomstig onderzoek. Zo wordt aangegeven 
dat er consensus zou moeten komen over de uitkomstmaat in economische evaluaties in 
de gezondheidszorg: dienen voor kwaliteit gecorrigeerde levensjaren de aanbevolen 
uitkomstmaat te blijven, of is een bredere visie wellicht relevanter? Daarnaast is meer 
onderzoek nodig naar de validiteit van het direct meten van WTP. Meer onderzoek is ook 
nodig naar de vragen waarom het verschil tussen WTA en WTP zich voordoet in een 
keuze-experiment, en wanneer men kortingen of extra kosten dient te gebruiken in het 
kostenattribuut. Andere belangrijke gebieden voor verder onderzoek zijn de vragen of 
audiciens in staat zijn om patiënten die medische zorg nodig hebben te identificeren, en of 
ketenzorg in de hoortoestelverstrekking de drempel om hulp te zoeken voor 
gehoorklachten zal verlagen.  
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Dit proefschrift gaat over ketenzorg, over interdisciplinair werken. Het ultieme voorbeeld 
van een succesvol interdisciplinair samenwerkingsverband zijn mijn co-promotoren: 
Lucien Anteunis, Frans van der Horst en Manuela Joore. Ik besef me goed hoeveel geluk ik 
heb gehad dat ik werd begeleid door deze klinisch fysicus audioloog, medisch socioloog 
en HTA-onderzoeker. Bedankt dat jullie me deze kans hebben gegeven, voor alles wat ik 
van jullie heb geleerd en voor jullie vertrouwen in mij. Jullie zijn de belangrijkste reden dat 
ik dit proefschrift met zoveel plezier heb geschreven. 
Manuela, omdat je op dezelfde afdeling zat als ik was jij meestal mijn eerste 
aanspreekpunt bij problemen of vragen. Jij hebt dus de meeste last van me gehad, maar 
daar staat tegenover dat ik geweldig veel van je heb geleerd. Bedankt dat ik altijd bij je kon 
binnenlopen. Je zit boordevol ideeën en ik weet dat ik nog heel veel van je kan leren, dus 
wat mij betreft blijven we nog lange tijd samenwerken! Lucien, je bent een inspirerend en 
motiverend, maar bovenal ook een heel prettig persoon. Bedankt dat je er voor me was, 
tijdens onze bijeenkomsten, als ik weer eens bij je kwam binnenvallen of in de auto na een 
vergadering. Vier jaar geleden hebben we na een erg gezellig etentje bij jou thuis 
afgesproken dat we dat na elk hoofdstuk van mijn boekje over zouden doen: de eerste is 
nu in ieder geval van mij! Frans, ik vond het erg prettig, maar ook heel bijzonder om met je 
samen te werken. Je humor, maar ook je kijk op het leven draagt daar voor een groot deel 
aan bij. Je bent sociaal heel sterk, wat belangrijk was voor een project als AZOS, maar ook 
voor mij persoonlijk. 
 
Prof. dr. Manni, bedankt dat u mijn promotor wilde zijn, bedankt voor uw steun en met 
name voor uw grote vertrouwen in het team. 
 
De leden van de beoordelingscommissie, te weten voorzitter prof. dr. B. Kremer, prof. dr. 
W.N.J. Groot, prof. dr. J.L. Severens, prof. dr. ir. A.F.M. Snik en dr. T. van der Weijden, wil 
ik van harte bedanken voor het beoordelen van dit proefschrift. 
 
Mijn proefschrift had niet bestaan zonder al die bereidwillige en geduldige slechthorenden, 
audiciens, huisartsen, KNO-artsen en audiologen die vragenlijsten wilden invullen, 
geweldig bedankt daarvoor. 
 
Aan de basis van dit proefschrift stond het AZOS-project. In het bijzonder wil ik daar Silvia 
Bours voor bedanken, die bergen werk heeft verzet voor het project en die er, naar mijn 
bescheiden mening, hoogstpersoonlijk voor heeft gezorgd dat Maastricht verreweg de 
meeste patiënten heeft geïncludeerd. Daarnaast bedank ik natuurlijk ook onze 
projectgroep, te weten Wout Dreschler, Hans Verschuure, Nienke Homans, Monique 
Boymans, Bas Franck, Arjo Rozeboom en Mariëlle Stokdijk. Ook wil ik de leden van het 
Nationaal Overleg Audiologische Hulpmiddelen, alsmede de afdeling KNO en het 
Audiologisch Centrum in Maastricht bedanken voor alles wat zij voor het project hebben 
gedaan. Het AZOS project was nooit wat geworden zonder de deelnemende audiciens, in 
het bijzonder Jos Bosch, Carlo Habets en Peter Reiters. Ontzettend bedankt voor jullie 
tomeloze inzet, maar zeker ook voor jullie enthousiasme en gezelligheid. 
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Twee hoofdstukken van dit proefschrift zijn het resultaat van een ander project dat we 
hebben gedaan. Jolien en Judy, hartstikke bedankt voor al het werk dat jullie hebben verzet 
en het geduld dat jullie hebben gehad. Ook wil ik iedereen van Hans Anders Maastricht, 
Beter Horen Maastricht en Streukens Heerlen en Maastricht bedanken voor hun 
medewerking. 
 
De artikelen in dit proefschrift heb ik uiteraard niet alleen geschreven. Ik ben dan ook erg 
dankbaar voor de hulp van alle co-auteurs. Fons, Carmen en Debby, bedankt voor jullie 
hulp bij het discrete choice experiment. Fons, om maar even wat psychologen-statistiek te 
gebruiken: zonder jou waren hoofdstuk 5 en 6 statistisch significant minder valide (en leuk 
om te schrijven) geweest (p-value 0.001). Mickey, ook jij bedankt voor je hulp bij de 
statistiek, en bij de Engelse taal. Maar ook voor je interesse, hoe druk je het zelf ook had. 
Professor Davis, Adrian, thanks for your help on chapter 6. Hopefully this is the start of a 
fruitful Maastricht-Manchester cooperation! Robert Stokroos, bedankt voor je hulp bij 
hoofdstuk 7. Jan Duijvestijn, bedankt dat ik je data mocht gebruiken voor het laatste artikel 
en veel succes met jouw eigen boekje. Harry Streukens, bedankt voor je enthousiasme en 
je hulp bij de studies in dit proefschrift. 
 
Uiteraard wil ik al mijn collega’s bedanken. Zowel bij KEMTA als bij het AC en de MTA-
club had ik collega’s die altijd bereid waren me te helpen en het werk vele malen leuker 
maakten. Speciaal wil ik daarvoor Daniëlle bedanken, voor alles, maar ook Irene, Ester en 
Edith, die in de afgelopen jaren zo ontzettend veel voor mij geregeld hebben. 
 
Anita en Susanne, super bedankt dat jullie er voor me zijn, niet alleen nu als paranimf, 
maar altijd. Bianca, bedankt voor je hulp bij het ontwerpen van de kaft van mijn boekje. 
 
Tenslotte denk ik dat een lieve, grappige, relativerende, geïnteresseerde en begripvolle 
superheld (met een drukke baan), collega’s die in hetzelfde schuitje zitten, collega’s om 
mee te squashen, wandelen of lunchen, een fantastische en flexibele baas, maar ook lieve, 
geïnteresseerde en voor de nodige ontspanning zorgende ouders, broers, schoonouders, 
ooms (THX MCHL!), nichies, vrienden en familie essentieel zijn om het afronden van je 
proefschrift in combinatie met een nieuwe baan te overleven. Dankzij jullie heb ik het 
gered, en hopelijk hebben jullie genoten van de rust, want vanaf nu heb ik eindelijk weer 
tijd voor jullie! 
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Janneke Grutters was born on March 30, 1980, in Rijkevoort, the Netherlands. She 
attended primary school at De Klimop in Rijkevoort and secondary school at the Elzendaal 
College in Boxmeer. After graduation she studied Health Sciences at the University of 
Maastricht, with specialization Work & Health, which she finished in 2002. 
In 2003 she started as a research assistant at the University Hospital Maastricht, with the 
departments of Otolaryngology, Head & Neck Surgery and Clinical Epidemiology & 
Medical Technology Assessment. Here she worked on a project regarding the social impact 
of not reimbursing hearing aids. Later that year she started a new project at the same 
departments. In this AZOS (Aangepast ZOrgmodel Slechthorendheid) project she was 
involved as researcher. The AZOS project was a collaboration between the University 
Hospital Maastricht, the Amsterdam Medical Centre and the Erasmus Medical Centre in 
Rotterdam. After finishing the project in 2006 she has performed additional research 
regarding the organization of hearing aid provision. Since May 2007 Janneke works as a 
post doc researcher at MAASTRO clinic in Maastricht, where she evaluates the cost-
effectiveness of radiotherapy with particles (protons and carbon-ions) in the treatment of 
lung cancer. 
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But if the world could remain 
within a frame 
like a painting on a wall. 
Then I think we would see the beauty. 
Then we would stand staring in awe 
 
at our still lives posed 
like a bowl of oranges 
like a story told 
by the fault lines and the soil. 
 
Bright Eyes, Bowl of Oranges (Lifted, or the story is in the soil, keep your ear to the ground) 
